id,generic_name,company_name,contact_info,presentation,update_type,update_date,availability,related_info,resolved_note,reason_for_shortage,therapeutic_category,status,change_date,date_discontinued
1,Abciximab (ReoPro) Injection,"Janssen Biotech, Inc.",800-586-7736,2mg/mL (NDC 57894-200-01),Revised,8/15/19,,Janssen has made a business decision to discontinue manufacture of the drug product.,,,Cardiovascular,To be Discontinued,8/15/19,8/15/19
2,Acarbose (Precose) Tablets,Bayer,888-842-2937,Bottles of 100 Tablets 25 mg (NDC 50419-863-51),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
3,Acarbose (Precose) Tablets,Bayer,888-842-2937,Bottles of 100 Tablets 50 mg (NDC 50419-861-51),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
4,Acarbose (Precose) Tablets,Bayer,888-842-2937,Bottles of 100 Tablets 100 mg (NDC 50419-862-51),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
5,Acarbose (Precose) Tablets,Bayer,888-842-2937,Unit Dose 50 mg (NDC 50419-861-48),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Endocrinology/Metabolism,To be Discontinued,2/1/19,2/1/19
6,Acyclovir (Zovirax) Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Acyclovir (Zovirax) 200mg Capsules 100s (NDC 40076-991-55),New,12/21/18,,,,,Anti-Infective,To be Discontinued,12/21/18,12/21/18
7,Acyclovir (Zovirax) Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Acyclovir (Zovirax) 400mg Tablets 100s (NDC 40076-949-55),New,12/21/18,,,,,Anti-Infective,To be Discontinued,12/21/18,12/21/18
8,Acyclovir (Zovirax) Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Acyclovir (Zovirax) 800mg Tablets 100s (NDC 40076-945-55),New,12/21/18,,,,,Anti-Infective,To be Discontinued,12/21/18,12/21/18
9,"Acyclovir Capsules, USP",Teva Pharmaceuticals,800-545-8800,"200 mg, 100 count (NDC 0093-8940-01)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
10,"Acyclovir Capsules, USP",Teva Pharmaceuticals,800-545-8800,"200 mg, 500 count (NDC 0093-8940-05)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
11,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"400 mg, 100 count (NDC 0093-8943-01)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
12,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"400 mg, 500 count (NDC 0093-8943-05)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
13,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"800 mg, 100 count (NDC 0093-8947-01)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
14,"Acyclovir Tablets, USP",Teva Pharmaceuticals,800-545-8800,"800 mg, 500 count, (NDC 0093-8947-05)",New,3/21/19,,Teva made a business decision to discontinue product.,,,Antiviral,To be Discontinued,3/21/19,3/21/19
15,Albuterol Sulfate and Ipratropium Bromide Inhalation Solution,Teva Pharmaceuticals,800-545-8800,0.3 mg mg/3 mL and 0.5 mg/3 mL (NDC 0591-3817-39),New,7/3/19,,This product discontinuation is a business related decision.,,,Pulmonary/Allergy,To be Discontinued,7/3/19,7/3/19
16,Alogliptin Tablets,Perrigo Company PLC,269-673-8451,"12.5mg, 30 Tablets (NDC 45802-0103-65)",Revised,12/10/19,On backorder – expected release the week of late December/early January,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
17,Alogliptin Tablets,Perrigo Company PLC,269-673-8451,"25mg, 30 Tablets (NDC 45802-0150-65)",Revised,12/10/19,On backorder – expected release the week of 12/16/2019,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
18,Alogliptin Tablets,Perrigo Company PLC,269-673-8451,"6.25mg, 30 Tablets (NDC 45802-0087-65)",Revised,12/10/19,On backorder – expected release the week of 01/27/2020,,,Demand increase for the drug,Endocrinology/Metabolism,Current,,
19,Alogliptin Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,"6.25 mg, 30 Tablets (NDC 64764-625-30)",New,8/15/19,Product available.,,,,Endocrinology/Metabolism,Current,,
20,Alogliptin Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,"12.5 mg, 30 Tablets (NDC 64764-125-30)",New,8/15/19,Product available.,,,,Endocrinology/Metabolism,Current,,
21,Alogliptin Tablets,Takeda Pharmaceuticals USA Inc.,877-825-3327,"25 mg, 30 Tablets (NDC 64764-250-30)",New,8/15/19,Product available.,,,,Endocrinology/Metabolism,Current,,
22,Amino Acids,B. Braun Medical Inc.,800-227-2862,"15% Amino Acid (Plenamine) Pharmacy Bulk Package in 1,000 mL plastic container, catalog S4500, (NDC 0264-4500-00)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
23,Amino Acids,B. Braun Medical Inc.,800-227-2862,"15% Amino Acid (Plenamine) in 1,000mL glass container, catalog S3200-SS, (NDC 0264-3200-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,9/24/19
24,Amino Acids,B. Braun Medical Inc.,800-227-2862,"10% FreAmine III (Amino Acid Injection) in 1,000mL glass container, catalog S9010-SS, (NDC 0264-9010-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
25,Amino Acids,B. Braun Medical Inc.,800-227-2862,"TrophAmine (10% Amino Acid Injection) in 500mL glass container, catalog S9341-SS, (NDC 0264-9341-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
26,Amino Acids,B. Braun Medical Inc.,800-227-2862,"TrophAmine (6% Amino Acid Injection) in 500mL glass container, catalog S9361-SS, (NDC 0264-9361-55)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
27,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN™-PF 7%, Sulfite-Free, 500 mL (NDC 0409-4178-03)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
28,Amino Acids,"ICU Medical, Inc.",877-946-7747,"AMINOSYN II 10%, Sulfite-Free, (Pediatric Formula) 1000 mL (NDC 0409-4179-05)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
29,Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 10% Sulfite-Free BLK PK 2000 mL (NDC 0409-7172-17),Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
30,Amino Acids,"ICU Medical, Inc.",877-946-7747,Aminosyn II 15% Sulfite-Free BLK PK 2000 mL (NDC 0409-7171-17),Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
31,Amino Acids,Baxter Healthcare,888-229-0001,"PREMASOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Codes: 2B0009 10% 1000 mL (NDC 0338-1130-04), 2B0010 10% 2000 mL (NDC 0338-1130-06),
2B0012 10% 500 mL (NDC 0338-1130-03)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
32,Amino Acids,Baxter Healthcare,888-229-0001,"10% TRAVASOL (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Codes: 1B6624 10% 1000 mL (NDC 0338-0644-04),
1B6623 10% 500 mL (NDC 0338-0644-03),
1B6626P 10% 2000 mL (NDC 0338-0644-06)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
33,Amino Acids,Baxter Healthcare,888-229-0001,"15% CLINISOL - sulfite-free (Amino Acid) Injection in VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Codes: 2B6189 15% 2000 mL (NDC 0338-0502-06), 2B6187 15% 500 mL (NDC 0338-0502-03)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
34,Amino Acids,Baxter Healthcare,888-229-0001,"20% PROSOL - sulfite-free (Amino Acid) Injection, 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package. Not for Direct Infusion.  Product Code 2B6186 (NDC 0338-0499-06)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
35,Amino Acids,Baxter Healthcare,888-229-0001,CLINIMIX E sulfite-free (Amino Acid with Electrolytes in Dextrose with Calcium) Injection in CLARITY Dual Chamber Container,Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
36,Amino Acids,Baxter Healthcare,888-229-0001,CLINIMIX sulfite-free (Amino Acid in Dextrose) Injection in CLARITY Dual Chamber Container,Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
37,Amino Acids,Baxter Healthcare,888-229-0001,SYNTHAMIN 17 without Electrolytes - 10% Amino Acids Intravenous Infusion 3000 mL. Product code FKB6642.  Pack factor 3  (NDC 0338-9575-03),Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
38,Amino Acids,Baxter Healthcare,888-229-0001,"CLINIMIX N9G15E-Solution for Infusion, 1000 mL (2.75% Amino Acid in 7.5% Glucose with Electrolytes). Product code FKB6669C - Pack factor of 8 (NDC 0338-9570-08)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
39,Amino Acids,Baxter Healthcare,888-229-0001,"CLINIMIX N9G20E-Solution for Infusion, 1000 mL  (2.75% Amino Acid in 10% Glucose with Electrolytes) Product code FKB6670C - Pack factor of 8 
(NDC 0338-9566-08)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
40,Amino Acids,Baxter Healthcare,888-229-0001,"CLINIMIX N14G30E-Solution for Infusion, 2000 mL (4.25% Amino Acid in 15% Dextrose with Electrolytes) Product code FKB6654V - Pack factor of 4 (NDC 0338-9587-04)",Revised,9/24/19,,,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,9/24/19,
41,"Aminophylline Injection, USP","Hospira, Inc.",844-646-4398,250 mg/10mL (25 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-5921-01),Reverified,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Pulmonary/Allergy,Current,,
42,"Aminophylline Injection, USP","Hospira, Inc.",844-646-4398,500 mg/20mL (25 mg/mL) Single Dose Glass Fliptop Vial (NDC 0409-5922-01),Reverified,12/20/19,Available,,,Other,Pulmonary/Allergy,Current,,
43,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 60 count bottle (NDC 0185-0144-60)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
44,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 90 count bottle (NDC 0185-0144-09)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
45,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 200 mg, 500 count bottle (NDC 0185-0144-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
46,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 500 count bottle (NDC 0245-0145-15)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
47,Amiodarone Tablets,Sandoz,800-525-8747,"Amiodarone hydrochloride tablets, 400 mg, 30 count bottle (NDC 0245-0145-30)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Amiodarone HCl Tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
48,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-2610-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
49,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 1000 count bottle (NDC 0378-2610-10)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
50,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100 count bottle (NDC 0378-2625-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
51,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000 count bottle (NDC 0378-2625-10)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
52,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100 count bottle (NDC 0378-2650-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
53,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 1000 count bottle (NDC 0378-2650-10)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
54,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"75 mg, 100 count bottle (NDC 0378-2675-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
55,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100 count bottle (NDC 0378-2685-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
56,Amitriptyline Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 100 count bottle (NDC 0378-2695-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
57,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,2.5 mg/10 mg (NDC 0093-7370-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
58,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,5 mg/10 mg (NDC 0093-7371-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
59,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,5 mg/20 mg (NDC 0093-7372-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
60,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,5 mg/40 mg (NDC 0093-7670-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
61,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,10 mg/20 mg (NDC 0093-7373-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
62,Amlodipine Besylate and Benazepril Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,10 mg/40 mg (NDC 0093-7671-01),New,6/5/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,6/5/19,6/5/19
63,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,5 mg/20 mg tablets (NDCs 0093-7027-56 and 0093-7027-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
64,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,5 mg/40 mg tablets (NDCs 0093-7028-56 and 0093-7028-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
65,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,10 mg/20 mg tablets (NDCs 0093-7029-56 and 0093-7029-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
66,Amlodipine Besylate and Olmesartan Medoxomil Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,10 mg/20 mg tablets (NDCs 0093-7030-56 and 0093-7030-98),New,3/11/19,,This product discontinuation is a business related decision.,,,Cardiovascular,To be Discontinued,3/11/19,3/11/19
67,Amoxicillin (Moxatag) Extended Release Tablets,"Pragma Pharmaceuticals, LLC",414-434-6604,775 mg tablets (NDCs 69442-030-10 and NDCs 69442-030-30),New,12/19/18,,"The last batches will expire September 30, 2019.",,,Anti-Infective,To be Discontinued,12/19/18,12/19/18
68,Amoxicillin Powder for Suspension,Teva Pharmaceuticals,800-545-8800,"125 mg/5 mL powder for suspension (NDCs 0093-4150-73, 0093-4150-79 and 0093-4150-80)",New,6/3/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,6/3/19,6/3/19
69,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"5 mg, 100 Count Bottle (NDC 68382-950-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
70,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"7.5 mg, 100 Count Bottle (NDC 68382-951-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
71,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"10 mg, 100 Count Bottle (NDC 68382-952-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
72,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"12.5 mg, 100 Count Bottle (NDC 68382-953-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
73,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"15 mg, 100 Count Bottle (NDC 68382-954-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
74,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"20 mg, 100 Count Bottle (NDC 68382-955-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
75,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Nesher Pharmaceuticals (USA) LLC,877-993-8779,"30 mg, 100 Count Bottle (NDC 68382-956-01)",New,9/12/19,Available; allocating inventory.,Product is on allocation to its current committed customers.,,Shortage of an active ingredient,Psychiatry,Current,,
76,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"30 mg, 100 Count Bottle (NDC 0185-0864-01)",Reverified,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
77,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"20 mg, 100 Count Bottle (NDC 0185-0853-01)",Reverified,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
78,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"10 mg, 100 Count Bottle (NDC 0185-0842-01)",Reverified,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
79,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Sandoz,800-525-8747,"5 mg, 100 Count Bottle (NDC 0185-0831-01)",Reverified,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
80,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 10mg 100 (NDC 57844-0110-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
81,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 12.5mg 100 (NDC 57844-0112-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
82,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 15mg 100 (NDC 57844-0115-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
83,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 20mg 100 (NDC 57844-0120-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
84,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 30mg 100 (NDC 57844-0130-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
85,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 5mg 100 (NDC 57844-0105-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
86,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,Adderall(R) Tablets 7.5mg 100 (NDC 57844-0117-01),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
87,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5mg [1.25/1.25/1.25/1.25mg] 100s (NDC 0378-4541-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
88,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,7.5mg [1.875/1.875/1.875/1.875mg] 100s (NDC 0378-4542-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
89,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10mg [2.5/2.5/2.5/2.5mg] 100s (NDC 0378-4543-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
90,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5mg [3.125/3.125/3.125/3.125mg] 100s (NDC 0378-4544-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
91,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,15mg [3.75/3.75/3.75/3.75mg] 100s (NDC 0378-4545-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
92,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20mg [5/5/5/5mg] 100s (NDC 0378-4546-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
93,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,30mg [7.5/7.5/7.5/7.5mg] 100s (NDC 0378-4547-01),Reverified,11/26/19,Out of Stock – Resupply TBD,,,Other,Psychiatry,Current,,
94,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 13107-0068-01)",New,9/12/19,Product under allocation,Stocks available to support customer demand,,Demand increase for the drug,Psychiatry,Current,,
95,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 13107-0070-01)",New,9/12/19,Product under allocation,Stocks available to support customer demand,,Demand increase for the drug,Psychiatry,Current,,
96,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 13107-0072-01)",New,9/12/19,Product under allocation,Stocks available to support customer demand,,Demand increase for the drug,Psychiatry,Current,,
97,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 13107-0073-01)",New,9/12/19,Product under allocation,Stocks available to support customer demand,,Demand increase for the drug,Psychiatry,Current,,
98,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Aurobindo Pharma,732-839-9400,"Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 13107-0074-01)",New,9/12/19,Product under allocation,Stocks available to support customer demand,,Demand increase for the drug,Psychiatry,Current,,
99,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,12.5  mg 100 count (NDC 0555-0776-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
100,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,15  mg 100 count (NDC 0555-0777-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
101,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,7.5  mg 100 count (NDC 0555-0775-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
102,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,10  mg 100 count (NDC 0555-0972-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
103,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0555-0973-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
104,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,30 mg 100 count (NDC 0555-0974-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
105,Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0555-0971-02),Reverified,12/16/19,Product is Available,,,,Psychiatry,Current,,
106,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,1 MG 100 Capsules (NDC 0172-5240-60),Reverified,12/16/19,Allocating inventory,Rolling backorders into December 2019; Expected recovery March 2020,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
107,Anagrelide Hydrochloride Capsules,Teva Pharmaceuticals,800-545-8800,0.5 MG 100 Capsules (NDC 0172-5241-60),Reverified,12/16/19,Allocating inventory,Rolling backorders into December 2019; Expected recovery March 2020,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
108,Anagrelide Hydrochloride Capsules,Shire US Inc. now part of Takeda,800-828-2088,"AGRYLIN 0.5 mg Capsule,100 capsules in 1 bottle (NDC 54092-063-01)",Reverified,12/2/19,Available,Takeda is actively working to mitigate a recent unexpected increase in demand for the product.,,Demand increase for the drug,Hematology,Current,,
109,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,0.5 mg per capsule Bottles of 100 (NDC 13668-453-01),Revised,12/13/19,Estimated availability: January 2020,,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
110,Anagrelide Hydrochloride Capsules,Torrent Pharma Inc.,908-280-3333,"1 mg per capsule, Bottles of 100 (NDC 13668-462-01)",Revised,12/13/19,Available and shipping,,,Requirements related to complying with good manufacturing practices,Hematology,Current,,
111,Aprepitant (Emend) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,40-mg capsules unit-of-use package of 1 (NDC 0006-0464-10),New,12/3/18,,,,,Gastroenterology,To be Discontinued,12/3/18,12/3/18
112,Aprepitant (Emend) Capsules,Merck Sharp & Dohme Corp.,800-672-6372,40-mg capsules unit-of-use package of 5 (NDC 0006-0464-05),New,12/3/18,,,,,Gastroenterology,To be Discontinued,12/3/18,12/3/18
113,Asparaginase Erwinia Chrysanthemi (Erwinaze),"Jazz Pharmaceuticals, Inc.",800-520-5568,"ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 5 vial carton (NDC 57902-249-05)",Revised,12/9/19,Available.  For further information and to sign up for supply alerts by Jazz Pharmaceuticals please visit Erwinazesupply.com https://erwinazesupply.com/,,,Other,Hematology;Oncology;Pediatric,Current,,
114,Asparaginase Erwinia Chrysanthemi (Erwinaze),"Jazz Pharmaceuticals, Inc.",800-520-5568,"ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 1 vial (NDC 57902-249-01)",Revised,12/9/19,Available.  For further information and to sign up for supply alerts by Jazz Pharmaceuticals please visit Erwinazesupply.com https://erwinazesupply.com/,,,Other,Hematology;Oncology;Pediatric,Current,,
115,"Atracurium Besylate Injection, USP",Mylan Institutional,800-796-9526,"10 mg/mL, 10 mL, 10PK (NDC 67457-698-10)",New,9/24/19,,,,,Anesthesia,To be Discontinued,9/24/19,9/24/19
116,"Atracurium Besylate Injection, USP",Mylan Institutional,800-796-9526,"10 mg/mL, 5 mL, 10 PK (NDC 67457-699-05)",New,9/24/19,,,,,Anesthesia,To be Discontinued,9/24/19,9/24/19
117,Atropine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,8 mg per 20 mL (0.4 mg per mL); MDV; (NDC 63323-580-20),Reverified,12/20/19,Available,Check wholesaler inventory,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
118,Atropine Sulfate Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"0.1 mg/mL; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3339-1, Old NDC 0548-3339-00)",Reverified,12/16/19,Available,,,,Anesthesia;Neurology;Pediatric,Current,,
119,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); Ansyr Plastic Syringe
(NDC 0409-1630-10)",Revised,12/20/19,Next Delivery: March 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology;Pediatric,Current,,
120,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,"0.25 mg/5 mL (0.05 mg/mL); Ansyr Plastic Syringe
(NDC 0409-9630-05)",Revised,12/20/19,Next Delivery: March 2020; Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology;Pediatric,Current,,
121,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,0.5 mg/5 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4910-34),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology;Pediatric,Current,,
122,Atropine Sulfate Injection,"Hospira, Inc.",844-646-4398,1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4911-34),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Neurology;Pediatric,Current,,
123,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"0.4 mg/mL, 1 mL single-dose vial, package of 25
(NDC 00517-0401-25)",Reverified,11/27/19,Limited Availability,"American Regent is currently releasing the 0.4mg/mL, 1 mL vial, NDC 00517-0401-25",,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
124,Atropine Sulfate Injection,American Regent/Luitpold,800-645-1706,"1 mg/mL, 1 mL single-dose vial, package of 25 (NDC 00517-1010-25)",Reverified,11/27/19,Limited Availability,"American Regent is currently releasing the 1mg/mL, 1 mL vial, (NDC 00517-1010-25)",,Other,Anesthesia;Neurology;Pediatric,Current,,
125,Atropine Sulfate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.4 mg/mL, 20 mL vial (NDC 0641-6006-10)",Revised,12/13/19,"January 2020, has inventory",,,Demand increase for the drug,Anesthesia;Neurology;Pediatric,Current,,
126,Atropine Sulfate Ophthalmic Ointment,Bausch Health,800-321-4576,"1% (10 mg/g), 3.5 g tube (NDC 24208-825-55)",Revised,12/13/19,Availability limited to product already in pharmacies until resumption of manufacturing in January 2020 and distribution in February 2020,Currently qualifying alternate supplier of inactive ingredient,,Shortage of an inactive ingredient,Ophthalmology,Current,,
127,Avelox® (moxifloxacin HCl) Tablets,Bayer,888-842-2937,Bottles of 30 Tablets (NDC 50419-530-01),New,2/1/19,,Business decision to discontinue marketing in the US.,,,Anti-Infective,To be Discontinued,2/1/19,2/1/19
128,Azacitidine Injection,Teva Pharmaceuticals,800-545-8800,100 mg/1 unit (NDC 0591-2897-49),New,10/30/19,,The product has not been marketed for an extended period of time. Teva made a business decision to discontinue this product.,,,Oncology,To be Discontinued,10/30/19,10/30/19
129,Azithromycin (Azasite) Ophthalmic Solution 1%,Akorn Pharmaceuticals,800-932-5676,Azasite (Azithromycin Ophthalmic Solution) 1% 2.5 mL in 5 mL bottle (NDC 17478-307-03),Revised,9/11/19,,,,,Ophthalmology,Resolved,9/11/19,
130,Bacitracin Ophthalmic Ointment,Perrigo Pharmaceuticals,866-634-9120,Bacitracin Ophthalmic Ointment 3.5 g (NDC 0574-4022-35),Reverified,12/10/19,On backorder. Expected release early January 2020,,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
131,Belatacept (Nulojix) Lyophilized Powder for Injection,Bristol Myers Squibb Co.,800-721-5072 ; 877-417-1523,20cc vial 250mg lyophilized powder per vial for IV infusion (NDC 0003-0371-13),Reverified,12/16/19,"No disruption to existing patients is anticipated. Until further notice, BMS will continue to limit distribution of NULOJIX via the US NULOJIX Distribution Program, initiated 15-Feb-2017. Starting in August 2018, the restrictions of the NDP will be eased to allow for expansion of use to appropriate new patients if the treating physician determines that Nulojix is the best treatment option for the patient.  For further information, contact BMS Medical Information.",Increased demand for the drug exacerbated by a delay in transition to a more efficient manufacturing process.,,Demand increase for the drug,Transplant,Current,,
132,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 69202-780-08),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
133,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 69202-780-88),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
134,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 23594-780-08),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
135,Benzyl Alcohol (Ulesfia) Lotion 5%,Shionogi Inc.,800-849-9707,Ulesfia (benzyl alcohol) lotion 5% (50 mg/g of lotion) Bottles (NDC 23594-780-88),New,9/18/19,,"Business decision to discontinue marketing in the US. This product discontinuation is not related to product quality, safety, or efficacy.",,,Dermatology,To be Discontinued,9/18/19,9/18/19
136,Bisoprolol Fumarate Tablets,Unichem Pharmaceuticals (USA) Inc.,866-931-0704,"5 mg, 30 count bottle (NDC 29300-126-13)",Revised,6/14/19,,,Available,,Cardiovascular,Resolved,6/14/19,
137,Bisoprolol Fumarate Tablets,Unichem Pharmaceuticals (USA) Inc.,866-931-0704,"5 mg, 100 count bottle (NDC 29300-126-01)",Revised,6/14/19,,,Available,,Cardiovascular,Resolved,6/14/19,
138,Bisoprolol Fumarate Tablets,Unichem Pharmaceuticals (USA) Inc.,866-931-0704,"10 mg, 30 count bottle (NDC 29300-127-13)",Revised,6/14/19,,,Available,,Cardiovascular,Resolved,6/14/19,
139,Bisoprolol Fumarate Tablets,Unichem Pharmaceuticals (USA) Inc.,866-931-0704,"10 mg, 100 count bottle (NDC 29300-127-01)",Revised,6/14/19,,,Available,,Cardiovascular,Resolved,6/14/19,
140,Bosentan Tablets,"Janssen Research and Development, LLC",800-526-7736,62.5 mg tablets (NDC 10148-625-60),New,10/15/19,,,,,Cardiovascular,To be Discontinued,10/15/19,10/15/19
141,Bosentan Tablets,"Janssen Research and Development, LLC",800-526-7736,125 mg tablets (NDC 10148-125-60),New,10/15/19,,,,,Cardiovascular,To be Discontinued,10/15/19,10/15/19
142,Budesonide Capsules,Teva Pharmaceuticals,800-545-8800,3 mg capsules (NDC 0093-7445-01),New,12/23/19,,,,,Gastroenterology,To be Discontinued,12/23/19,12/23/19
143,"Bumetanide Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 4 mL vial (NDC 0641-6008-10)",Revised,12/13/19,"Temporary back-order, additional lots available end of December/January 2020",,,Demand increase for the drug,Cardiovascular,Current,,
144,"Bumetanide Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.25 mg/mL, 10 mL vial (NDC 0641-6007-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured in the October - November 2019 timeframe. Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
145,"Bumetanide Injection, USP","Hospira, Inc.",844-646-4398,1 mg/4 mL (0.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1412-04),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: January 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
146,"Bumetanide Injection, USP","Hospira, Inc.",844-646-4398,2.5 mg/10 mL (0.25 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1412-10),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: November 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
147,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-461-57),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
148,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine w/EPI 0.5% (250 mg per 50 mL) (5 mg per mL) MDV (NDC 63323-463-57),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
149,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.25% (25 mg per 10 mL) (2.5 mg per mL) SDV (NDC 63323-468-17),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
150,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI .25% (75 mg per 30 mL) (2.5 mg per mL) SDV (NDC 63323-468-37),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
151,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (50 mg per 10 mL) (5 mg per mL) SDV (NDC 63323-462-17),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
152,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) SDV (NDC 63323-462-37),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
153,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF w/EPI 0.5% (150 mg per 30 mL) (5 mg per mL) Sterile-Pak, SDV (NDC 63323-462-31)",Revised,12/20/19,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
154,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine MPF w/EPI 0.75% (225 mg per 30 mL) (7.5 mg per mL)  SDV  (NDC 63323-460-37),Revised,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
155,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-01),Reverified,12/20/19,Next Delivery: February 2020; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
156,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9042-17),Reverified,12/20/19,Next Delivery: March 2020; Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
157,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9043-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: May 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
158,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-01),Reverified,12/20/19,Next Delivery: March 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
159,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-9045-17),Reverified,12/20/19,Next Delivery: March 2020; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
160,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-9046-01),Reverified,12/20/19,Next Delivery: March 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
161,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-10)",Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: June 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
162,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1746-30)",Reverified,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
163,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-10)",Reverified,12/20/19,Next Delivery: January 2020; Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
164,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000); Single Dose Glass Fliptop Vial (NDC 00409-1749-29)",Reverified,12/20/19,Next Delivery and Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
165,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1752-50)",Reverified,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: June 2021,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
166,"Bupivacaine Hydrochloride and Epinephrine Injection, USP","Hospira, Inc.",844-646-4398,"Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-1755-50)",Reverified,12/20/19,Next Delivery: January 2020; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
167,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.25% (125 mg per 50 mL) (2.5 mg per mL) MDV (NDC 63323-465-57),Reverified,12/20/19,Available,All Bupivacaine presentations are on intermittent back order and will be released as the product becomes available.  Product will ship into the wholesalers.,,Demand increase for the drug,Anesthesia,Current,,
168,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,Sensorcaine 0.5% (250 mg per 50 mL) (5 mg per mL)                    MDV (NDC 63323-467-57),Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
169,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (25 mg per 10 mL) (2.5 mg per mL) MPF,         SDV (NDC 63323-464-17)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
170,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine MPF 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF, SDV (NDC 63323-464-37)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
171,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.25% (75 mg per 30 mL) (2.5 mg per mL) MPF,             Sterile-Pak, SDV (NDC 63323-464-31)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
172,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (50 mg per 10 mL) (5 mg per mL)  MPF,                 SDV  (NDC 63323-466-17)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
173,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                 SDV (NDC 63323-466-37)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
174,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.5% (150 mg per 30 mL) (5 mg per mL) MPF,                Sterile-Pak, SDV (NDC 63323-466-31)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia,Current,,
175,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (75 mg per 10 mL) (7.5 mg per mL) MPF,             SDV (NDC 63323-472-17)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
176,"Bupivacaine Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"Sensorcaine 0.75% (225 mg per 30 mL) (7.5 mg per mL) MPF,     SDV (NDC 63323-472-37)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia,Current,,
177,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 10 mL Single Dose Vials (NDC 55150-167-10),Revised,11/7/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
178,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 30 mL Single Dose Vials (NDC 55150-168-30),Revised,11/7/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
179,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 10 mL Single Dose Vials (NDC 55150-169-10),Revised,11/7/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
180,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-170-30),Revised,12/11/19,Currently backordered,Next shipment TBD,,Demand increase for the drug,Anesthesia,Current,,
181,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 10 mL Single Dose Vials (NDC 55150-171-10),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
182,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 30 mL Single Dose Vials (NDC 55150-172-30),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
183,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.25% 50 mL Multiple Dose Vials (NDC 55150-249-50),Revised,12/11/19,Available,Check wholesaler for inventory,,Demand increase for the drug,Anesthesia,Current,,
184,"Bupivacaine Hydrochloride Injection, USP",AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 50 mL Multiple Dose Vials (NDC 55150-250-50),Revised,12/11/19,Available,Check wholesaler for inventory,,Demand increase for the drug,Anesthesia,Current,,
185,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,25 mg/10 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-01),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
186,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,75 mg/30 mL (2.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1159-02),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
187,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1160-01),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
188,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-01),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
189,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1162-02),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: February 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
190,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1163-01),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
191,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,75 mg/10 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-01),Revised,12/20/19,Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
192,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,225 mg/30 mL (7.5 mg/mL); Single Dose Glass Teartop Vial (NDC 00409-1165-02),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
193,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL); Glass Ampul (NDC 00409-3613-01),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
194,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 25 mg/10 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-10),Revised,12/20/19,Next Delivery and Estimated Recovery: April 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
195,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 75 mg/30 mL (2.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1559-30),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: February 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
196,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 125 mg/50 mL (2.5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1587-50),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
197,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-10),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: February 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
198,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1560-29),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
199,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 250 mg/50 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1610-50),Revised,12/20/19,Next Delivery: March 2020; Estimated Recovery: May 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
200,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 75 mg/10 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-10),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: June 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
201,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine 225 mg/30 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1582-29),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: April 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
202,"Bupivacaine Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,Marcaine Spinal 15 mg/2 mL (7.5 mg/mL); Glass Ampul (NDC 00409- 1761-02),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
203,"Bupivacaine Hydrochloride Injection, USP",Baxter Healthcare,888-229-0001,"Bupivacaine HCL in 8.25% Dextrose lnjection, USP (7.5 mg/mL) 2 mL Single Dose Ampule (10 x 2 mL)(NDC 36000-092-10)",Reverified,12/11/19,Available,SPINAL 0.75% - Sterile Hyperbaric Solution for Spinal Anesthesia,,,Anesthesia,Current,,
204,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 5 mL single-dose ampules (NDC 59923-717-05),New,9/12/19,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
205,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.25% 10 mL single-dose ampules (NDC 59923-719-10),New,9/12/19,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
206,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 5 mL single-dose ampules (NDC 59923-718-05),New,9/12/19,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
207,"Bupivacaine Hydrochloride Injection, USP","Areva Pharmaceuticals, Inc.","812-399-3599,  Option # 1",0.5% 10 mL single-dose ampules (NDC 59923-720-10),New,9/12/18,Available,"Areva Pharmaceuticals Inc., in conjunction with FDA, has initiated temporary importation of Bupivacaine Hydrochloride Injection USP (Preservative free, Latex free) 0.25% and 0.5% into the US market to address drug shortage.  Importation will begin mid-September 2019.  Product is available via authorized distributors (McKesson, Cardinal Health, Amerisource Bergen) . All orders must be placed with your authorized wholesalers.  Please call Areva Pharmaceutical Customer Service at  812-399-3599,  Option # 1 or email us at customerservice@arevapharma.com if you would like drop shipments.",,,Anesthesia,Current,,
208,Buprenorphine Hydrochloride Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2 mg, 30 count bottle (NDC 0378-0923-93)",New,5/2/19,,,,,Analgesia/Addiction,To be Discontinued,5/2/19,5/2/19
209,Buprenorphine Hydrochloride Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"8 mg, 30 count bottle (NDC 0378-0924-93)",New,5/2/19,,,,,Analgesia/Addiction,To be Discontinued,5/2/19,5/2/19
210,Bupropion Hydrochloride (Zyban) Tablets,GlaxoSmithKline,888-825-5249,150 mg  (NDC 0173-0556-01),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately July 2019.,,,Psychiatry,To be Discontinued,6/28/19,6/28/19
211,Bupropion Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 90 count bottle (NDC 0378-2008-77)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
212,Bupropion Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg, 500 count bottle (NDC 0378-2009-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
213,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"10mg, 100 (NDC 69238-1117-01)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
214,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"10mg, 500 (NDC 69238-1117-05)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
215,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"15mg, 100 (NDC 69238-1118-01)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
216,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"15mg, 500 (NDC 69238-1118-05)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
217,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"15mg, 60 (NDC 69238-1118-06)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
218,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"30mg, 60 (NDC 69238-1119-06)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
219,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"5mg, 100 (NDC 69238-1115-01)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
220,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"5mg, 500 (NDC 69238-1115-05)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
221,Buspirone HCl Tablets,Amneal Pharmaceutical,877-835-5472,"7.5mg, 100 (NDC 69238-1116-01)",Reverified,12/17/19,Available,,,Other,Psychiatry,Current,,
222,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"15 mg, 60 count bottle (NDC 64380-743-03)",Revised,5/16/19,Currently out of stock. Re-supply by the first week of June 2019.,,,Demand increase for the drug,Psychiatry,Current,,
223,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"15 mg, 180 count bottle (NDC 64380-743-18)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
224,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"5 mg, 100 count bottle (NDC 16729-200-01)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
225,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"5 mg, 500 count bottle (NDC 16729-200-16)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
226,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"7.5 mg, 100 count bottle (NDC 16729-201-01)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
227,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"10 mg, 100 count bottle (NDC 16729-202-01)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
228,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"10 mg, 500 count bottle (NDC 16729-202-16)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
229,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"15 mg, 60 count bottle (NDC 16729-203-12)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
230,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"15 mg, 100 count bottle (NDC 16729-203-01)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
231,Buspirone HCl Tablets,Accord Healthcare Inc.,866-941-7875,"30 mg, 60 count bottle (NDC 16729-289-12)",Revised,12/11/19,"Sufficient stocks available to support customer demand; Product not on allocation effective Dec 1, 2019",,,Demand increase for the drug,Psychiatry,Current,,
232,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"5 mg, 100 count bottle (NDC 0115-1690-01)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
233,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"5 mg, 500 count bottle (NDC 0115-1690-02)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
234,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"5 mg, 1000 count bottle (NDC 0115-1690-03)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
235,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"10 mg, 100 count bottle (NDC 0115-1691-01)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
236,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"10 mg, 500 count bottle (NDC 0115-1691-02)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
237,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"10 mg, 1000 count bottle (NDC 0115-1691-03)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
238,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"15 mg, 60 count bottle (NDC 0115-1692-13)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
239,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"15 mg, 180 count bottle (NDC 0115-1692-19)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
240,Buspirone HCl Tablets,Impax Laboratories,877-994-6729,"15 mg, 500 count bottle (NDC 0115-1692-02)",Reverified,1/29/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
241,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"7.5 mg, 100 count bottle (NDC 49884-725-01)",Reverified,11/26/19,Available,"Manufactured and marketed by Par Pharmaceutical. For product availability inquiries, call 1-800-828-9393, option # 5 then option # 2",,Demand increase for the drug,Psychiatry,Current,,
242,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"7.5 mg, 500 count bottle (NDC 49884-725-05)",Reverified,11/26/19,Available,"Manufactured and marketed by Par Pharmaceutical. For product availability inquiries, call 1-800-828-9393, option # 5 then option # 2",,Demand increase for the drug,Psychiatry,Current,,
243,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-1140-01)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
244,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-1140-05)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
245,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, unit-dose blister pack, 100 count (NDC 51079-985-20)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
246,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"7.5 mg, 100 count bottle (NDC 0378-1145-01)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
247,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-1150-01)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
248,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 500 count bottle (NDC 0378-1150-05)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
249,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, unit-dose blister pack, 100 count (NDC 51079-986-20)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
250,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 60 count bottle (NDC 0378-1165-91)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
251,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 180 count bottle (NDC 0378-1165-80)",Reverified,11/26/19,Unavailable. Re-supply: November 2019,,,Other,Psychiatry,Current,,
252,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 500 count bottle (NDC 0378-1165-05)",Reverified,11/26/19,Unavailable. Re-supply: November 2019,,,Other,Psychiatry,Current,,
253,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, unit-dose blister pack, 100 count (NDC 51079-960-20)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
254,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 60 count bottle (NDC 0378-1175-91)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
255,Buspirone HCl Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, unit-dose blister pack, 100 count (NDC 51079-994-20)",Reverified,11/26/19,Available,,,Other,Psychiatry,Current,,
256,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 100 count bottle (NDC 64380-741-06)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
257,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 500 count bottle (NDC 64380-741-07)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
258,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"5 mg, 1000 count bottle (NDC 64380-741-08)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
259,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"7.5 mg, 100 count bottle (NDC 64380-787-06)",Revised,5/16/19,Currently out of stock. Re-supply by the first week of June 2019.,,,Demand increase for the drug,Psychiatry,Current,,
260,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 100 count bottle (NDC 64380-742-06)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
261,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 500 count bottle (NDC 64380-742-07)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
262,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"10 mg, 1000 count bottle (NDC 64380-742-08)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
263,Buspirone HCl Tablets,Strides Pharma Inc.,855-273-0146,"30 mg, 60 count bottle (NDC 64380-744-03)",Revised,5/16/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
264,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0093-0053-01)",Revised,12/16/19,Available,,,,Psychiatry,Current,,
265,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"5 mg, 500 count bottle (NDC 0093-0053-05)",Revised,12/16/19,Available,,,,Psychiatry,Current,,
266,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count bottle (NDC 0093-0054-01)",Revised,12/16/19,Available,,,,Psychiatry,Current,,
267,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"10 mg, 500 count bottle (NDC 0093-0054-05)",Revised,12/16/19,Available,,,Increase in demand,Psychiatry,Current,,
268,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 100 count bottle (NDC 0093-1003-01)",Revised,12/16/19,Available,,,Increase in demand,Psychiatry,Current,,
269,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"15 mg, 500 count bottle (NDC 0093-1003-05)",Revised,12/16/19,Available,,,Increase in demand,Psychiatry,Current,,
270,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"30 mg, 60 count bottle (NDC 0093-5200-06)",Revised,12/16/19,Available,,,Increase in demand,Psychiatry,Current,,
271,Buspirone HCl Tablets,Teva Pharmaceuticals,800-545-8800,"30 mg, 500 count bottle (NDC 0093-5200-05)",Revised,12/16/19,Available,,,Increase in demand,Psychiatry,Current,,
272,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"5 mg, 100 count bottle (NDC 68382-180-01)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
273,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"5 mg, 500 count bottle (NDC 68382-180-05)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
274,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"10 mg, 100 count bottle (NDC 68382-181-01)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
275,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"10 mg, 500 count bottle (NDC 68382-181-05)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
276,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"15 mg, 100 count bottle (NDC 68382-182-01)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
277,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"15 mg, 500 count bottle (NDC 68382-182-05)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
278,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"30 mg, 60 count bottle (NDC 68382-183-14)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
279,Buspirone HCl Tablets,Zydus Pharmaceuticals USA Inc.,877-993-8779,"30 mg, 500 count bottle (NDC 68382-183-05)",Revised,12/18/19,Available,,,Demand increase for the drug,Psychiatry,Current,,
280,Calcitriol Injection USP 1MCG /ML,Akorn Pharmaceuticals,800-932-5676,"Calcitriol Injection USP, 1 mcg/mL, 1 mL ampule  (NDC 17478-931-01)",Revised,12/2/19,Available,,,Other,Endocrinology/Metabolism,Current,,
281,"Calcium Chloride Injection, USP","Hospira, Inc.",844-646-4398,1 g/10 mL (100 mg/mL); Ansyr Plastic Syringe (NDC 00409-1631-10),Reverified,12/20/19,Next Delivery: April 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric,Current,,
282,"Calcium Chloride Injection, USP","Hospira, Inc.",844-646-4398,1 g/10 mL (100 mg/mL); LifeShield Abboject Glass Syringe (NDC 00409-4928-34),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric,Current,,
283,"Calcium Chloride Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Calcium Chloride Inj. USP, 10%, 10mL Luer-Jet Prefilled Syringe, (NDC 0548-3304-00), new (NDC 76329-3304-1)",Revised,11/6/19,Intermittent supply,"IMS is releasing product, but market demand continues to exceed our capacity",,Demand increase for the drug,Gastroenterology;Pediatric,Current,,
284,"Calcium Chloride Injection, USP","Medefil, Inc.",630-682-4600,"Calcium Chloride Inj. USP, 10%, 10mL Prefilled Syringe, (NDC 64253-900-36)",Revised,12/11/19,Available,Check wholesaler for inventory,,Other,Gastroenterology;Pediatric,Current,,
285,"Calcium Chloride Injection, USP",American Regent/Luitpold,800-645-1706,"10% Calcium Chloride Injection, USP, 1 gram/10mL (100mg/mL), single dose vial, (NDC 0517-6710-01)",Reverified,11/27/19,Limited availability.,,,Requirements related to complying with good manufacturing practices,Gastroenterology;Pediatric,Current,,
286,"Capreomycin Injection, USP",Akorn Pharmaceuticals,800-932-5676,"Capastat Sulfate (Capreomycin for Injection USP) Eq to 1 g Capreomycin activity, 10mL (NDC 17478-080-50)",Revised,12/2/19,Available,,,Delay in shipping of the drug,Anti-Infective,Current,,
287,Carbamazepine Extended Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg capsules (NDC 29033-019-12),New,6/19/19,,,,,Neurology,To be Discontinued,6/19/19,6/19/19
288,Carbamazepine Extended Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,200 mg capsules (NDC 29033-020-12),New,6/19/19,,,,,Neurology,To be Discontinued,6/19/19,6/19/19
289,Carbamazepine Extended Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,300 mg capsules (NDC 29033-004-12),New,6/19/19,,,,,Neurology,To be Discontinued,6/19/19,6/19/19
290,Carbidopa and Levodopa Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"Carbidopa and Levodopa Extended Release Tablets, 25/100 mg (NDC 0378-0088-01)",Revised,7/12/19,,,,,Neurology,Resolved,7/12/19,
291,Carbidopa and Levodopa Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"Carbidopa and Levodopa Extended Release Tablets, 50/200 mg (NDC 0378-0094-01)",Revised,7/12/19,,,,,Neurology,Resolved,7/12/19,
292,Carbidopa and Levodopa Extended Release Tablets,Merck Sharp & Dohme Corp.,800-637-2579,"Carbidopa levodopa (50 mg of carbidopa and 200 mg of levodopa)  (SINEMET CR 50-200) sustained-release tablets, (NDC 0006-3919-68)bottles of 100",New,7/17/19,,To be discontinued on or near November 2019.,,,Neurology,To be Discontinued,7/17/19,7/17/19
293,Carbidopa and Levodopa Extended Release Tablets,Merck Sharp & Dohme Corp.,800-637-2579,"Carbidopa levodopa  (25 mg of carbidopa and 100 mg of levodopa) (SINEMET CR 25-100 ) sustained-release tablets, (NDC 0006-3918-68) bottles of 100",New,7/17/19,,To be discontinued on or near February 2020.,Available,,Neurology,To be Discontinued,7/17/19,
294,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 100CT; (NDC 1672907901),Revised,7/12/19,,,Stocks available to support current customer demand,,Neurology,Resolved,7/12/19,
295,Carbidopa and Levodopa Extended Release Tablets,Sun Pharmaceutical Industries Inc.,800-810-4555,Carbidopa and Levodopa Extended Release Tablets  25-100 mg (NDC  62756-461-88 ),Revised,7/12/19,,,Available,,Neurology,Resolved,7/12/19,
296,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 50MG/200MG 1000CT; (NDC 1672907917),Revised,7/12/19,,,Stocks available to support current customer demand,,Neurology,Resolved,7/12/19,
297,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 100CT; (NDC 1672907801),Revised,7/12/19,,,Due to manufacturing constraints; we estimate the delay to continue until January 2020,,Neurology,Resolved,7/12/19,
298,Carbidopa and Levodopa Extended Release Tablets,Accord Healthcare Inc.,"866-941-7875, Option 1 or 3",CARBIDOPA & LEVODOPA ER TABLETS 25MG/100MG 1000CT; (NDC 1672907817),Revised,7/12/19,,,Due to manufacturing constraints; we estimate the delay to continue until January 2020,,Neurology,Resolved,7/12/19,
299,Carbidopa and Levodopa Extended Release Tablets,Sun Pharmaceutical Industries Inc.,800-810-4555,Carbidopa and Levodopa Extended Release Tablets  50-200 (NDC 62756-457-88),Revised,7/12/19,,,Available,,Neurology,Resolved,7/12/19,
300,Carbinoxamine Maleate,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",4 mg/5 mL oral solution (NDCs 64376-612-16 and 64376-612-40),Revised,9/11/19,,,,,Pulmonary/Allergy,To be Discontinued,9/11/19,9/11/19
301,Carbinoxamine Maleate,"Endo Pharmaceuticals, Inc.","800-828-9393 option 5, then option 2",4 mg tablets (NDC 64376-605-01),Revised,9/11/19,,,,,Pulmonary/Allergy,To be Discontinued,9/11/19,9/11/19
302,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose,"Chiesi USA, Inc.",888-466-6505 x6511,Cardene IV (nicardipine hydrochloride) 0.2 mg/mL in 5% Dextrose (NDC 10122-326-10),New,3/20/18,,The decision to discontinue the 0.2 mg/mL in 5% Dextrose formulation was business related.  Other formulations of Cardene IV remain available.,,,Cardiovascular,To be Discontinued,3/20/18,3/20/18
303,"Carisoprodol Tablets, USP",Mylan Specialty,800-796-9526,"Soma, 250 mg 30 count bottle (NDC 0037-2250-30)",Reverified,11/26/19,Available,Distributed by Meda Pharmaceuticals,,Available,Analgesia/Addiction;Musculoskeletal,Current,,
304,"Carisoprodol Tablets, USP",Ingenus Pharmaceuticals LLC,866-321-5031,"350 mg, 100 count tablets (NDC 50742-656-01)",Reverified,9/19/19,Available,Distributed by Ingenus Pharmaceuticals LLC,,,Analgesia/Addiction;Musculoskeletal,Current,,
305,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 100 tablets (NDC 16714-510-01)",Reverified,10/1/19,Available,Distributed by Northstar Rx LLC,,,Analgesia/Addiction;Musculoskeletal,Current,,
306,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 500 tablets (NDC 16714-510-02)",Reverified,10/1/19,Available,Distributed by Northstar Rx LLC,,,Analgesia/Addiction;Musculoskeletal,Current,,
307,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 1000 tablets (NDC 16714-510-03)",Reverified,10/1/19,Available,Distributed by Northstar Rx LLC,,,Analgesia/Addiction;Musculoskeletal,Current,,
308,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 100 tablets (NDC 61442-451-01)",Reverified,10/1/19,Available,"Distributed by Carlsbad Technology, Inc.",,,Analgesia/Addiction;Musculoskeletal,Current,,
309,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 500 tablets (NDC 61442-451-05)",Reverified,10/1/19,Available,"Distributed by Carlsbad Technology, Inc.",,,Analgesia/Addiction;Musculoskeletal,Current,,
310,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 1000 tablets (NDC 61442-451-10)",Reverified,10/1/19,Available,"Distributed by Carlsbad Technology, Inc.",,,Analgesia/Addiction;Musculoskeletal,Current,,
311,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 100 tablets (NDC 59746-705-01)",Reverified,10/1/19,Unavailable,Distributed by Jubilant Cadista; Stopped distribution,,,Analgesia/Addiction;Musculoskeletal,Current,,
312,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 500 tablets (NDC 59746-705-05)",Reverified,10/1/19,Unavailable,Distributed by Jubilant Cadista; Stopped distribution,,,Analgesia/Addiction;Musculoskeletal,Current,,
313,"Carisoprodol Tablets, USP","Orient Pharma Co., Ltd",858-246-6096,"350 mg, 1000 tablets (NDC 59746-705-05)",Reverified,10/1/19,Unavailable,Distributed by Jubilant Cadista; Stopped distribution,,,Analgesia/Addiction;Musculoskeletal,Current,,
314,"Carisoprodol Tablets, USP",Teva Pharmaceuticals,800-545-8800,"350 mg, 100 count (NDC 0591-5513-01)",Reverified,12/16/19,Available,,,,Analgesia/Addiction;Musculoskeletal,Current,,
315,"Carisoprodol Tablets, USP",Teva Pharmaceuticals,800-545-8800,"350 mg, 500 count (NDC 0591-5513-05)",Reverified,12/16/19,Available,,,,Analgesia/Addiction;Musculoskeletal,Current,,
316,"Carisoprodol Tablets, USP",Teva Pharmaceuticals,800-545-8800,"350 mg, 1000 count (NDC 0591-5513-10)",Reverified,12/16/19,Available,,,,Analgesia/Addiction;Musculoskeletal,Current,,
317,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 100 count (NDC 50228-109-01)",Reverified,9/23/19,Available,Labeler: ScieGen,,Other,Analgesia/Addiction;Musculoskeletal,Current,,
318,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 500 count (NDC 50228-109-05)",Reverified,9/23/19,Available,Labeler: ScieGen,,Other,Analgesia/Addiction;Musculoskeletal,Current,,
319,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 1000 count (NDC 50228-109-10)",Reverified,9/23/19,Available,Labeler: ScieGen,,Other,Analgesia/Addiction;Musculoskeletal,Current,,
320,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 1000 count (NDC 60429-508-10)",Reverified,9/23/19,Available,Labeler: GSMS (Golden State Medical Supply),,Other,Analgesia/Addiction;Musculoskeletal,Current,,
321,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 100 count (NDC 42543-700-01)",Reverified,9/23/19,Unavailable,"Labeler: Vensun, stopped distribution",,Other,Analgesia/Addiction;Musculoskeletal,Current,,
322,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 500 count (NDC 42543-700-05)",Reverified,9/23/19,Unavailable,"Labeler: Vensun, stopped distribution",,Other,Analgesia/Addiction;Musculoskeletal,Current,,
323,"Carisoprodol Tablets, USP","ScieGen Pharmaceuticals, Inc.",631-434-2723 x107,"350 mg, 1000 count (NDC 42543-700-10)",Reverified,9/23/19,Unavailable,"Labeler: Vensun, stopped distribution",,Other,Analgesia/Addiction;Musculoskeletal,Current,,
324,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100’s count bottle (NDC 00603-2582-21),New,4/26/19,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,,Analgesia/Addiction;Musculoskeletal,Current,,
325,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,500's count bottle (NDC 00603-2582-28),New,4/26/19,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,,Analgesia/Addiction;Musculoskeletal,Current,,
326,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100's count bottle (NDC 00603-2582-32),New,4/26/19,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,,Analgesia/Addiction;Musculoskeletal,Current,,
327,"Carisoprodol Tablets, USP",Mylan Specialty,800-796-9526,"Soma, 250 mg, 30 count bottle (NDC 0037-2250-30); 100 count bottle (NDC 0037-2250-10)",Reverified,11/26/19,Available,Distributed by Meda Pharmaceuticals,,Available,Analgesia/Addiction;Musculoskeletal,Current,,
328,"Carisoprodol Tablets, USP",Mylan Specialty,800-796-9526,"Soma, 350 mg, 100 count bottle (NDC 0037-2001-01)",Reverified,11/26/19,Available,Distributed by Meda Pharmaceuticals,,Available,Analgesia/Addiction;Musculoskeletal,Current,,
329,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100’s count bottle (NDC 00603-2582-21),New,3/18/19,,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,Musculoskeletal,To be Discontinued,3/18/19,3/18/19
330,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,500's count bottle (NDC 00603-2582-28),New,3/18/19,,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,Musculoskeletal,To be Discontinued,3/18/19,3/18/19
331,"Carisoprodol Tablets, USP","Endo Pharmaceuticals, Inc.",800-828-9393,100's count bottle (NDC 00603-2582-32),New,3/18/19,,Endo has made a business decision to permanently discontinue Carisoprodol 350mg tablets.,,,Musculoskeletal,To be Discontinued,3/18/19,3/18/19
332,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1100-1),New,3/12/19,Available,,,,Anti-Infective,Current,,
333,Cefazolin Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,300 gram SmartPak® Pharmacy Bulk Package (NDC 66288-1300-1),New,3/13/19,Available,,,,Anti-Infective,Current,,
334,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 10 g (10 vials) (NDC 60505-6143-04),Reverified,11/27/19,Available,,,,Anti-Infective,Current,,
335,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,1g 25 vials (NDC 25021-101-10),Revised,12/20/19,Available. On allocation. Estimated availability March,,,Manufacturing delay,Anti-Infective,Current,,
336,Cefazolin Injection,Apotex Corp.,800-706-5575,Cefazolin for Injection 1 g (25 vials) (NDC 60505-6142-05),Reverified,11/27/19,Available,,,,Anti-Infective,Current,,
337,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,10g 10 vials (NDC 25021-102-99),Revised,12/20/19,Available. On allocation. Estimated availability January,,,Manufacturing delay,Anti-Infective,Current,,
338,Cefazolin Injection,Sagent Pharmaceuticals,866-625-1618,500mg 25 vials (NDC 25021-100-10),Revised,12/20/19,Available. On allocation,,,Manufacturing delay,Anti-Infective,Current,,
339,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 2 gram/50 mL in DUPLEX Catalog 3105-11 (NDC 00264-3105-11),Reverified,12/11/19,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
340,Cefazolin Injection,B. Braun Medical Inc.,800-227-2862,Cefazolin Injection 1 gram/50 mL in DUPLEX Catalog 3103-11 (NDC 0264-3103-11),Reverified,12/11/19,Product on allocation to contracted customers,,,Other,Anti-Infective,Current,,
341,Cefazolin Injection,WG Critical Care,888-493-0861,500mg Cefazolin SDV (NDC 44567-706-25),Revised,11/4/19,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
342,Cefazolin Injection,WG Critical Care,888-493-0861,1g Cefazolin SDV (NDC 44567-707-25),Revised,11/4/19,Available,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
343,Cefazolin Injection,WG Critical Care,888-493-0861,10g Cefazolin PBP (NDC 44567-708-10),Revised,11/4/19,On backorder - Product continues to be manufactured with monthly releases.,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
344,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single Dose Glass Fliptop Vial (NDC 00409-0805-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,
345,Cefazolin Injection,"Hospira, Inc.",844-646-4398,1g Single-dose ADD-Vantage Vial (NDC 00409-2585-01),Reverified,12/20/19,Available,,,Other,Anti-Infective,Current,,
346,Cefazolin Injection,"Hospira, Inc.",844-646-4398,10 g Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-0806-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,
347,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9923-90),Reverified,12/13/19,Available,,,Demand increase for the drug,Anti-Infective,Current,,
348,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9924-90),Reverified,12/13/19,Available,,,Demand increase for the drug,Anti-Infective,Current,,
349,Cefazolin Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 mg/ 100 mL vial (NDC 0143-9983-03),Reverified,12/13/19,This presentation is temporarily on backorder.,Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
350,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 500 mg (NDC 0781-3450-95),Reverified,12/18/19,Available,,,,Anti-Infective,Current,,
351,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 1 g (NDC 0781-3451-96),Reverified,12/18/19,Available,,,,Anti-Infective,Current,,
352,Cefazolin Injection,Sandoz,800-525-8747,Cefazolin Na Injection 10 g (NDC 0781-3452-95),Reverified,12/18/19,Limited availablity until February 2020,,,,Anti-Infective,Current,,
353,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 1 gram/50 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3503)(NDC 0338-3503-41)",Reverified,12/11/19,Available,,,,Anti-Infective,Current,,
354,Cefazolin Injection,Baxter Healthcare,888-229-0001,"Cefazolin Injection, USP, 2 gram/100 mL, in GALAXY Plastic Container. Frozen Premix. (Product code 2G3508)(NDC 0338-3508-41)",Reverified,12/11/19,Product on allocation for existing customers,,,Demand increase for the drug,Anti-Infective,Current,,
355,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 1 g (10 vials) (NDC 60505-6146-04),Reverified,11/27/19,Available,,,,Anti-Infective;Pediatric,Current,,
356,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 1 g (1 vial) (NDC 60505-6146-00),Reverified,11/27/19,Available,,,,Anti-Infective;Pediatric,Current,,
357,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 2 g (10 vials) (NDC 60505-6147-04),Reverified,11/27/19,Available,,,,Anti-Infective;Pediatric,Current,,
358,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 2 g (1 vial) (NDC 60505-6147-00),Reverified,11/27/19,Available,,,,Anti-Infective;Pediatric,Current,,
359,Cefepime Injection,Apotex Corp.,800-706-5575,Cefepime for Injection 1 g (1 vial) (NDC 60505-0834-00),Revised,3/1/19,,"Product was manufactured by Hospira, no longer distributed by Apotex",,,Anti-Infective;Pediatric,To be Discontinued,3/1/19,3/1/19
360,Cefepime Injection,B. Braun Medical Inc.,800-227-2862,Cefepime 1 g (NDC 0264-3193-11),Reverified,12/11/19,Product on allocation to contracted custormers,,,Other,Anti-Infective;Pediatric,Current,,
361,Cefepime Injection,B. Braun Medical Inc.,800-227-2862,Cefepime 2 g (NDC 0264-3195-11),Reverified,12/11/19,Product on allocation to contracted customers,,,Other,Anti-Infective;Pediatric,Current,,
362,Cefepime Injection,Sagent Pharmaceuticals,866-625-1618,1 g vial (NDC 25021-121-20),Reverified,12/20/19,Available,,,,Anti-Infective;Pediatric,Current,,
363,Cefepime Injection,Sagent Pharmaceuticals,866-625-1618,2 g vial (NDC 25021-122-50),Reverified,12/20/19,Available,,,,Anti-Infective;Pediatric,Current,,
364,Cefepime Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 g single dose vial, sterile powder (NDC 63323-326-20)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
365,Cefepime Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 g single dose vial, sterile powder (NDC 63323-340-20)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
366,Cefepime Injection,Baxter Healthcare,888-229-0001,"Cefepime Injection, 1 gram/50mL, GALAXY Container (NDC 0338-1301-41)",Reverified,12/11/19,Available,,,,Anti-Infective;Pediatric,Current,,
367,Cefepime Injection,Baxter Healthcare,888-229-0001,"Cefepime Injection, 2 gram/100mL, GALAXY Container (NDC 0338-1301-48)",Reverified,12/11/19,On allocation,,,Other,Anti-Infective;Pediatric,Current,,
368,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 2 g; Single Dose ADD-Vantage Glass Vial (NDC 00409-0218-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
369,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 1 g; Single Dose ADD-Vantage Glass Vial (NDC 00409-0217-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
370,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 1 g; Single Dose Glass Fliptop Vial (NDC 00409-0219-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
371,Cefepime Injection,"Hospira, Inc.",844-646-4398,Maxipime 2 g; Single Dose Glass Fliptop Vial (NDC 00409-0220-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
372,Cefepime Injection,WG Critical Care,888-493-0861,1 g vial (NDC 44567-0240-10),Reverified,11/4/19,Available,Please check wholesalers and distributors for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
373,Cefepime Injection,WG Critical Care,888-493-0861,2 g vial (NDC 44567-0241-10),Reverified,11/4/19,Available,Please check wholesalers and distributors for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
374,Cefepime Injection,"Samson Medical Technologies, L.L.C.",856-751-5051,100 gram SmartPak Pharmacy Bulk Package (NDC 66288-8100-1),Revised,3/27/19,Available,,,,Anti-Infective;Pediatric,Current,,
375,Cefotaxime Sodium Injection,Apollo Pharmaceuticals Inc.,561-469-9058,"2g/vial, (NDC 21586-012-2)",New,8/28/19,Available,"Apollo in conjunction with FDA has initiated a temporary importation of Cefotaxime sodium for Injection, BP into the U.S. market to address drug shortage. To place an order, please contact FFF Enterprises at 1-800-843-7477",,Other,Anti-Infective;Pediatric,Current,,
376,Cefotaxime Sodium Injection,Apollo Pharmaceuticals Inc.,561-469-9058,"1g/vial, (NDC 21586-011-2)",New,8/28/19,Available,"Apollo in conjunction with FDA has initiated a temporary importation of Cefotaxime sodium for Injection, BP into the U.S. market to address drug shortage. To place an order, please contact FFF Enterprises at 1-800-843-7477",,Other,Anti-Infective;Pediatric,Current,,
377,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg/ 10 mL vial (NDC 0143-9930-10),Reverified,12/13/19,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
378,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1 g/ 10 mL vial (NDC 0143-9931-25),Reverified,12/13/19,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
379,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2 g/ 10 mL vial (NDC 0143-9933-25),Reverified,12/13/19,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
380,Cefotaxime Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10 g/ 100 mL vial (NDC 0143-9935-01),Reverified,12/13/19,Currently unavailable,On backorder. Shortage duration is unknown at this time.,,Delays due to manufacturing issues.,Anti-Infective;Pediatric,Current,,
381,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,1 gram/50 mL in DUPLEX (NDC 00264-3173-11),Revised,12/11/19,Product available,,,Other,Anti-Infective,Current,,
382,Cefotetan Disodium Injection,B. Braun Medical Inc.,800-227-2862,2 gram/50 mL in DUPLEX (NDC 00264-3175-11),Revised,12/11/19,Product available,,,Other,Anti-Infective,Current,,
383,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,1 g SDV (NDC 63323-0385-10),Reverified,12/20/19,Available,Check wholesalers for inventory,,Manufacturing delay,Anti-Infective,Current,,
384,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,2 g SDV (NDC 63323-0386-20),Reverified,12/20/19,Available,Check wholesalers for inventory,,Manufacturing delay,Anti-Infective,Current,,
385,Cefotetan Disodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 g PBP (NDC 63323-0396-61),Reverified,12/20/19,No release date available at this time.,,,Manufacturing delay,Anti-Infective,Current,,
386,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 2g Vial 10 (NDC 52565-0053-10),Revised,1/10/18,Available,,,,Anti-Infective,Current,,
387,Cefotetan Disodium Injection,"Teligent Pharma, Inc.",856-697-1441,Cefotan 1g Vial 10 (NDC 52565-0052-10),Revised,1/10/18,Available,,,,Anti-Infective,Current,,
388,"Cefoxitin for Injection, USP",Apotex Corp.,800-706-5575,1 g (25 vials) (NDC 60505-0759-05),Reverified,11/27/19,Product is temporarily discontinued,Product manufactured by Hospira,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
389,"Cefoxitin for Injection, USP",Apotex Corp.,800-706-5575,2 g (25 vials) (NDC 60505-0760-05),Reverified,11/27/19,Product is temporarily discontinued,Product manufactured by Hospira,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
390,"Cefoxitin for Injection, USP",Apotex Corp.,800-706-5575,10 g (10 vials) (NDC 60505-0761-04),Reverified,11/27/19,Product is temporarily discontinued,Product manufactured by Hospira,,Discontinuation of the manufacture of the drug,Anti-Infective,Current,,
391,"Cefoxitin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,1 g per vial; SDV; (NDC 63323-341-25),Reverified,12/20/19,Backordered.  Next release January 2020.,Check wholesalers for inventory,,Manufacturing delays,Anti-Infective,Current,,
392,"Cefoxitin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,2 grams per vial; SDV; (NDC 63323-342-25),Reverified,12/20/19,Backordered.  Next release January 2020.,Check wholesalers for inventory,,Manufacturing delays,Anti-Infective,Current,,
393,"Cefoxitin for Injection, USP",Sagent Pharmaceuticals,866-625-1618,"10 g, package of 10 vials (NDC 25021-111-99)",Reverified,12/20/19,On backorder. Product continues to be manufactured with monthly releases. Estimated availability Feb-2020,,,Demand increase for the drug,Anti-Infective,Current,,
394,"Cefoxitin for Injection, USP",Sagent Pharmaceuticals,866-625-1618,"1 g, package of 10 vials (NDC 25021-109-10)",Reverified,12/20/19,Available. On allocation,,,Manufacturing delay,Anti-Infective,Current,,
395,"Cefoxitin for Injection, USP",Sagent Pharmaceuticals,866-625-1618,"2 g, package of 10 vials (NDC 25021-110-20)",Reverified,12/20/19,On allocation. Product continues to be manufactured with monthly releases. Estimated availability Jan-2020,,,Demand increase for the drug,Anti-Infective,Current,,
396,"Cefoxitin for Injection, USP",WG Critical Care,888-493-0861,1 g (NDC 44567-245-25),Revised,11/4/19,On backorder.  Next release December.,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
397,"Cefoxitin for Injection, USP",WG Critical Care,888-493-0861,2 g (NDC 44567-246-25),Revised,11/4/19,On backorder.  Next release December.,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
398,"Cefoxitin for Injection, USP",WG Critical Care,888-493-0861,10 g (NDC 44567-247-10),Revised,11/4/19,On backorder.  Next release December.,Please check wholesalers for available inventory.,,Demand increase for the drug,Anti-Infective,Current,,
399,"Cefoxitin for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1g vial (NDC 0143-9878-25),Revised,12/13/19,Available,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
400,"Cefoxitin for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,2g vial (NDC 0143-9877-25),Revised,12/13/19,Available,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
401,"Cefoxitin for Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,10g vial (NDC 0143-9876-10),Revised,12/13/19,Available,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Anti-Infective,Current,,
402,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 1g Bag 24 x 50mL (NDC 24987-0412-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
403,Ceftazidime (Fortaz) Injection,"Teligent Pharma, Inc.",856-697-1441,Ceftazidime (Fortaz) Premix Sol Frozen 2g Bag 24 x 50mL (NDC 24987-0413-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
404,Cefuroxime Sodium (Zinacef) Injection,"Teligent Pharma, Inc.",856-697-1441,Cefuroxime Sodium (Zinacef) Premix Sol Frozen 1.5g Bag 24 x 50mL (NDC 24987-0425-00),New,3/20/18,,No longer manufacturing product,,,Anti-Infective;Pediatric,To be Discontinued,3/20/18,3/20/18
405,Cetirizine Hydrochloride,Torrent Pharma Inc.,888-544-2299 option 4,5 mg/5 mL oral syrup (NDC 13668-596-07),New,4/24/19,,,,,Pulmonary/Allergy,To be Discontinued,4/24/19,4/24/19
406,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,5 mg (NDC 43547-251-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
407,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,10 mg (NDC 43547-252-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
408,"Chlordiazepoxide Hydrochloride USP, Capsules",Bausch Health,800-321-4576,25 mg (NDC 43547-253-10),New,11/19/19,,"Product discontinuation as per business decision, non-safety related. Distributed by Solco Healthcare U.S., LLC. 
For additional information, please contact : 
Solco Healthcare US
email: chris.keith@solcohealthcare.com",,,Neurology;Psychiatry,To be Discontinued,11/19/19,11/19/19
409,Chloroquine Phosphate Tablets,"Rising Pharmaceuticals, Inc.",800-521-5340,500 mg (NDC 64980-178-02),Revised,3/25/16,,,Available,,Anti-Infective;Pediatric,Resolved,3/25/15,
410,Chlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100 count bottle (NDC 0378-0150-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
411,Chlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100 count bottle (NDC 0378-0162-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
412,Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride Oral Solution,"Paddock Laboratories, LLC",800-775-2054,4 mg/5 mL; 5 mg/5 mL; 60 mg/5 mL (NDC 0574-1103-16),New,6/12/19,,,,,Pulmonary/Allergy,To be Discontinued,6/12/19,6/12/19
413,Chlorpropamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100 count bottle (NDC 0378-0197-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
414,Chlorpropamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100 count bottle (NDC 0378-0210-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
415,Ciprofloxacin Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 50 count bottle (NDC 0378-1743-89)",New,5/2/19,,,,,Anti-Infective,To be Discontinued,5/2/19,5/2/19
416,Ciprofloxacin Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1000 mg, 50 count bottle (NDC 0378-1745-89)",New,5/2/19,,,,,Anti-Infective,To be Discontinued,5/2/19,5/2/19
417,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,300 mg per 2 mL (150 mg per mL); SDV; (NDC 63323-282-02),New,5/10/19,,3 & 6 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
418,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,600 mg per 4 mL (150 mg per mL); SDV; (NDC 63323-282-04),New,5/10/19,,6 & 8 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
419,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,900 mg per 6 mL (150 mg per mL); SDV; (NDC 63323-282-06),New,5/10/19,,3 & 5 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
420,"Clindamycin Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,9 grams per Pharmacy Bulk Package (150 mg per mL); (NDC 63323-282-60),New,5/10/19,,8 months dating available for direct or drop ship orders by request. Check wholesalers for inventory,,,Anti-Infective,To Be Discontinued,5/10/19,5/10/19
421,Clindamycin Phosphate and Benzoyl Peroxide (Duac) Topical Gel,GlaxoSmithKline,888-825-5249,10 mg; 50 mg  (NDC 0145-2371-05),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately November 2019.,,,Dermatology,To be Discontinued,6/28/19,6/28/19
422,Clomiphene Citrate,Teva Pharmaceuticals,800-545-8800,50 mg/1 unit tablet (NDC 0093-0041-65),New,6/10/19,,,,,Reproductive,To be Discontinued,6/10/19,6/10/19
423,Clomiphene Citrate,Teva Pharmaceuticals,800-545-8800,50 mg/1 unit tablet (NDC 0093-0041-03),New,6/10/19,,,,,Reproductive,To be Discontinued,6/10/19,6/10/19
424,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg  (90s)(NDC 0378-1910-77),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
425,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (100s)(NDC 0378-1910-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
426,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 0.5mg (1000s)(NDC 0378-1910-10),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
427,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (90s)(NDC 0378-1912-77),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
428,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (100s)(NDC 0378-1912-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
429,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 1mg (1000s)(NDC 0378-1912-10),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
430,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (100s)(NDC 0378-1914-01),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
431,Clonazepam Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Clonazepam Tablets 2mg (500s)(NDC 0378-1914-05),New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric,To be Discontinued,5/8/18,5/8/18
432,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0185-0063-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
433,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0185-0063-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
434,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0185-0063-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
435,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 0781-8018-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
436,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 0781-8018-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
437,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 1000 count bottle (NDC 0781-8018-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
438,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-752-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
439,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-752-02)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
440,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 100 count bottle (NDC 16714-469-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
441,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 0.5 mg, 500 count bottle (NDC 16714-469-02)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Northstar Rx LLC",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
442,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0185-0064-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
443,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0185-0064-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
444,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0185-0064-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
445,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 100 count bottle (NDC 0781-5567-01)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
446,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 500 count bottle (NDC 0781-5567-05)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
447,Clonazepam Tablets,Sandoz,800-525-8747,"Clonazepam tablets, 1 mg, 1000 count bottle (NDC 0781-5567-10)",New,6/5/18,,"Sandoz Inc. has made a business decision to permanently discontinue Clonazepam Tablets, marketed by Sandoz",,,Neurology;Pediatric,To be Discontinued,6/5/18,6/5/18
448,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg Tablet, 100 CT Bottle (NDC 18860-104-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
449,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"12.5 mg tablet, 100 CT Bottle (NDC 18860-101-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
450,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablets, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-102-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
451,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"25 mg tablet, 100  CT bottle (NDC 18860-102-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
452,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"100 mg tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-104-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
453,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-105-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
454,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"150 mg Tablet, 100 CT Bottle (NDC 18860-105-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
455,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablet, 8 Blister Pack In 1 Carton > 6 Tablets in 1 Blister Pack (NDC 18860-106-01)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
456,Clozapine (FazaClo® ) Orally Disintegrating Tablets,"Jazz Pharmaceuticals, Inc.",800-520-5568,"200 mg Tablets, 100 CT Bottle (NDC 18860-106-10)",New,11/22/19,,A commercial decision has been made to discontinue the sale of the product.,,,Psychiatry,To be Discontinued,11/22/19,11/22/19
457,"Cycloserine Capsules, USP",Purdue GMP Center,833-304-9569,250mg capsules blister pack x 30 (NDC 13845-1202-2),Revised,4/17/19,,,Available,,Anti-Infective,Resolved,4/17/19,
458,Cysteine Hydrochloride Injection,"Exela Pharma Sciences, LLC",828-758-5474 ext. 154 or 230,Elcys (Cysteine Hydrochloride injection) 500mg/10ml Single-dose vials (NDC 51754-1007-1) Packaged as 10 per carton (NDC 51754-1007-3),Revised,9/3/19,,,Available,,Other;Pediatric,Resolved,9/3/19,
459,Daclatasvir Tablets,Bristol Myers Squibb Co.,800-332-2056,60 mg tablets (NDC 0003-0215-01),Revised,1/4/19,,Planned cease distribution is June 2019.,,,Antiviral,To be Discontinued,1/4/19,1/4/19
460,Daclatasvir Tablets,Bristol Myers Squibb Co.,800-332-2056,30 mg tablets (NDC 0003-0213-01),Revised,1/4/19,,Planned cease distribution is June 2019.,,,Antiviral,To be Discontinued,1/4/19,1/4/19
461,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 15 mg Bottle of 30, (NDC 10370-171-11)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
462,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 15 mg Bottle of 90 (NDC 10370-171-09)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
463,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 7.5 mg Bottle of 30 (NDC 10370-170-11)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
464,Darifenacin Hydrobromide Tablets,Par Pharmaceutical,800-828-9393,"Extended-Release Tablet, 7.5 mg Bottle of 90 (NDC 10370-170-09)",New,10/30/19,,Par has made a business decision to permanently discontinue the drug product.,,,Urology,To be Discontinued,10/30/19,10/30/19
465,Dasabuvir Sodium; Ombitasvir; Paritaprevir; Ritonavir (Viekira XR) Tablets,Abbvie,800-255-5162,"200mg; 8.33mg; 50mg; 33.33 tablets, (NDC 0074-0063-28)",New,5/22/18,,"Estimated product availability until January 1, 2019. The product discontinuation is voluntary.",,,Antiviral,To be Discontinued,5/22/18,5/22/18
466,"Deferoxamine Mesylate for Injection, USP","ApoPharma USA, Inc.",866-931-0740,"500 mg per vial, Single use vial, Carton of 4 vials (NDC 52609-4505-6)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
467,"Deferoxamine Mesylate for Injection, USP","ApoPharma USA, Inc.",866-931-0740,"2 g per vial, Single use vial, Carton of 4 vials (NDC 52609-4504-6)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
468,"Deferoxamine Mesylate for Injection, USP","Hospira, Inc.",844-646-4398,500 mg; Single Dose Glass Fliptop Vial (NDC 00409-2336-10),Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
469,"Deferoxamine Mesylate for Injection, USP","Hospira, Inc.",844-646-4398,2 g; Single Dose Glass Fliptop Vial (NDC 00409-2337-25),Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
470,"Deferoxamine Mesylate for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg per vial, 10 mL vial (NDC 63323-597-10)",Revised,9/10/19,,,,,Hematology,Resolved,9/10/19,
471,Delavirdine Mesylate (RESCRIPTOR) Tablets,ViiV Healthcare,877-844-8872,200 mg tablets; bottles of 180 tablets (NDC 49702-225-17),New,6/26/19,,This decision is business-related and the anticipated final date for availability to patients is January 2020.,,,Antiviral,To be Discontinued,6/26/19,6/26/19
472,Desloratadine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-4017-01)",New,5/2/19,,,,,Pulmonary/Allergy,To be Discontinued,5/2/19,5/2/19
473,Desloratadine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-4017-05)",New,5/2/19,,,,,Pulmonary/Allergy,To be Discontinued,5/2/19,5/2/19
474,Desogestrel and Ethinyl Estradiol Tablets (ORTHO-CEPT),Janssen Pharmaceuticals,800-526-7736,ORTHO-CEPT (NDC 50458-196-15),Revised,10/8/14,,Product will be delisted. Last distribution March 2015.,,Discontinuation of the manufacture of the drug.,,To Be Discontinued,10/8/14,
475,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection SDV [4 mg / 1 ml] 25PK (NDC 67457-423-12),Reverified,11/26/19,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
476,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [20 mg / 5 ml] 25PK (NDC 67457-422-54),Reverified,11/26/19,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
477,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [120 mg / 30 ml] 25 PK (NDC 67457-421-30),Reverified,11/26/19,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
478,Dexamethasone Sodium Phosphate Injection,Mylan Institutional,800-796-9526,Dexamethasone Sodium Phosphate Injection MDV [100 mg / 10 ml] 10PK (NDC 67457-420-10),Reverified,11/26/19,Available,,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
479,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,4 mg/1 mL SDV (NDC 55150-237-01),Revised,10/7/19,Currently available,Check wholesalers for inventory,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
480,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,20 mg/5 mL MDV  (NDC 55150-238-05),Revised,10/7/19,Backordered — next shipment anticipated late Oct. 2019.,Intermittent availability expected.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
481,Dexamethasone Sodium Phosphate Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),866-850-2876,120 mg/30 mL MDV (NDC 55150-239-30),Revised,10/7/19,Backordered — next shipment anticipated late Oct. 2019.,Intermittent availability expected.,,Other,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
482,Dexamethasone Sodium Phosphate Injection,"Somerset Therapeutics, LLC",732-554-1019,"Dexamethasone Sodium Phosphate Injection USP, 10 mg/mL, 1 mL Single Dose Vial (Preservative Free)(NDC 70069-021-25)",New,2/8/19,Currently in Stock (we have capacity constraint but product available at this time). Estimated Release Dates: Released Product Available,,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
483,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,20 mg per 5 mL (4 mg per mL); MDV;  Amber vial (NDC 63323-165-05),Reverified,12/20/19,Available,Check wholesalers for inventory.,,Delay in manufacturing,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
484,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mg per 10 mL (10 mg per mL); MDV;  Amber Vial (NDC 63323-516-10),Reverified,12/20/19,Available,Check wholesalers for inventory.,,Delay in manufacturing,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
485,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,120 mg per 30 mL (4 mg per mL); MDV; Amber Vial (NDC 63323-165-30),Reverified,12/20/19,Available,Check wholesalers for inventory.,,Delay in manufacturing,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
486,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,4 mg per mL (4 mg per mL); SDV; Amber Vial (NDC 63323-165-01),Reverified,12/20/19,Available,Check wholesalers for inventory.,,Delay in manufacturing,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
487,Dexamethasone Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per mL (10 mg per mL); SDV; Preservative Free; Amber Vial (NDC 63323-506-01),Reverified,12/20/19,Available,Check wholesalers for inventory.,,Increase in demand,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
488,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6145-25)",Revised,12/13/19,"Available, additional lots manufactured Jan/feb 2020.",,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
489,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 5 mL vial (NDC 0641-6146-25)",Revised,12/13/19,"Available, additional lots manufactured Jan/feb 2020.",,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
490,Dexamethasone Sodium Phosphate Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-0367-25)",Revised,12/13/19,"Available, additional lots manufactured Jan/feb 2020.",,,Demand increase for the drug,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Neurology;Oncology;Ophthalmology;Other;Pulmonary/Allergy;Rheumatology,Current,,
491,Dexmethylphenidate Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,10 mg 100 Count (NDC 0093-5277-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
492,Dexmethylphenidate Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2.5 mg 100 Count (NDC 0093-5275-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
493,Dexmethylphenidate Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg 100 Count (NDC 0093-5276-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
494,Dexrazoxane Injection,Gland Pharma,609-250-7990,500 mg per vial (NDC 72266-101-01,Reverified,12/10/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Oncology;Pediatric,Current,,
495,Dexrazoxane Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,250 mg per vial (NDC 0143-9247-01),Reverified,12/13/19,Inventory is currently available,Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
496,Dexrazoxane Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,500 mg per vial (NDC 0143-9248-01),Reverified,12/13/19,This presentation is temporarily on backorder.,Additional lots are scheduled to be manufactured in the June 2019 timeframe. Product will be made available as it is released.,,Demand increase for the drug,Oncology;Pediatric,Current,,
497,Dexrazoxane Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),250 mg Kit (NDC 67457-207-25),Revised,12/20/19,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,,
498,Dexrazoxane Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),500 mg Kit (NDC 67457-208-50),Revised,12/20/19,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,,
499,Dexrazoxane Injection,Pfizer Pharmaceuticals,844-646-4398,Zinecard 250 mg; Single Dose Vial (NDC 00013-8717-62),Reverified,12/20/19,Available,,,Other,Oncology;Pediatric,Current,,
500,Dexrazoxane Injection,Pfizer Pharmaceuticals,844-646-4398,Zinecard 500 mg; Single Dose Vial (NDC 00013-8727-89),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Oncology;Pediatric,Current,,
501,Dexrazoxane Injection,Clinigen Healthcare Ltd,615-255-0068,Totect® (Dexrazoxane) for injection; 1 vial (500 mg)(NDC 66220-110-01),Revised,5/10/19,Available,,,Available,Oncology;Pediatric,Current,,
502,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-1070-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
503,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100s (NDC 0378-1071-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
504,Dextroamphetamine Sulfate Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-1072-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Neurology;Pediatric;Psychiatry,To be Discontinued,5/8/18,5/8/18
505,Dextrose 25% Injection,"Hospira, Inc.",844-646-4398,250 mg/mL (25%); Ansyr Plastic Syringe (NDC 0409-1775-10),Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
506,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, in VIAFLO container Product codes:  UE0062D (250mL, NDC 0338-0062-30); UE0063D (500mL, NDC 0338-0066-20); UE0064D (1000mL, NDC 0338-0070-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
507,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, 25 mL, in VIAFLEX Plastic Container. Quad Pack.  Product code 2B0080  (NDC 0338-0017-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
508,Dextrose 5% Injection Bags,Baxter Healthcare,800-229-0001,"5% Dextrose Injection, USP, 100 mL MINI-BAG Plus Container, in VIAFLEX Plastic Container.  Single Pack. Product code EZPB0041 (NDC 0338-9147-30)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
509,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL VIAFLEX Plastic Container.  Product code 2B0062Q  (NDC 0338-0017-02)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
510,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL VIAFLEX Plastic Container.  Product code 2B0063Q  (NDC 0338-0017-03)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
511,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 1000 mL VIAFLEX Plastic Container. Product code 2B0064X  (NDC 0338-0017-04)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
512,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 250 mL AVIVA Container.  Product code 6E0062 (NDC 0338-6346-02)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
513,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 500 mL AVIVA Container. Product code 6E0063  (NDC 0338-6346-03)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
514,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL (NDC 0409-7922-02),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
515,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,500 mL (NDC 0409-7922-03),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
516,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,1000 mL (NDC 0409-7922-09),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
517,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL VisIV™ Container (NDC 0409-7922-25),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
518,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,250 mL (NDC 0409-7922-53),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
519,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,500 mL (NDC 0409-7922-55),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
520,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,150 mL (NDC 0409-7922-61),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
521,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,50 mL VisIV™ Container (NDC 0409-7923-06),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
522,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,100 mL VisIV™ Container (NDC 0409-7923-11),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
523,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,50 mL (NDC 0409-7923-13),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
524,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"25 mL, Quad Pack (NDC 0409-7923-20)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
525,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,100 mL (NDC 0409-7923-23),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
526,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL, Quad Pack (NDC 0409-7923-36)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
527,Dextrose 5% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL, Quad Pack (NDC 0409-7923-37)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
528,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 100mL 
(NDC 63323-624-61)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
529,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 250mL 
(NDC 63323-624-74)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
530,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 50 mL, in VIAFLEX Plastic Container: Single Pack (NDC 0338-0017-41)
Quad Pack (NDC 0338-0017-11)
Multi Pack (NDC 0338-0017-31)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
531,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, 100 mL, in VIAFLEX Plastic Container: Single Pack (NDC 0338-0017-48)
Quad Pack (NDC 0338-0017-18
Multi Pack (NDC 0338-0017-38)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
532,Dextrose 5% Injection Bags,"Hospira, Inc.",844-646-4398,50 mL (5%); ADD-Vantage Flexible Container (NDC 00409-7100-66),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
533,Dextrose 5% Injection Bags,"Hospira, Inc.",844-646-4398,100 mL (5%); ADD-Vantage Flexible Container (NDC 00409-7100-67),Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
534,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 500mL 
(NDC 63323-624-75)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
535,Dextrose 5% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"5% Dextrose Injection, USP, 1000mL 
(NDC 63323-624-10)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
536,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, in MINI-BAG Plus container, 50 mL,  Product code 2B0040 (NDC 0338-0551-11)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
537,Dextrose 5% Injection Bags,Baxter Healthcare,888-229-0001,"5% Dextrose Injection, USP, in MINI-BAG Plus container, 100 mL,  Product code 2B0041 (NDC 0338-0551-18)",Revised,9/23/19,,,,,Gastroenterology;Other;Pediatric,Resolved,9/23/19,
538,Dextrose 50% Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"DEXTROSE INJECTION, USP, 50%, [500 mg / mL](NDC 76329-3301-1)",Reverified,12/16/19,Intermittent supply,"IMS is releasing product, but market demand continues to exceed our capacity",,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,9/23/19,
539,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,25 g/50 mL (50%; 0.5 g/mL); LifeShield Abboject Glass Syringe (NDC 0409-4902-34),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: June 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,9/23/19,
540,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,25 g/50 mL (50%; 0.5 g/mL); Single Dose Glass Fliptop Vial (NDC 0409-6648-02),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,9/23/19,
541,Dextrose 50% Injection,"Hospira, Inc.",844-646-4398,25 g/50 mL (50%; 0.5 g/mL); Ansyr Plastic Syringe (NDC 0409-7517-16),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: June 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
542,"Diazepam Injection, USP","Beloteca, Inc.",512-669-8765,"Diazepam Injection, USP 10 mg/2 mL (5 mg/mL) Prefilled Single-dose Syringe with Luer Lock (NDC 69339-136-32)",Revised,12/17/19,,,,,Neurology,Resolved,12/17/19,
543,"Diazepam Injection, USP","Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1273-32),Revised,12/17/19,,,,,Neurology,Resolved,12/17/19,
544,"Diazepam Injection, USP","Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-3213-12),Revised,12/17/19,,,,,Neurology,Resolved,12/17/19,
545,Diclofenac Sodium Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0355-01),New,4/4/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction;Rheumatology,To be Discontinued,4/4/18,4/4/18
546,Dicyclomine Hydrochloride (BENTYL®) Capsule & Tablet,Allergan Sales LLC,800-678-1605,10 mg capsules in bottles of 100 (NDC 58914-012-10),New,3/29/19,,Product discontinued October 2017,,,Gastroenterology,To be Discontinued,3/29/19,3/29/19
547,Dicyclomine Hydrochloride (BENTYL®) Capsule & Tablet,Allergan Sales LLC,800-679-1605,20 mg tablets in bottles of 100 (NDC 58914-013-10),New,3/29/19,,Product discontinued December 2016,,,Gastroenterology,To be Discontinued,3/29/19,3/29/19
548,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 10mg C 100s (NDC 0378-1610-01),Reverified,11/26/19,Out of Stock. Resupply is Q4 2019.,,,Other,Gastroenterology,Current,,
549,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 10mg C 500s (NDC 0378-1610-05),Reverified,11/26/19,Out of Stock. Resupply is Q4 2019.,,,Other,Gastroenterology,Current,,
550,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 20mg T 100s (NDC 0378-1620-01),Reverified,11/26/19,Available,,,Other,Gastroenterology,Current,,
551,Dicyclomine Oral Tablets/Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Dicyclomine HCl 20mg T 500s (NDC 0378-1620-05),Reverified,11/26/19,Out of Stock. Resupply is Q4 2019.,,,Other,Gastroenterology,Current,,
552,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Capsules USP, 10 mg (100 count bottles) (NDC 0527-0586-01)",Revised,9/12/19,Available,,,,Gastroenterology,Current,,
553,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Capsules USP, 10 mg (1000 count bottles) (NDC 0527-0586-10)",Revised,9/12/19,Available,,,,Gastroenterology,Current,,
554,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Tablets USP, 20 mg (100 count bottles) (NDC 0527-1282-01)",Revised,9/12/19,Available,,,,Gastroenterology,Current,,
555,Dicyclomine Oral Tablets/Capsules,"Lannett Company, Inc.",215-333-9000,"Dicyclomine Hydrochloride Tablets USP, 20 mg (1000 count bottles) (NDC 0527-1282-10)",Revised,9/12/19,Available,,,,Gastroenterology,Current,,
556,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 10MG CAPSULES 100 count (NDC 0591-0794-01),Reverified,12/16/19,Available,Cannot support additional business currently.,,,Gastroenterology,Current,,
557,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 10MG CAPSULES 1000 count (NDC 0591-0794-10),Reverified,12/16/19,Available,Cannot support additional business currently.,,,Gastroenterology,Current,,
558,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 20MG TABLETS 100 count (NDC 0591-0795-01),Reverified,12/16/19,Available,Cannot support additional business currently.,,,Gastroenterology,Current,,
559,Dicyclomine Oral Tablets/Capsules,Teva Pharmaceuticals,800-545-8800,DICYCLOMINE HCL 20MG TABLETS 1000 count (NDC 0591-0795-10),Reverified,12/16/19,Available,Cannot support additional business currently.,,,Gastroenterology,Current,,
560,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Caps, USP, 10mg 1000s (NDC 0143-3126-10)",Reverified,12/13/19,Available,,,,Gastroenterology,Current,,
561,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Caps, USP, 10mg 100s (NDC 0143-3126-01)",Reverified,12/13/19,Available,,,,Gastroenterology,Current,,
562,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Tabs, USP, 20mg 1000s (NDC 0143-1227-10)",Reverified,12/13/19,Available,,,,Gastroenterology,Current,,
563,Dicyclomine Oral Tablets/Capsules,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Dicyclomine HCl Tabs, USP, 20mg 100s (NDC 0143-1227-01)",Reverified,12/13/19,Available,,,,Gastroenterology,Current,,
564,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 200 mg, 30 count bottles (NDC 0555-0588-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
565,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 250 mg, 30 count bottles (NDC 0555-0589-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
566,Didanosine Delayed-Release Capsules USP,Teva Pharmaceuticals,800-545-8800,"Didanosine Delayed-Release Capsules, USP, 400 mg, 30 count bottles (NDC 0555-0590-01)",New,5/9/18,,This was a business-related decision to discontinue manufacturing these products,,,Antiviral,To be Discontinued,5/9/18,5/9/18
567,Diethylpropion Hydrochloride Controlled-Release Tablets,Teva Pharmaceuticals,800-545-8800,75 mg tablets (NDC 0591-0782-01),New,6/11/19,,This product discontinuation is a business related decision.,,,Endocrinology/Metabolism,To be Discontinued,6/11/19,6/11/19
568,Diethylpropion Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,25 mg tablets (NDC 0591-0783-01),New,6/11/19,,This product discontinuation is a business related decision.,,,Endocrinology/Metabolism,To be Discontinued,6/11/19,6/11/19
569,Difluprednate (Durezol) Ophthalmic Emulsion,Novartis,888-669-6682,0.05% 5mL in 8mL bottle (NDC 0065-9204-07),Revised,10/15/19,,,,,Ophthalmology,Resolved,10/15/19,
570,Diltiazem Hydrochloride,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 5 mL vial  (NDC 0641-6013-10)",Revised,12/13/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
571,Diltiazem Hydrochloride,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 10 mL vial (NDC 0641-6014-10)",Revised,12/13/19,Temporarily backorderd. Additional lots available end of December 2019 and additional product manufactured Jan/Feb 2020.,,,Demand increase for the drug,Cardiovascular,Current,,
572,Diltiazem Hydrochloride,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 30 mL vial (NDC 0641-6015-10)",Revised,12/13/19,Temporarily backorderd. Additional lots available end of December 2019 and additional product manufactured Jan/Feb 2020.,,,Demand increase for the drug,Cardiovascular,Current,,
573,Diltiazem Hydrochloride,"Hospira, Inc.",844-646-4398,100 mg; Single Dose ADD-Vantage Vial (NDC 00409-4350-03),Reverified,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,,,Demand increase for the drug,Cardiovascular,Current,,
574,Diltiazem Hydrochloride,"Hospira, Inc.",844-646-4398,25 mg/5 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
575,Diltiazem Hydrochloride,"Hospira, Inc.",844-646-4398,50 mg/10 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1171-02),Reverified,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
576,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 10 mL, 10 vials (NDC 17478-0937-10)",Revised,12/2/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
577,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 25 mg / 5 mL, 10 mL, 10 vials (NDC 17478-0817-10)",Revised,12/2/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
578,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 5 mg / mL, 25 mL, 1 vial (NDC 17478-0817-25)",Revised,12/2/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
579,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 5 mg / mL, 25 mL, 10 vials (NDC 17478-0817-26)",Revised,12/2/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
580,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 1 vial (NDC 17478-0937-25)",Revised,12/2/19,Unavailable. Estimated recovery Dec 2019,,,Demand increase for the drug,Cardiovascular,Current,,
581,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 25 mL, 10 vials (NDC 17478-0937-26)",Revised,12/2/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
582,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection 5 mg / mL, 5 mL, 10 vials (NDC 17478-0937-05)",Revised,12/2/19,Unavailable. Estimated recovery Dec 2019,,,Demand increase for the drug,Cardiovascular,Current,,
583,Diltiazem Hydrochloride,Akorn Pharmaceuticals,800-932-5676,"Diltiazem HCl Injection (Premier) 0.5 mg / mL, 30 gram, 10 vials (NDC 17478-0817-05)",Revised,12/2/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
584,Diltiazem Hydrochloride ER (Twice-a-Day) Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,60 mg (NDC 0378-6060-01),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
585,Diltiazem Hydrochloride ER (Twice-a-Day) Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,90 mg (NDC 0378-6090-01),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
586,Diltiazem Hydrochloride ER (Twice-a-Day) Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,120 mg (NDC 0378-6120-01),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
587,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 100 count bottle (NDC 0378-5220-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
588,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 500 count bottle (NDC 0378-5220-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
589,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"180 mg, 100 count bottle (NDC 0378-5280-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
590,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"180 mg, 500 count bottle (NDC 0378-5280-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
591,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"240 mg, 100 count bottle (NDC 0378-5340-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
592,Diltiazem Hydrochloride Extended-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"240 mg, 500 count bottle (NDC 0378-5340-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
593,Diphenhydramine Injection,"Hospira, Inc.",844-646-4398,50 mg/mL Carpuject™ Luer Lock Glass Syringe (NDC 00409-2290-31),Reverified,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Pediatric;Pulmonary/Allergy,Current,,
594,Diphenhydramine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL vial (NDC 0641-0376-25)",Reverified,12/13/19,Available,,,Demand increase for the drug,Pediatric;Pulmonary/Allergy,Current,,
595,Diphenhydramine Injection,Mylan Institutional,800-796-9526,500 mg / 10mL(NDC 67457-124-10),Reverified,11/26/19,Available,,,Demand increase for the drug,Pediatric;Pulmonary/Allergy,Current,,
596,Diphenhydramine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"50 mg per vial, Single dose, Amber vial (NDC 63323-664-01)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Pediatric;Pulmonary/Allergy,Current,,
597,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100s (NDC 0378-4140-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
598,Disulfiram Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100s (NDC 0378-4141-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
599,Disulfiram Tablets,Teva Pharmaceuticals,800-545-8800,"250 mg, 100 count (NDC 0093-5035-01)",Reverified,12/16/19,Availability and estimated duration of supply interruption is unknown,,,Other,Analgesia/Addiction,Current,,
600,Disulfiram Tablets,Teva Pharmaceuticals,800-545-8800,"500 mg, 100 count (NDC 0093-5036-01)",Reverified,12/16/19,Availability and estimated duration of supply interruption is unknown,,,Other,Analgesia/Addiction,Current,,
601,Disulfiram Tablets,"Alvogen, Inc.",866-770-3024,"250 mg, 30 count (NDC 47781-607-30)",Revised,11/20/19,Next delivery: February 2020,,,Delay in shipping of the drug,Analgesia/Addiction,Current,,
602,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,500 mg Bottle of 500 (NDC 10370-511-50),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
603,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,500 mg Bottle of 100 (NDC 10370-511-10),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
604,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,250 mg Bottle of 100 (NDC 10370-510-10),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
605,Divalproex Sodium Extended-Release Tablets,Par Pharmaceutical,800-828-9393,250 mg Bottle of 500 (NDC 10370-510-50),New,10/31/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,10/31/19,10/31/19
606,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/250 mL (1 mg/mL); Flexible Container (NDC 00409-2346-32),Reverified,12/20/19,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
607,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/250 mL (2 mg/mL); Flexible Container (NDC 00409-2347-32),Reverified,12/20/19,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
608,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,1000 mg/250 mL (4 mg/mL); Flexible Container (NDC 00409-3724-32),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: May 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
609,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-20),Reverified,12/20/19,Next Delivery: March 2020; Estimated Recovery: June 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
610,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,500 mg/40 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2025-54),Reverified,12/20/19,Next Delivery and Estimated Recovery: December 2019,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pediatric;Renal,Current,,
611,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-01),Reverified,12/20/19,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
612,Dobutamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,250 mg/20 mL (12.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2344-02),Reverified,12/20/19,Available,,,Other,Cardiovascular;Pediatric;Renal,Current,,
613,Dobutamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"250 mg/250 mL (NDC 0338-1073-02) Product code 2B0791, 500 mg/250 mL (NDC 0338-1075-02) Product code 2B0792, 1000 mg/250 mL (NDC 0338-1077-02) Product code 2B0793",Reverified,12/11/19,Available,,,,Cardiovascular;Pediatric;Renal,Current,,
614,"Docusate Sodium Capsules, USP",Par Pharmaceutical,800-828-9393,"100mg, count bottle (NDC 0603-0150-21)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,4/9/19,4/9/19
615,"Docusate Sodium Capsules, USP",Par Pharmaceutical,800-828-9393,"100mg, count bottle (NDC 0603-0150-32)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,4/9/19,4/9/19
616,Dopamine Hydrochloride Injection,Baxter Healthcare,888-229-0001,"800 mcg/mL (250 mL bag) Product code 2B0832 (NDC 0338-1005-02), 800 mcg/mL (500 mL bag)  Product code 2B0833 (NDC 0338-1005-03), 1600 mcg/mL (250 mL bag) Product code 2B0842 (NDC 0338-1007-02), 1600 mcg/mL (500 mL bag) Product code 2B0843 (NDC 0338-1007-03), 3200 mcg/mL (250 mL bag) Product code 2B0846 (NDC 0338-1009-02)",Reverified,12/11/19,Available,,,,Cardiovascular,Current,,
617,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"400 mg/250 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-22)",Revised,12/20/19,Available,,,Other,Cardiovascular,Current,,
618,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/500 mL (1,600 mcg/mL); Flexible Container (NDC 00409-7809-24)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
619,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,"800 mg/250 mL (3,200 mcg/mL); Flexible Container (NDC 00409-7810-22)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
620,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-5820-01),Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
621,Dopamine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,400 mg/10 mL (40 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9104-20),Revised,12/20/19,Next Delivery and Estimated Recovery: June 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
622,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 17478-605-10)",Revised,12/20/19,Available,,,,Ophthalmology,Current,,
623,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 50383-233-10)",Revised,12/20/19,"Limit availability / Recovery expected Q1, 2020","Manufacturer interruption production issues.  Marketed by Hi-Tech Pharmacal Co., Inc. To order, contact Akorn Customer Service (1-800-932-5676)",,Other,Ophthalmology,Current,,
624,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Cosopt-PF® dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 0.2 mL single use, 60 count (NDC 17478-604-30)",Revised,12/20/19,Available,"Marketed by Akorn, Inc. To order, contact Akorn Customer Service (1-800-932-5676)",,Other,Ophthalmology,Current,,
625,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 61314-030-02)",Reverified,12/18/19,Supply available,"Labeled under Sandoz Inc. To order, contact Sandoz Inc. at 1-800-525-8747",,Demand increase for the product,Ophthalmology,Current,,
626,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 24208-486-10)",Revised,12/13/19,Intermittent backorders through Q1 2020. Estimated availability: Late January 2020/February 2020,"Marketed by Bausch & Lomb Inc. To order, contact Bausch & Lomb, a division of Valeant Pharmaceuticals North America at pharcs@valeant.com",,Other,Ophthalmology,Current,,
627,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL and Timolol maleate 6.8 mg/mL, 10 mL (NDC 0591-2482-79)",Reverified,12/16/19,Unavailable,This was a business-related decision to discontinue manufacturing these products.,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,,
628,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride and Timolol Maleate 20 mg and 5 mg/mL, 10 mL (0591-2482-79)",New,4/20/18,,This was a business-related decision to discontinue manufacturing this product.,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
629,Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution,Aurobindo Pharma,866-850-2876,"Dorzolamide HCl and Timolol Maleate (Cosopt® PF) Ophthalmic Solution 2%/0.5% Preservative Free, 2mL single use container (NDC 65862-0947-60)",Reverified,12/13/19,Available,Available,,Other,Ophthalmology,Current,,
630,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",New,4/20/18,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
631,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",New,4/20/18,,This was a business-related decision to discontinue manufacturing these products,,,Ophthalmology,To be Discontinued,4/20/18,4/20/18
632,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride 22.3 mg/mL, 10 mL (NDC 0591-2481-79)",Reverified,12/16/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,4/20/18,4/20/18
633,Dorzolamide Hydrochloride Ophthalmic Solution,Teva Pharmaceuticals,800-545-8800,"Dorzolamide Hydrochloride 22.3 mg/mL, 10 mL (NDC 0093-7618-43)",Reverified,12/16/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Ophthalmology,Current,4/20/18,4/20/18
634,Dorzolamide Hydrochloride Ophthalmic Solution,Akorn Pharmaceuticals,800-932-5676,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 50383-232-10)",Revised,12/2/19,"Limit availability / Recovery expected Q1, 2020","Manufacturer interruption production issues. Distributed by Hi-Tech Pharmacal Co., Inc. To order, contact Akorn Customer Service (1-800-932-5676)",,Other,Ophthalmology,Current,,
635,Dorzolamide Hydrochloride Ophthalmic Solution,Merck Sharp & Dohme Corp.,800-637-2579,"TRUSOPT® dorzolamide hydrochloride ophthalmic solution 2%, 10 mL in an 18 mL capacity bottle (NDC 0006-3519-36)",Reverified,6/1/18,Product is available,"For additional information please contact: Merck National Service Center, Telephone Number: 1-800-672-6372",,Demand increase for the drug,Ophthalmology,Current,,
636,Dorzolamide Hydrochloride Ophthalmic Solution,Bausch Health,800-321-4576,"Dorzolamide hydrochloride USP 2%, 10 mL (NDC 24208-485-10)",Revised,12/13/19,Currently on backorder. Estimated availability: January 2020,"Marketed by Bausch & Lomb Inc. To order, contact Bausch & Lomb, a division of Bausch Health US, LLC at pharcs@bauschhealth.com",,Other,Ophthalmology,Current,,
637,Dorzolamide Hydrochloride Ophthalmic Solution,Sandoz,800-525-8747,"Dorzolamide hydrochloride 22.3 mg/mL, 10 mL (NDC 61314-019-10)",Reverified,12/18/19,Supply available,"Labeled under Sandoz Inc. To order, contact Sandoz Inc. at 1-800-525-8747",,Demand increase for the product,Ophthalmology,Current,,
638,Doxycycline Capsules,Teva Pharmaceuticals,800-545-8800,50 mg capsules (NDC 0591-0410-01),New,4/29/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,4/29/19,4/29/19
639,Doxycycline Capsules,Teva Pharmaceuticals,800-545-8800,75 mg capsules (NDC 0591-2404-01),New,4/29/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,4/29/19,4/29/19
640,Doxycycline Capsules,Teva Pharmaceuticals,800-545-8800,100 mg capsules (NDC 0591-0411-50),New,4/29/19,,This product discontinuation is a business related decision.,,,Anti-Infective,To be Discontinued,4/29/19,4/29/19
641,Doxycycline Hyclate Capsules,Teva Pharmaceuticals,800-545-8800,50 mg  (NDC 0591-5535-50),New,10/15/19,,This product is being discontinued due to a business decision.,,,Anti-Infective,To be Discontinued,10/15/19,10/15/19
642,Doxycycline Hyclate Capsules,Teva Pharmaceuticals,800-545-8800,100 mg (NDCs 0591-5440-50 and 0591-5440-05),New,10/15/19,,This product is being discontinued due to a business decision.,,,Anti-Infective,To be Discontinued,10/15/19,10/15/19
643,Doxycycline Hyclate Delayed Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,150 mg tablets (NDC 0378-3030-01),New,9/9/19,,,,,Anti-Infective,To be Discontinued,9/9/19,9/9/19
644,Dronabinol Capsules,"Endo Pharmaceuticals, Inc.",800-462-3636,"2.5 mg capsules (NDC 498840-867-02), 5 mg capsules (NDC 498840-868-02), 10 mg capsules (NDC 498840-869-02)",New,2/7/19,,,,,Gastroenterology,To be Discontinued,2/7/19,2/7/19
645,Echothiophate Iodide (Phospholine Iodide) Ophthalmic Solution,Pfizer Pharmaceuticals,800-533-4535,6.25 mg package for 0.125% (NDC 0046-1065-05),Reverified,12/20/19,Next delivery and Estimated recovery: Q3 2020,Shortage per manufacturer: Manufacturing Delay,,Other,Ophthalmology,Current,,
646,Eflornithine Hydrochloride (Vaniqa) Cream,Allergan,800-678-1605,13.9% (NDC 0023-4857-45),Revised,6/12/19,,,,,Dermatology,Resolved,6/12/19,
647,Emedastine Difumarate (Emadine) 0.05% Ophthalmic Solution,Novartis,888-669-6682,Emadine (emedastine difumarate) 0.05% ophthalmic solution 5mL in 1 Bottle (NDC 0065-0325-05),New,1/29/19,,Novartis Pharmaceuticals has made a business decision to permanently discontinue this product.,,,Ophthalmology;Pulmonary/Allergy,To be Discontinued,1/29/19,1/29/19
648,"Enalaprilat Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2.5mg/2mL, vial (NDC 0143-9786-10)",Revised,12/13/19,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
649,"Enalaprilat Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1.25mg/mL, vial  (NDC 0143-9787-10)",Revised,12/13/19,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Cardiovascular,Current,,
650,"Enalaprilat Injection, USP","Hospira, Inc.",844-646-4398,1.25 mg/mL; Single Dose Glass Fliptop Vial (NDC 00409-2122-01),Reverified,12/20/19,Next Delivery: March 2020;  Estimated Recovery: June 2020,Shortage per manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
651,"Enalaprilat Injection, USP","Hospira, Inc.",844-646-4398,2.5 mg/2 mL (1.25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2122-02),Reverified,12/20/19,Next Delivery: March 2020;  Estimated Recovery: June 2020,Shortage per manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
652,Epinastine Hydrochloride (Elestat®) Ophthalmic Solution,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 00023-9201-05),New,8/19/19,,,,,Ophthalmology,To be Discontinued,8/19/19,8/19/19
653,"Epinephrine Injection, 0.1 mg/mL","Hospira, Inc.",844-646-4398,"1 mg/10 mL (0.1 mg/mL); LifeShield Abboject Glass Syringe (NDC 00409-4921-34, pack of 10; NDC 0409-4921-20, individual)",Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Pulmonary/Allergy,Current,,
654,"Epinephrine Injection, 0.1 mg/mL","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"1:10,000, 10mL Luer-Jet Prefilled Syringe
(NDC 76329-3316-1)(old NDC 0548-3316-00)",Reverified,12/16/19,Intermittent supply,"IMS is releasing product, but market demand continues to exceed our capacity",,Demand increase for the drug,Cardiovascular;Pulmonary/Allergy,Current,,
655,"Epinephrine Injection, Auto-Injector",Mylan Specialty,800-RXMYLAN (1-800-796- 9526),"0.3 mg (EpiPen® NDC 49502-500-02, pack of 2; NDC 49502-500-01, individual) (Authorized Generic NDC 49502-102-02, pack of 2; NDC 49502-102-01, individual)",Reverified,11/26/19,Available,"Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen® and the authorized generic version, continues to experience manufacturing constraints. Currently, supplies will vary from pharmacy to pharmacy. Mylan, the distributor, is expediting shipments to wholesalers upon receipt from Pfizer. Patients who are experiencing difficulty accessing product should continue to contact Mylan Customer Relations at 800-796-9526 for assistance in locating alternative pharmacies.",,Manufacturing delays,Pulmonary/Allergy,Current,,
656,"Epinephrine Injection, Auto-Injector",Mylan Specialty,800-RXMYLAN (1-800-796- 9526),0.15 mg (EpiPen® NDC 49502-501-02) (Authorized Generic NDC 49502-101-02),Reverified,11/26/19,Available,"Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen® and the authorized generic version, continues to experience manufacturing constraints. Currently, supplies will vary from pharmacy to pharmacy. Mylan, the distributor, is expediting shipments to wholesalers upon receipt from Pfizer. Patients who are experiencing difficulty accessing product should continue to contact Mylan Customer Relations at 800-796-9526 for assistance in locating alternative pharmacies.",,Manufacturing delays,Pulmonary/Allergy,Current,,
657,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.15 mg/0.15 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1695-49)",Revised,12/13/19,On allocation to current customers.,,,Manufacturing delays,Pulmonary/Allergy,Current,,
658,"Epinephrine Injection, Auto-Injector",Impax Laboratories,877-99-Impax(46729); option 2,"0.3 mg/0.3 mL epinephrine injection, USP, pre-filled auto-injector (two pack)(NDC 0115-1694-49)",Revised,12/13/19,On allocation to current customers.,,,Manufacturing delays,Pulmonary/Allergy,Current,,
659,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.3 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-023-01)",Reverified,12/13/19,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
660,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.15 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-022-01)",Reverified,12/13/19,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
661,"Epinephrine Injection, Auto-Injector",Kaleo,877-30-AUVIQ (1-877-302-8847),"Carton containing two AUVI-Q (epinephrine injection, USP) 0.1 mg auto-injectors and a single AUVI-Q Trainer (NDC 60842-021-01)",Reverified,12/13/19,Available,AUVI-Q is readily available and not currently in shortage.,,,Pulmonary/Allergy,Current,,
662,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.3 mg/mL epinephrine injection, USP, auto-injector (NDC 0093-5986-27)",Reverified,12/16/19,Available,,,,Pulmonary/Allergy,Current,,
663,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.3 mg single-dose, pre-filled syringes (NDC 0781-3442-20)",Reverified,12/17/19,Available,,,,Pulmonary/Allergy,Current,,
664,"Epinephrine Injection, Auto-Injector",Adamis Pharmaceuticals Corporation,800-230-3935,"Carton containing two SYMJEPI (epinephrine injection, USP) 0.15 mg single-dose, pre-filled syringes (NDC 0781-3448-20)",Reverified,12/17/19,Available,,,,Pulmonary/Allergy,Current,,
665,"Epinephrine Injection, Auto-Injector",Teva Pharmaceuticals,800-545-8800,"0.15 MG Epinephrine Injection, USP auto-injector (NDC 0093-5985-27)",Reverified,12/16/19,Available,,,,Pulmonary/Allergy,Current,,
666,Epirubicin Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,2 mg/1 mL  (NDCs 45963-608-60 and 45963-608-68),New,7/17/19,,This product discontinuation is a business related decision.  Anticipated discontinuance time is first quarter of the year 2020.,,,Oncology,To be Discontinued,7/17/19,7/17/19
667,Epirubicin Hydrochloride Injection,Cipla Limited,844-247-5287,2 mg/1 mL  (NDCs 25021-203-25 and 59923-701-25),New,7/17/19,,Anticipated unavailability of product is September 2019.,,,Oncology,To be Discontinued,7/17/19,7/17/19
668,Eprosartan Mesylate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Eprosartan Mesylate 600mg T 30s (NDC 0378-6629-93),Reverified,11/26/19,Out of stock. Resupply TBD,,,Other,Cardiovascular,Current,,
669,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,0.75 mg/mL (NDCs 0085-1136-02 and 0085-1136-03),New,11/18/19,,The following presentation will continue to be available: 0.75 mg/mL (NDC 0085-1136-01 ),,,Cardiovascular,To be Discontinued,11/18/19,11/18/19
670,Eptifibatide (Integrilin) Injection,Merck Sharp & Dohme Corp.,800-672-6372,2 mg/mL (NDCs 0085-1177-03 and 0085-1177-05),New,11/18/19,,The following presentations will continue to be available: 2 mg/mL (NDCs 0085-1177-01 and 0085-1177-02),,,Cardiovascular,To be Discontinued,11/18/19,11/18/19
671,"Erythromycin Lactobionate for Injection, USP","Hospira, Inc.",844-646-4398,500 mg Single Dose Glass Fliptop Vial (NDC 00409-6482-01),Revised,12/20/19,Available,,,Other,Anti-Infective,Current,,
672,"Erythromycin Lactobionate for Injection, USP","Hospira, Inc.",844-646-4398,500 mg Single-dose ADD-Vantage® Vial (NDC 00409-6476-44),Revised,12/20/19,Available,,,Other,Anti-Infective,Current,,
673,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-070-35),Revised,12/2/19,Limited availability.,"Expected availability Dec, 2019",,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
674,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g  tube (unit dose) (NDC17478-070-01),Revised,12/2/19,On backorder,"Expected availability Oct 1, 2019",,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
675,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 3.5 g tube (NDC 17478-824-35)(Premier),Revised,12/2/19,No longer distributing,,,,Ophthalmology,Current,,
676,Erythromycin Ophthalmic Ointment,Akorn Pharmaceuticals,800-932-5676,Erythromycin Ophthalmic Ointment 0.5%: 1 g  tube (unit dose) (NDC 17478-824-01)(Premier),Revised,12/2/19,No longer distributing,,,,Ophthalmology,Current,,
677,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-4576,3.5 g in 1 Tube (NDC 24208-910-55),Reverified,12/13/19,Available,"Distributed by: Bausch & Lomb Incorporated, a division of  Bausch Health Americas, Inc, Bridgewater, NJ 08807 USA",,Demand increase for the drug,Ophthalmology,Current,,
678,Erythromycin Ophthalmic Ointment,Bausch Health,800-321-5676,1 g in cartons of 50 (NDC 24208-910-19),Reverified,12/13/19,Available,"Distributed by: Bausch & Lomb Incorporated, a division of  Bausch Health Americas, Inc, Bridgewater, NJ 08807 USA",,Demand increase for the drug,Ophthalmology,Current,,
679,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"1 gram, 50-count (NDC 00574-4024-50)",Revised,12/10/19,Available and shipping,,,Demand increase for the drug,Ophthalmology,Current,,
680,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"3.5 gram, 1-count (NDC 00574-4024-35)",Revised,12/10/19,Available and shipping,,,Demand increase for the drug,Ophthalmology,Current,,
681,Erythromycin Ophthalmic Ointment,Perrigo Company PLC,269-673-8451,"3.5 gram, 24-count (NDC 00574-4024-39)",Revised,12/10/19,Available and shipping,,,Demand increase for the drug,Ophthalmology,Current,,
682,Escitalopram (Lexapro) 5 mg/5 mL Oral Solution,Allergan Sales LLC,800-678-1605,Lexapro oral solution 240 mL bottle 5 mg/5mL (NDC 0456-2101-08),New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
683,Escitalopram (Lexapro) 5 mg/5 mL Oral Solution,Allergan Sales LLC,800-678-1605,Escitalopram Oxalate oral solution 240 mL bottle (NDC 0591-4151-38),New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
684,Ethinyl Estradiol and Levonorgestrel (Myzilra),"Endo Pharmaceuticals, Inc.",800-462-3636,"0.03mg, 0.04mg, 0.03mg, 0.05mg, 0.075mg, 0.125mg; 6 blister pack in 1 carton (NDC 0603-7625-17)",New,5/10/19,,Discontinued due to business reasons.,,,Reproductive,To be Discontinued,5/10/19,5/10/19
685,Ethinyl Estradiol and Levonorgestrel (Myzilra),"Endo Pharmaceuticals, Inc.",800-462-3636,"0.03mg, 0.04mg, 0.03mg, 0.05mg, 0.075mg, 0.125mg; 3 blister pack in 1 carton (NDC 0603-7625-49)",New,5/10/19,,Discontinued due to business reasons.,,,Reproductive,To be Discontinued,5/10/19,5/10/19
686,Ethiodized Oil (Lipiodol) Injection,Guerbet LLC,877-729-6679,Box of one 10 mL ampoule (NDC 67684-1901-1),Revised,8/1/19,,,Available,,Medical Imaging;Oncology,Resolved,8/1/19,
687,Ethiodized Oil (Lipiodol) Injection,Guerbet LLC,877-729-6679,Box of one 10 mL ampoule (NDC 67684-1901-1),Revised,7/31/19,,,,,Medical Imaging;Oncology,Resolved,7/31/19,
688,"Ethosuximide Oral Solution, USP",Teva Pharmaceuticals,800-545-8800,"250 mg/5mL, 474 mL Bottle (NDC 0093-9660-16)",New,5/17/19,,Teva made a business decision to discontinue this product.,,,Neurology,To be Discontinued,5/17/19,5/17/19
689,Etoposide Injection,Accord Healthcare Inc.,866-941-7875,ETOPOSIDE INJ USP 20MG/ML 5ML (NDC 16729-114-31),Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
690,Etoposide Injection,Accord Healthcare Inc.,866-941-7875,ETOPOSIDE INJ USP 20MG/ML (Nova Plus) 5ML (NDC 16729-262-31),Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
691,Etoposide Injection,Accord Healthcare Inc.,866-941-7875,ETOPOSIDE INJ. USP 20MG/ML 25 ML (NDC 16729-114-08),Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
692,Etoposide Injection,Accord Healthcare Inc.,866-941-7875,ETOPOSIDE INJ. USP 20MG/ML 50 ML (NDC 16729-114-11),Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
693,Etoposide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"100 mg per 5 mL, 20 mg per mL, MDV (NDC 63323-104-05)",Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
694,Etoposide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 25 mL, 20 mg per mL, MDV (NDC 63323-104-25)",Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
695,Etoposide Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 gram per 50 mL, 20 mg per mL, MDV (NDC 63323-104-50)",Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
696,Etoposide Injection,Teva Pharmaceuticals,800-545-8800,100 mg/5 mL Multiple-dose Vials (NDC 0703-5653-01),Revised,8/16/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,8/16/19,8/16/19
697,Etoposide Injection,Teva Pharmaceuticals,800-545-8800,500 mg/25 mL Multiple-dose Vials (NDC 0703-5656-01),Revised,8/16/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,8/16/19,8/16/19
698,Etoposide Injection,Teva Pharmaceuticals,800-545-8800,1 gram/50 mL Multiple-dose Vials (NDC 0703-5657-01),Revised,8/16/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,8/16/19,8/16/19
699,Etoposide Injection,West-Ward Pharmaceuticals,800-631-2174,"20 mg/mL, 5 mL vial (NDC 0143-9510-01)",Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
700,Etoposide Injection,West-Ward Pharmaceuticals,800-631-2174,"20 mg/mL, 25 mL vial (NDC 0143-9511-01)",Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
701,Etoposide Injection,West-Ward Pharmaceuticals,800-631-2174,"20 mg/mL, 50 mL vial (NDC 0143-9512-01)",Revised,6/12/19,,,,,Oncology,Resolved,6/12/19,
702,Etoposide Phosphate (Etopophos) Injection,Bristol Myers Squibb Co.,800-332-2056,Etopophos Injection 100 mg (1VL) 10.6 mL US (NDC 0015-3404-20),Revised,6/12/19,, ,,,Oncology,Resolved,6/12/19,
703,Exenatide (BYDUREON) Extended Release for Injectable Suspension,AstraZeneca,800-236-9933,"BYDUREON® (exenatide extended-release) for injectable suspension, for subcutaneous use;  Single Dose Tray presentation; (2 mg) (NDC 0310-6520-04)",New,4/3/18,,"The planned permanent discontinuance of the Bydureon Single Dose Tray inventory from the U.S. market is September 30, 2018.  There are currently 2 other delivery options for exenatide-extended-release:  the Bydureon® Dual Chamber Pen presentation (NDC 0310-6530-04) and Bydureon® BCise™ (NDC 0310-6540-04).",,,Endocrinology/Metabolism,To be Discontinued,4/3/18,4/3/18
704,Fenofibric Acid Delayed-Release Capsules,Par Pharmaceutical,800-828-9393,Fenofibric Acid Delayed-Release Capsules 45mg 90s (NDC 10370-209-09),New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
705,Fenofibric Acid Delayed-Release Capsules,Par Pharmaceutical,800-828-9393,Fenofibric Acid Delayed-Release Capsules 135mg 90s (NDC 10370-210-09),New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
706,Fenofibric Acid Delayed-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"45 mg, 90 count bottle (NDC 0378-2589-77)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
707,Fenofibric Acid Delayed-Release Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"135 mg, 90 count bottle (NDC 0378-2590-77)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
708,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 25 pack (NDC 17478-0030-55),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
709,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1276-32),Revised,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
710,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-32),Revised,12/20/19,Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
711,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-35),Revised,12/20/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
712,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,1000 mcg/20 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-38),Revised,12/20/19,Discontinued,,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Pediatric,Current,,
713,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,100 mcg/2 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-22),Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
714,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,250 mcg/5 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-25),Revised,12/20/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
715,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,500 mcg/10 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-28),Revised,12/20/19,Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
716,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"1,000 mcg/20 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-31)",Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
717,Fentanyl Citrate (Sublimaze) Injection,"Hospira, Inc.",844-646-4398,"2,500 mcg/50 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-61)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction;Pediatric,Current,,
718,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 2 mL ampul (NDC 0641-6024-10),Revised,12/13/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
719,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 5 mL ampul (NDC 0641-6025-10),Revised,12/13/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
720,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL ampul (NDC 0641-6026-05),Revised,12/13/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
721,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 2 mL vial
(NDC 0641-6027-25)",Revised,12/13/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
722,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL 5 mL vial
(NDC 0641-6028-25)",Revised,12/13/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
723,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,50 mcg/mL 20 mL vial (NDC 0641-6029-25),Revised,12/13/19,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing as needed.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
724,Fentanyl Citrate (Sublimaze) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mcg/mL  50 mL vial
(NDC 0641-6030-01)",Revised,12/13/19,This presentation is temporarily on backorder.,Additional lots will be scheduled for manufacturing as needed.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
725,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule 10 pack (NDC 17478-0030-02),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
726,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,2 mL ampule; 25 pack (NDC 17478-0030-25),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
727,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,5 mL ampule 10 pack (NDC 17478-0030-05),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
728,Fentanyl Citrate (Sublimaze) Injection,Akorn Pharmaceuticals,800-932-5676,20 mL ampule (NDC 17478-0030-20),Revised,12/2/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
729,Finasteride Tablets,Mylan Pharmaceuticals Inc.,800-RXMYLAN (1-800-796- 9526),5 mg tablet (NDC 0378-5036-05)(NDC 0378-5036-77)(NDC 0378-5036-93),New,5/23/18,,The discontinuation of this product is a business decision,,,Urology,To be Discontinued,5/23/18,5/23/18
730,Fludrocortisone Acetate Tablets,Teva Pharmaceuticals,800-545-8800,"0.1 mg, 100 count bottle (NDC 0555-0997-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
731,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 100 count bottle (NDC 0115-7033-01)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
732,Fludrocortisone Acetate Tablets,Impax Laboratories,877-835-5472,"0.1 mg, 500 count bottle (NDC 0115-7033-02)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism,Resolved,8/7/19,
733,Flumazenil Injection,Mylan,800-796-9526,"1 mg in 10 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-444-10)",Revised,7/19/19,,Discontinuation of the manufacture of the drug.,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,7/19/19,7/19/19
734,Flumazenil Injection,Mylan,800-796-9526,"0.5 mg in 5 mL (0.1 mg/mL), multi-dose vial, 10 vials (NDC 67457-447-53)",New,12/16/19,,Expected Discontinuation April 2020,,,Analgesia/Addiction;Neurology;Pediatric,To be Discontinued,12/16/19,12/16/19
735,Fluorescein Injection,Novartis,888-669-6682,Fluorescite (fluorescein injection) 10% 5 mL vial (NDC 0065-0092-65),Reverified,12/11/19,Available,,,Other,Ophthalmology,Current,,
736,Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR® (fluorescein injection, USP) 10%, 100 mg/mL in a 5 mL single use vial (NDC 17478-253-10)",Revised,12/2/19,Available,Continue to allocate available inventory,,Shortage of an active ingredient,Ophthalmology,Current,,
737,Fluorescein Injection,Akorn Pharmaceuticals,800-932-5676,"AK-FLUOR® (fluorescein injection, USP) 25%, 250 mg/mL in a 2 mL single use vial (NDC 17478-250-20)",Revised,12/2/19,Available,Continue to allocate available inventory,,Shortage of an active ingredient,Ophthalmology,Current,,
738,Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution,Altaire,631-722-5988 ext. 27,"Altafluor Solution Fluorescein sodium 0.25% and Benoxinate HCl 0.4%, 5 mL bottle (NDC 59390-0218-05)",Revised,12/10/19,,,,,Ophthalmology,Resolved,12/10/19,
739,Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution,Altaire,631-722-5988 ext.27,"Flurox Solution  Fluorescein sodium 2.5mg (0.25%), benoxinate hydrochloride 4mg (0.4%), 5mL bottle (NDC 54799-508-05)",Revised,12/11/19,,,,,Ophthalmology,Resolved,12/11/19,
740,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 100 Strips per box (ndc 17238-900-11),Revised,10/23/19,Available,,,,Ophthalmology,Current,,
741,Fluorescein Strips,HUB Pharmaceuticals,800-EYE-DROP,BIOGLO Fluorescein Sodium Ophthalmic Strips USP 300 Strips per box (NDC 17238-900-30),Revised,10/23/19,Available,,,,Ophthalmology,Current,,
742,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 1.0 mg 100 sterile strips (NDC 17478-404-01),Revised,12/2/19,On backorder,Availability Q12020,,Other,Ophthalmology,Current,,
743,Fluorescein Strips,Akorn Pharmaceuticals,800-932-5676,Ful-Glo 0.6 mg 300 sterile strips (NDC 17478-403-03),Revised,12/2/19,On backorder,Availability Q12020,,Other,Ophthalmology,Current,,
744,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 100 count bottle (NDC 0781-2823-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
745,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 10 mg, 1000 count bottle (NDC 0781-2823-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
746,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 100 count bottle (NDC 0781-2822-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
747,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 20 mg, 1000 count bottle (NDC 0781-2822-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
748,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 100 count bottle (NDC 0781-2824-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
749,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 1000 count bottle (NDC 0781-2824-10)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
750,Fluoxetine Capsules,Sandoz,800-525-8747,"Fluoxetine capsules, 40 mg, 30 count bottle (NDC 0781-2824-31)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Fluoxetine Capsules.,,,Psychiatry,To be Discontinued,2/23/18,2/23/18
751,Fluoxetine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 28 count bottle (NDC 0378-5410-28)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
752,Fluoxetine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 28 count bottle (NDC 0378-5420-28)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
753,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100 count bottle (NDC 0378-6004-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
754,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 500 count bottle (NDC 0378-6004-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
755,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2.5 mg, 100 count bottle (NDC 0378-6009-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
756,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2.5 mg, 500 count bottle (NDC 0378-6009-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
757,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-6074-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
758,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-6074-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
759,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-6097-01)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
760,Fluphenazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 500 count bottle (NDC 0378-6097-05)",New,5/2/19,,,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
761,Flurazepam Hydrochloride Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Flurazepam HCl 15mg C 100s (NDC 0378-4415-01),Reverified,11/26/19,Out of Stock. Resupply is Q4 2019.,,,Other,Psychiatry,Current,,
762,Flurazepam Hydrochloride Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,Flurazepam HCl 30mg C 100s (NDC 0378-4430-01),Reverified,11/26/19,Out of Stock. Resupply is Q1 2020.,,,Other,Psychiatry,Current,,
763,Flurbiprofen Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100 count bottle (NDC 0378-0076-01)",New,5/2/19,,,,,Rheumatology,To be Discontinued,5/2/19,5/2/19
764,Flurbiprofen Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100 count bottle (NDC 0378-0093-01)",New,5/2/19,,,,,Rheumatology,To be Discontinued,5/2/19,5/2/19
765,"Flutamide Capsules, USP",Teva Pharmaceuticals,800-545-8800,125 mg 180 count (NDC 0591-2466-18),New,6/10/19,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,6/10/19,6/10/19
766,Fluvastatin Sodium Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 30 count bottle (NDC 0378-5121-93)",New,5/2/19,,,,,Endocrinology/Metabolism;Pediatric,To be Discontinued,5/2/19,5/2/19
767,Fluvastatin Sodium Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 100 count bottle (NDC 0378-5121-01)",New,5/2/19,,,,,Endocrinology/Metabolism;Pediatric,To be Discontinued,5/2/19,5/2/19
768,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",100 mg. 30’s count (NDC 10370-175-11),Revised,12/6/19,On backorder. Estimated availability January 2020,,,Shortage of an active ingredient,Psychiatry,Current,,
769,Fluvoxamine ER Capsules,Par Pharmaceutical,"800-828-9393, option 5 then option 2",150 mg. 30’s count (NDC 10370-176-11),Revised,12/16/19,On backorder. Estimated availability January 2020,,,Shortage of an active ingredient,Psychiatry,Current,,
770,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 100 mg Extended Release Capsules, 30 count (NDC 0228-2848-03)",Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
771,Fluvoxamine ER Capsules,Teva Pharmaceuticals,800-545-8800,"Fluvoxamine 150 mg Extended Release Capsules, 30 count (NDC 0228-2849-03)",Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
772,"Folic Acid Tablets, USP",Par Pharmaceutical,800-828-9393,"1 mg, bottle of 100 (NDC 0603-3162-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology;Reproductive,To be Discontinued,4/19/19,4/19/19
773,"Folic Acid Tablets, USP",Par Pharmaceutical,800-828-9393,"1 mg, bottle of 1000 (NDC 0603-3162-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology;Reproductive,To be Discontinued,4/19/19,4/19/19
774,"Folic Acid Tablets, USP",Par Pharmaceutical,800-828-9393,"1 mg, bottle of 2500 (NDC 0603-3162-30)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology;Reproductive,To be Discontinued,4/19/19,4/19/19
775,Gabapentin Tablets,Teva Pharmaceuticals,800-545-8800,"Gabapentin Tablets USP, 600 mg, 100 count (NDC 0093-4443-01)",New,12/6/18,"This was a business-related decision to discontinue manufacturing these products. TEVA is replacing this same strength product under NDC 0228-2636-11 Gabapentin Tablets, 600mg, 100 count.",,,,Neurology,To be Discontinued,12/6/18,12/6/18
776,Gabapentin Tablets,Teva Pharmaceuticals,800-545-8800,"Gabapentin Tablets USP, 600 mg, 500 count (NDC 0093-4443-05)",New,12/6/18,"This was a business-related decision to discontinue manufacturing these products. TEVA is replacing this same strength product under NDC 0228-2636-50 Gabapentin Tablets, 600mg, 500 count.",,,,Neurology,To be Discontinued,12/6/18,12/6/18
777,Gabapentin Tablets,Teva Pharmaceuticals,800-545-8800,"Gabapentin Tablets USP, 600 mg, 1000 count (NDC 0093-4443-10)",New,12/6/18,This was a business-related decision to discontinue manufacturing these products.,,,,Neurology,To be Discontinued,12/6/18,12/6/18
778,Gabapentin Tablets,Teva Pharmaceuticals,800-545-8800,"Gabapentin Tablets USP, 800 mg, 100 count (NDC 0093-4444-01)",New,12/6/18,"This was a business-related decision to discontinue manufacturing these products. TEVA is replacing this same strength product under NDC 0228-2637-11 Gabapentin Tablets, 800mg, 100 count.",,,,Neurology,To be Discontinued,12/6/18,12/6/18
779,Gabapentin Tablets,Teva Pharmaceuticals,800-545-8800,"Gabapentin Tablets USP, 800 mg, 500 count (NDC 0093-4444-05)",New,12/6/18,"This was a business-related decision to discontinue manufacturing these products. TEVA is replacing this same strength product under NDC 0228-2637-50 Gabapentin Tablets, 600mg, 500 count.",,,,Neurology,To be Discontinued,12/6/18,12/6/18
780,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 5 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-81)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
781,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 10 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-82)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
782,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 15 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-83)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
783,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Vials 20 mL single-dose vials, rubber stoppered, in individual cartons of 10, 2 cartons per Box (NDC 50419-188-84)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
784,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Pre-Filled Syringes 10 mL pre-filled disposable syringe, Boxes of 5 (NDC 50419-188-36)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
785,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Pre-Filled Syringes 15 mL pre-filled disposable syringe, Boxes of 5 (NDC 50419-188-37)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
786,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Single-Dose Pre-Filled Syringes 20 mL pre-filled disposable syringe, Boxes of 5 (NDC 50419-188-38)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
787,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Pharmacy Bulk Package 50 mL Pharmacy Bulk Package, rubber stoppered, 10 per box (NDC 50419-188-58)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
788,Gadopentetate Dimeglumine (Magnevist) Injection,Bayer,888-842-2937,"Pharmacy Bulk Package 100 mL Pharmacy Bulk Package, rubber stoppered, 10 per box (NDC 50419-188-11)",New,7/17/19,,"Business decision to discontinue marketing in the US. Product discontinuation is not related to product quality, safety, or efficacy.",,,Medical Imaging,To be Discontinued,7/17/19,7/17/19
789,Galantamine Hydrobromide Tablets,Janssen Pharmaceuticals,800-526-7736,4 mg tablets (NDCs 50458-396-60 and 10147-0881-6),New,10/29/18,,The last batches will be distributed April 2019.,,,Neurology,To be Discontinued,10/29/18,10/29/18
790,Galantamine Hydrobromide Tablets,Janssen Pharmaceuticals,800-526-7736,8 mg tablets (NDCs 50458-397-60 and 10147-0882-6),New,10/29/18,,The last batches will be distributed April 2019.,,,Neurology,To be Discontinued,10/29/18,10/29/18
791,Galantamine Hydrobromide Tablets,Janssen Pharmaceuticals,800-526-7736,12 mg tablets (NDCs 50458-398-60 and 10147-0883-6),New,10/29/18,,The last batches will be distributed April 2019.,,,Neurology,To be Discontinued,10/29/18,10/29/18
792,Gemcitabine Hydrochloride Injection,Mylan,800-796-9526,"1 g, single dose vial (NDC 67457-462-01)",New,12/16/19,,Expected Discontinuation March/April 2020,,,Oncology,To be Discontinued,12/16/19,12/16/19
793,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 7 Tablets in 1 Blister Pack (NDC 44004-321-07)",Reverified,12/18/19,Estimated recovery to be determined.,License to manufacture and distribute FACTIVE is under legal dispute.,,Other,Anti-Infective,Current,,
794,Gemifloxacin Mesylate (Factive) Tablets,"LG Chem, Ltd.",866-686-6174,"320mg, 5 Tablets in 1 Blister Pack (NDC 44004-321-05)",Reverified,12/18/19,Estimated recovery to be determined.,License to manufacture and distribute FACTIVE is under legal dispute.,,Other,Anti-Infective,Current,,
795,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,1 mg 100 Count (NDC 0093-7254-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
796,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg 100 Count (NDC 0093-7255-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
797,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,4 mg 100 Count (NDC 0093-7256-01),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
798,Glimepiride Tablets,Teva Pharmaceuticals,800-545-8800,4 mg 250 Count (NDC 0093-7256-52),New,5/17/19,,Teva made a business decision to discontinue this product.,,,Endocrinology/Metabolism,To be Discontinued,5/17/19,5/17/19
799,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100 count bottle (NDC 0378-1061-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
800,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"2 mg, 100 count bottle (NDC 0378-1062-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
801,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"3 mg, 100 count bottle (NDC 0378-1063-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
802,Guanfacine Hydrochloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"4 mg, 100 count bottle (NDC 0378-1065-01)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
803,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 1 mg, 100 Count (NDC 42806-048-01)",New,6/12/19,Available,,,Other,Cardiovascular,Current,,
804,Guanfacine Hydrochloride Tablets,"Epic Pharma, LLC",203-564-0568,"Guanfacine Tablets 2 mg, 100 Count (NDC 42806-296-01)",New,6/12/19,Available,,,Other,Cardiovascular,Current,,
805,Guanfacine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-1160-01),Reverified,11/26/19,Unavailable. Estimated recovery: Q1 2020.,,,Other,Cardiovascular,Current,,
806,Guanfacine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-1190-01),Reverified,11/26/19,Unavailable. Estimated recovery: Q1 2020.,,,Other,Cardiovascular,Current,,
807,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1mg tablets 100 count bottle (NDC 0591-0444-01),Reverified,12/16/19,"Available, however limited supply until mid December 2019",,,Shortage of an active ingredient,Cardiovascular,Current,,
808,Guanfacine Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,2 mg tablets 100 count bottle (NDC 0591-0453-01),Reverified,12/16/19,Available,,,,Cardiovascular,Current,,
809,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,1 mg bottles of 30 (NDC 65162-711-03); 1 mg bottles of 100 (NDC 65162-711-10),Reverified,12/17/19,Available,,,Other,Cardiovascular,Current,,
810,Guanfacine Hydrochloride Tablets,Amneal Pharmaceutical,877-835-5472,2 mg bottles of 30 (NDC 65162-713-03); 2 mg bottles of 100 (NDC 65162-713-10); 2 mg bottles of 500 (NDC 65162-713-50),Reverified,12/17/19,Available,,,Other,Cardiovascular,Current,,
811,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,0.5 mg (NDC 0378-0351-01) and (NDC 0378-0351-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
812,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-0257-01) and (NDC 0378-0257-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
813,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0214-01) and (NDC 0378-0214-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
814,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-0327-01) and (NDC 0378-0327-10),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
815,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0334-01),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
816,Haloperidol Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg (NDC 0378-0355-01),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
817,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 100 CT (NDC 68382-079-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
818,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 5MG 1000 CT (NDC 68382-079-10),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
819,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 10MG 100 CT (NDC 68382-080-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
820,Haloperidol Tablets,Zydus Pharmaceuticals USA Inc.,609-730-1900,HALOPERIDOL TAB 20MG 100 CT (NDC 68382-081-01),Revised,11/20/19,,,Available,,Psychiatry,Resolved,11/20/19,
821,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-13-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
822,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-83-9101),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
823,Haloperidol Tablets,Sandoz,800-525-8747,0.5 mg 100 count unit dose (NDC 0781-13-9113),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
824,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-13-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
825,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-83-9201),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
826,Haloperidol Tablets,Sandoz,800-525-8747,1 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
827,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-13-9801),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
828,Haloperidol Tablets,Sandoz,800-525-8747,2 mg 100 count unit dose (NDC 0781-13-9213),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
829,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-13-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
830,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 1000 count bottle (NDC 0781-83-9610),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
831,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-13-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
832,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-83-9601),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
833,Haloperidol Tablets,Sandoz,800-525-8747,5 mg 100 count unit dose (NDC 0781-13-9613),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
834,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-13-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
835,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-83-9701),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
836,Haloperidol Tablets,Sandoz,800-525-8747,10 mg 100 count unit dose (NDC 0781-13-9713),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
837,Haloperidol Tablets,Sandoz,800-525-8747,20 mg 100 count bottle (NDC 0781-83-9301),Revised,11/20/19,,,,,Psychiatry,Resolved,11/20/19,
838,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium BP 2,000 IU/L  in 0.9% w/v Sodium Chloride IV Infusion in VIAFLEX container  (1,000 units / 500 mL)  Product code FKB0953G (NDC 0338-9556-20)",Revised,12/11/19,Available,Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Heparin IV Infusion into the U.S. market to address drug shortages.,,,Hematology,Current,,
839,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL.  Product code 2B0944  (NDC 0338-0433-04)",Revised,12/11/19,Available,,,,Hematology,Current,,
840,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL.  Product code 2B0953 (NDC 0338-0431-03)",Revised,12/11/19,Unavailable,,,Other,Hematology,Current,,
841,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03)",Reverified,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Hematology,Current,,
842,Heparin Sodium and Sodium Chloride 0.9% Injection,"Hospira, Inc.",844-646-4398,"2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59)",Reverified,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Hematology,Current,,
843,Heparin Sodium and Sodium Chloride 0.9% Injection,Baxter Healthcare,888-229-0001,"Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container.  AHB0953U  (NDC 0338-0424-18)",New,12/11/19,Available,,,,Hematology,Current,,
844,Hydrochlorothiazide (Microzide) Capsules,Allergan Sales LLC,800-678-1605,12.5 mg (NDC 52544-622-01),New,10/22/19,,"The authorized generic, Hydrochlorothiazide Capsules, USP, 12.5 mg remains commercially available.",,,Cardiovascular,To be Discontinued,10/22/19,10/22/19
845,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,20 mg/25 mg (NDC 0378-2025-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
846,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,12.5 mg/ 20 mg (NDC 0378-2012-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
847,Hydrochlorothiazide and Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/ 12.5 mg (NDC 0378-1012-01),New,5/22/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
848,Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution,Perrigo Pharmaceuticals,269-673-8451,Hydrocodone Bitartrate (5 mg/5 mL) and Homatropine Methylbromide (1.5 mg/5 mL)(NDC 0574-1105-16),New,6/5/18,,The discontinuation of this product is a business decision,,,Pediatric;Pulmonary/Allergy,To be Discontinued,6/5/18,6/5/18
849,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 12 suppositories (NDC 59741-301-12),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
850,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 24 suppositories (NDC 59741-301-24),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
851,Hydrocortisone Acetate Suppository,Torrent Pharma Inc.,908-280-3333,Boxes of 100 suppositories (NDC 59741-301-01),New,11/25/19,,,,,Other;Urology,To be Discontinued,11/25/19,11/25/19
852,"Hydrocortisone Butyrate Cream USP, 0.1%",Teva Pharmaceuticals,800-545-8800,"Hydrocortisone Butyrate Cream USP, 0.1% (Lipophilic), 45 g/Tube, (NDC 0472-0490-45)",New,12/21/18,,This was a business-related decision to discontinue manufacturing these products.,,,Dermatology,To be Discontinued,12/21/18,12/21/18
853,"Hydrocortisone Butyrate Cream USP, 0.1%",Teva Pharmaceuticals,800-545-8800,"Hydrocortisone Butyrate Cream USP, 0.1% (Lipophilic), 60 g/Tube, (NDC 0472-0490-60)",New,12/21/18,,This was a business-related decision to discontinue manufacturing these products.,,,Dermatology,To be Discontinued,12/21/18,12/21/18
854,"Hydrocortisone Tablets, USP",Par Pharmaceutical,800-828-9393,"5 mg, bottle of 50 (NDC 0603-3899-19)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Pulmonary/Allergy,To be Discontinued,4/19/19,4/19/19
855,"Hydrocortisone Tablets, USP",Par Pharmaceutical,800-828-9393,"10 mg, bottle of 100 (NDC 0603-3900-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Pulmonary/Allergy,To be Discontinued,4/19/19,4/19/19
856,"Hydrocortisone Tablets, USP",Par Pharmaceutical,800-828-9393,"20 mg, bottle of 100 (NDC 0603-3901-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology;Endocrinology/Metabolism;Gastroenterology;Hematology;Pulmonary/Allergy,To be Discontinued,4/19/19,4/19/19
857,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"32 mg, 100 count (NDC 0591-3631-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
858,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"16 mg, 100 count (NDC 0591-3630-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
859,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"12 mg, 100 count (NDC 0591-3739-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
860,"Hydromorphone Hydrochloride Extended-Release Tablets, CII",Teva Pharmaceuticals,800-545-8800,"8 mg, 100 count (NDC 0591-3629-01)",New,6/20/19,,This was a business-related decision to discontinue manufacturing these products.,,,Analgesia/Addiction,To be Discontinued,6/20/19,6/20/19
861,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-06)                                                                                           Microvault",Reverified,12/20/19,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
862,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-11)                                                                                                                                                                                     Microvault",Reverified,12/20/19,Available,Check wholesalers for inventory,,,Analgesia/Addiction,Current,,
863,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"1 mg per 1 mL, Single dose vial, (NDC 63323-852-25)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
864,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-853-25)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
865,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-854-10)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
866,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-10)",Reverified,12/20/19,Backordered.  Next release not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
867,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"50 mg per 5 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-15)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
868,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 50 mL, Single dose vial, high potency formulation (HPF), (NDC 63323-851-50)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
869,"Hydromorphone Hydrochloride Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 1 mL vial (NDC 0641-0121-25)",Revised,12/13/19,Inventory is currently available.,Additional lots will be scheduled for manufacturing Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
870,"Hydromorphone Hydrochloride Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0641-2341-41)",Revised,12/13/19,Temporarily on backorder.,Additional lots will be scheduled for manufacturing as needed.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
871,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,0.5 mg/0.5 mL (1 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-05),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
872,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/1 mL); iSecure Luer Lock Glass Syringe (NDC 00409-1283-10),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
873,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1312-10),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
874,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1283-31),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
875,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1312-30),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
876,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1304-31),Revised,12/20/19,Next Delivery and Estimated Recovery: January 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
877,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,1 mg/1 mL (1 mg/mL); Glass Ampul (NDC 00409-2552-01),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
878,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Glass Ampul (NDC 00409-3356-01),Revised,12/20/19,Next Delivery: April 2020; Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
879,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,4 mg/1 mL (4 mg/mL); Glass Ampul (NDC 00409-2540-01),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
880,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,2 mg/1 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3365-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
881,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-01),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
882,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-05),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
883,"Hydromorphone Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-2634-50),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
884,"Hydromorphone Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 1 mL ampule, 10 count (NDC 17478-0540-01)",Revised,12/2/19,Unavailable. Estimataed recovery Dec 2019,"Expected availability Dec, 2019",,Demand increase for the drug,Analgesia/Addiction,Current,,
885,"Hydromorphone Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 5 mL ampule, 10 count (NDC 17478-0540-05)",Revised,12/2/19,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
886,"Hydromorphone Hydrochloride Injection, USP",Akorn Pharmaceuticals,800-932-5676,"10 mg/mL, 50 mL vial, 10 count (NDC 17478-0540-50)",Revised,12/2/19,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
887,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 0.5 mg per 0.5 mL, prefilled syringe (NDC 76045-009-05)",Reverified,12/20/19,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
888,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 1 mg per 1 mL, prefilled syringe (NDC 76045-009-10)                                                                                                                                       Blister pack",Reverified,12/20/19,Check wholesalers for inventory,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
889,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 2 mg per 1 mL, prefilled syringe (NDC 76045-010-10)",Reverified,12/20/19,Backordered. Next release date not available at this time.,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
890,"Hydromorphone Hydrochloride Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"(Dilaudid) 4 mg per 1 mL, prefilled syringe (NDC 76045-011-10)",Reverified,12/20/19,Backordered. Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
891,"Hydromorphone Hydrochloride Injection, USP",Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC0703-0110-03),Reverified,12/16/19,Available,,,Other,Analgesia/Addiction,Current,,
892,"Hydromorphone Hydrochloride Injection, USP",Teva Pharmaceuticals,800-545-8800,10 MG/1ML (NDC 0703-0113-03),Reverified,12/16/19,Available,,,Other,Analgesia/Addiction,Current,,
893,"Hydromorphone Hydrochloride Injection, USP",Teva Pharmaceuticals,800-545-8800,10 MG/1 ML (NDC 0703-0018-01),Reverified,12/16/19,Available,,,Other,Analgesia/Addiction,Current,,
894,Hydroxyprogesterone Caproate Injection,American Regent/Luitpold,800-645-1706,"Hydroxyprogesterone Caproate Injection, USP 250mg/mL 1mL Single Dose Vial (NDC 0517-1767-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
895,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,"Hydroxyprogesterone Caproate Injection, USP 1,250 mg/ 5 ml (NDC 71225-104-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
896,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single dose auto-injector 1.1mL for subcutaneous injection: (NDC 64011-247-02),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
897,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
898,Hydroxyprogesterone Caproate Injection,"AMAG Pharmaceuticals, Inc.",800-847-3418,Multi-dose vial 5mL for intramuscular injection: (NDC 64011-243-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
899,Hydroxyprogesterone Caproate Injection,Prasco Laboratories,866-525-0688,Single-dose vial 1mL for intramuscular injection: (NDC 66993-038-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
900,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,Hydroxyprogesterone Caproate Injection USP 250 mg/1 mL single-dose vial (NDC 55150-309-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
901,Hydroxyprogesterone Caproate Injection,AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,"Hydroxyprogesterone Caproate Injection USP 1,250 mg/5 mL multiple-dose vial (NDC 55150-310-01)",Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
902,Hydroxyprogesterone Caproate Injection,Slayback Pharma,844-566-2505,Hydroxyprogesterone Caproate Injection 250 mg/ 1 ml (NDC 71225-105-01),Revised,8/2/19,,,,,Reproductive,Resolved,8/2/19,
903,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,100 mg 100 count (NDC 0555-0324-02),Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
904,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 100 count (NDC 0555-0323-02),Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
905,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,25 mg 500 count (NDC 0555-0323-04),Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
906,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 100 count (NDC 0555-0302-02),Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
907,Hydroxyzine Pamoate Oral Capsules,Teva Pharmaceuticals,800-545-8800,50 mg 500 count (NDC 0555-0302-04),Reverified,12/16/19,Available,,,Other,Psychiatry,Current,,
908,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 100 count (NDC 0185-0674-01),Reverified,12/18/19,Limited monthly supply through September due to increase in demand.  Working to increase production to meet current demand.,,,Demand increase for the drug,Psychiatry,Current,,
909,Hydroxyzine Pamoate Oral Capsules,Sandoz,800-525-8747,25 mg 500 count (NDC 0185-0674-05),Reverified,12/18/19,Limited monthly supply through September due to increase in demand.  Working to increase production to meet current demand.,,,Demand increase for the drug,Psychiatry,Current,,
910,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 100ct (NDC 00115-1803-01),Revised,12/13/19,Expected to be on allocation until sometime in 1Q20.,,,Other,Psychiatry,Current,,
911,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 25mg Cap 500ct (NDC 00115-1803-02),Revised,12/13/19,Expected to be on allocation until sometime in 1Q20.,,,OIther,Psychiatry,Current,,
912,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 100ct (NDC 00115-1804-01),Revised,12/13/19,Expected to be on allocation until sometime in 1Q20.,,,Other,Psychiatry,Current,,
913,Hydroxyzine Pamoate Oral Capsules,Impax Laboratories,877-835-5472,Hydroxyzine Pamoate 50mg Cap 500ct (NDC 00115-1804-02),Revised,12/13/19,Expected to be on allocation until sometime in 1Q20.,,,Other,Psychiatry,Current,,
914,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 25 mg Capsules; 100 count bottle (NDC 0069-5410-66),Reverified,12/20/19,Next delivery and Estimated recovery: July 2020,Shortage per manufacturer: Manufacturing Delay,,Other,Psychiatry,Current,,
915,Hydroxyzine Pamoate Oral Capsules,Pfizer Pharmaceuticals,800-533-4535,Vistaril (Hydroxyzine Pamoate Oral Capsules) 50 mg Capsules; 100 count bottle (NDC 0069-5420-66),Reverified,12/20/19,Available,,,Other,Psychiatry,Current,,
916,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 100 count (NDC 14539-674-01),New,11/15/19,Available,,,Other,Psychiatry,Current,,
917,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 25 mg 500 count (NDC 14539-674-05),New,11/15/19,Available,,,Other,Psychiatry,Current,,
918,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 100 count (NDC 14539-675-01),New,11/15/19,Available,,,Other,Psychiatry,Current,,
919,Hydroxyzine Pamoate Oral Capsules,Heritage Pharma,855-228-9470,Hydroxyzine Pamoate Caps 50 mg 500 count (NDC 14539-675-05),New,11/15/19,Available,,,Other,Psychiatry,Current,,
920,Ifosfamide/Mesna Kit,Teva Pharmaceuticals,800-545-8800,1 gram/20 mL; 1 gram/10 mL  (NDCs 0703-4100-48 and 0703-4100-58),New,10/18/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,10/18/19,10/18/19
921,Ifosfamide/Mesna Kit,Teva Pharmaceuticals,800-545-8800,3 gram/60 mL; 1 gram/10 mL (NDC 0703-4100-68 ),New,10/18/19,,This product is being discontinued due to a business decision.,,,Oncology,To be Discontinued,10/18/19,10/18/19
922,"Imipenem and Cilastatin for Injection, USP",Merck Sharp & Dohme Corp.,800-672-6372,500 mg  imipenem  equivalent  and  500 mg  cilastatin  equivalent  and  20 mg  sodium bicarbonate as a buffer in trays of 25 vials (NDC 0006-3516-59),Revised,12/18/17,Product is available,"For additional information, please contact: Merck National Service Center at 1-800-672-6372",,Demand increase for the drug,Anti-Infective,Current,,
923,"Imipenem and Cilastatin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"250 mg/250 mg per vial, single dose vial, sterile powder (NDC 63323-349-25)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Delay in shipping of the drug,Anti-Infective,Current,,
924,"Imipenem and Cilastatin for Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg/500 mg per vial, single dose vial, sterile powder (NDC  63323-322-25)",Reverified,12/20/19,Available,Check wholesaler inventory,,Delay in shipping of the drug,Anti-Infective,Current,,
925,"Imipenem and Cilastatin for Injection, USP","Hospira, Inc.",844-646-4398,500 mg/500 mg; Single Dose Glass Fliptop Vial (NDC 00409-3507-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,
926,"Imipenem and Cilastatin for Injection, USP","Hospira, Inc.",844-646-4398,250 mg/250 mg; Single Dose Glass Fliptop Vial (NDC 00409-3508-01),Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,
927,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 100s (NDC 0378-0143-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
928,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"25 mg, 1000s (NDC 0378-0143-10)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
929,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 100s (NDC 0378-0147-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
930,Indomethacin Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"50 mg, 500s (NDC 0378-0147-05)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
931,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4350-01),New,9/12/19,,To be discontinued in 2022,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
932,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent ((NDC 0085-4351-01)),New,9/12/19,,To be discontinued in 2022,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
933,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Powder for Injection (Interferon alfa-2b) 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01),New,9/12/19,,To be discontinued in 2022,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
934,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Solution for Injection (Interferon alfa-2b) 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1168-01),New,9/12/19,,To be discontinued in 2021,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
935,INTRON A (Interferon alfa-2b) Recombinant for Injection,Merck Sharp & Dohme Corp.,800-672-6372,INTRON A Solution for Injection (Interferon alfa-2b) 25 million IU multidose vial (32 million IU per 3.2 mL per vial); boxes containing 1 vial of INTRON A Solution for Injection (NDC 0085-1133-01),New,9/12/19,,To be discontinued in 2021,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
936,Isocarboxazid Tablets,Validus Pharmaceuticals LLC,866-982-5438 (1-866-9VALIDUS),10mg (NDC 30698-032-01),Reverified,12/10/19,"Due to the current critical shortage of Isocarboxazid Tablets in the United States (US) market, Validus Pharmaceuticals LLC is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of Isocarboxazid Tablets. Validus has initiated temporary importation of another manufacturer’s Isocarboxazid Tablets into the U.S. market.  This product is manufactured and marketed in Denmark by MediLink. MediLink's Marplan is commercially available under a new NDC 72604-032-01.",,,Requirements related to complying with good manufacturing practices,Psychiatry,Current,,
937,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"30 mg, bottle of 100 (NDC 0603-4110-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
938,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"30 mg, bottle of 500 (NDC 0603-4110-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
939,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"30 mg, bottle of 1000 (NDC 0603-4110-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
940,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"60 mg, bottle of 100 (NDC 0603-4111-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
941,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"60 mg, bottle of 500 (NDC 0603-4111-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
942,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"60 mg, bottle of 1000 (NDC 0603-4111-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
943,"Isosorbide Mononitrate Extended-Release Tablets, USP",Par Pharmaceutical,800-828-9393,"120 mg, bottle of 100 (NDC 0603-4112-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
944,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"100 mg/mL, 5 mL vial (NDC 0143-9509-10)",Reverified,12/13/19,Inventory is currently available.,,,,Anesthesia,Current,,
945,Ketamine Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),200 mg / 20 mL (NDC 67457-181-20),Reverified,11/26/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
946,Ketamine Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),500 mg / 10 mL (NDC 67457-001-10),Reverified,11/26/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
947,Ketamine Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),1000 mg / 10 mL (NDC 67457-108-10),Reverified,11/26/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
948,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/5 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2051-05),Reverified,12/20/19,Next Delivery: February 2020; Estimated Recovery: June 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
949,Ketamine Injection,"Hospira, Inc.",844-646-4398,500 mg/10 mL (50 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2053-10),Reverified,12/20/19,Next Delivery: January 2020; Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
950,Ketamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL vial (NDC 0143-9508-10)",Reverified,12/13/19,Inventory is currently available.,,,Demand increase for the drug,Anesthesia,Current,,
951,Ketamine Injection,Par Pharmaceutical,201-802-4000,"10 mg/mL, 20 mL MDV (NDC 42023-113-10)",Reverified,12/16/19,Product is currently available.,,,Demand increase for the drug,Anesthesia,Current,,
952,Ketamine Injection,Par Pharmaceutical,201-802-4000,"100 mg/mL, 5 mL MDV (NDC 42023-115-10)",Reverified,12/16/19,Product is currently available.,,,Demand increase for the drug,Anesthesia,Current,,
953,Ketamine Injection,Par Pharmaceutical,201-802-4000,"50 mg/mL, 10 mL MDV (NDC 42023-114-10)",Reverified,12/16/19,Product is currently available.,,,Demand increase for the drug,Anesthesia,Current,,
954,Ketoconazole Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100 count bottle (NDC 0378-0261-01)",New,5/2/19,,,,,Anti-Infective,To be Discontinued,5/2/19,5/2/19
955,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",New,11/25/19,,Avet is no longer marketing the 25 mg strength,,,Analgesia/Addiction;Rheumatology,To be Discontinued,11/25/19,11/25/19
956,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 69336-127-10)",Revised,11/25/19,Available,"Marketed by Sterling Knight Pharmaceuticals, LLC. Contact information: 662-661-3232.",,,Analgesia/Addiction;Rheumatology,Current,,
957,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 69336-127-11)",Revised,11/25/19,Available,"Marketed by Sterling Knight Pharmaceuticals, LLC. Contact information: 662-661-3232.",,,Analgesia/Addiction;Rheumatology,Current,,
958,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",Revised,11/25/19,Unavailable - Discontinuation of the manufacture of the drug,,,,Analgesia/Addiction;Rheumatology,Current,,
959,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 1000 count bottle (NDC 23155-020-10)",Revised,11/25/19,Unavailable - Discontinuation of the manufacture of the drug,,,,Analgesia/Addiction;Rheumatology,Current,,
960,Ketoprofen Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg Extended-Release Capsules, bottle of 100 (NDC 0378-8200-01)",Reverified,11/26/19,Available,,,Other,Analgesia/Addiction;Rheumatology,Current,12/23/16,
961,Ketoprofen Capsules,"Avet Pharmaceuticals, Inc. (formerly Heritage Pharma)",855-228-9470,"25 mg, 100 count bottle (NDC 23155-020-01)",New,11/25/19,,Avet is no longer marketing the 25 mg strength,,,Analgesia/Addiction;Rheumatology,To be Discontinued,11/25/19,11/25/19
962,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0093-3193-01)",Reverified,12/16/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
963,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 100 count bottle (NDC 0093-3195-01)",Reverified,12/16/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
964,Ketoprofen Capsules,Teva Pharmaceuticals,800-545-8800,"75 mg, 500 count bottle (NDC 0093-3195-05)",Reverified,12/16/19,Unavailable,This was a business-related decision to discontinue manufacturing these products,,Discontinuation of the manufacture of the drug,Analgesia/Addiction;Rheumatology,Current,,
965,Ketorolac Tromethamine Injection,Gland Pharma,855-273-0154,15 mg/mL vial (NDC 70860-700-01 and 70860-700-02),Reverified,12/16/19,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Analgesia/Addiction,Current,,
966,Ketorolac Tromethamine Injection,Gland Pharma,855-273-0154,30 mg/mL vial (NDC 70860-701-01 and 70860-701-03),Reverified,12/16/19,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Analgesia/Addiction,Current,,
967,Ketorolac Tromethamine Injection,Gland Pharma,855-273-0154,60 mg/mL vial (NDC 70860-701-02 and 70860-701-04),Reverified,12/16/19,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Analgesia/Addiction,Current,,
968,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 15MG/ML 25X1ML (NDC 25021-700-01),Reverified,12/20/19,Backordered. Estimated availability TBD,,,Manufacturing delays,Analgesia/Addiction,Current,,
969,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X2ML (NDC 25021-701-02),Reverified,12/20/19,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
970,Ketorolac Tromethamine Injection,Sagent Pharmaceuticals,866-625-1618,KETOROLAC TROMETHAMINE INJECTION 30MG/ML 25X1ML (NDC 25021-701-01),Reverified,12/20/19,Backordered. Estimated availability TBD,,,Manufacturing delay,Analgesia/Addiction,Current,,
971,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-2287-23),Revised,12/20/19,Next Delivery: August 2020; Estimated Recovery: June 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
972,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-31),Revised,12/20/19,Next Delivery: March 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
973,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2287-61),Revised,12/20/19,Next Delivery: August 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
974,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,15 mg/mL (15 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3793-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
975,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,30 mg/mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3795-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
976,Ketorolac Tromethamine Injection,"Hospira, Inc.",844-646-4398,60 mg/2 mL (30 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3796-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
977,Ketorolac Tromethamine Injection,Virtus Pharmaceuticals,888-843-3593,30MG/ML (NDC 69543-0386-25),New,3/26/18,Available,,,Other,Analgesia/Addiction,Current,,
978,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"15 mg/mL, 1 mL vial (NDC 0641-6041-25)",Revised,12/13/19,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
979,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 1 mL vial (NDC 0641-6042-25)",Revised,12/13/19,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
980,Ketorolac Tromethamine Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"30 mg/mL, 2 mL vial (NDC 0641-6043-25)",Revised,12/13/19,"Unavailable, shortage recovery TBD.",,,Demand increase for the drug,Analgesia/Addiction,Current,,
981,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"15 mg per mL, Single Dose Amber Vial, (NDC 63323-161-01)",Revised,12/20/19,Available,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
982,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-01)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
983,Ketorolac Tromethamine Injection,"Fresenius Kabi USA, LLC",888-386-1300,"30 mg per mL, Single Dose Amber Vial, (NDC 63323-162-02)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory.,,Manufacturing delays,Analgesia/Addiction,Current,12/4/15,
984,Ketorolac Tromethamine Injection,Baxter Healthcare,888-229-0001,"Ketorolac Tromethamine Injection, USP, 30 mg/ mL.  Single dose glass flip top vial - 25 units per carton (NDC 0338-0072-25)",New,12/12/19,Unavailable (anticipated delivery in January 2020),FOR INTRAVENOUS AND INTRAMUSCULAR USE. 30mg/mL (1 mL fill volume/ 2 mL container),,Demand increase for the drug,Analgesia/Addiction,Current,,
985,Ketorolac Tromethamine Injection,Gland Pharma,609-250-7990,"30 mg/mL, 1 mL vial (NDC 72266-118-25)",Reverified,12/16/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Demand increase for the drug,Analgesia/Addiction,Current,,
986,Ketorolac Tromethamine Injection,Gland Pharma,609-250-7990,"30 mg/mL, 2 mL vial (NDC 72266-119-25)",Reverified,12/16/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Analgesia/Addiction,Current,,
987,Labetalol Hydrochloride Injection,Gland Pharma,609-250-7990,"5mg/mL, 20 mL vial (NDC 72266-102-01)",Reverified,12/11/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Cardiovascular,Current,,
988,Labetalol Hydrochloride Injection,Gland Pharma,609-250-7990,"5 mg/mL, 40 mL vial (NDC 72266-103-01)",Reverified,12/11/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Cardiovascular,Current,,
989,Labetalol Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/20 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-20),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: February 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
990,Labetalol Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/40 mL (5 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-2267-54),Reverified,12/20/19,Next Delivery and Estimated Recovery: January 2021,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
991,Labetalol Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/4 mL (5 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-2339-34),Reverified,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
992,Labetalol Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,5mg/mL (100mg/20mL) Multi-Dose vial (NDC 17478-420-20),Revised,12/2/19,Available,,,Other,Cardiovascular,Current,,
993,Labetalol Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,5mg/mL (200mg/40mL) Multi-Dose vial (NDC 17478-420-40 ),Revised,12/2/19,Available,,,Other,Cardiovascular,Current,,
994,Labetalol Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 20 mL multidose vial (NDC 0143-9622-01)",Revised,12/13/19,This presentation is temporarily on backorder.,,,Demand increase for the drug,Cardiovascular,Current,,
995,Labetalol Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"5 mg/mL, 40 mL multidose vial (NDC 0143-9623-01)",Revised,12/13/19,Currently available,,,Demand increase for the drug,Cardiovascular,Current,,
996,Lamivudine and Zidovudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine and Zidovudine Tablets 150mg and 300mg (NDC 0378-5180-91),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
997,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 100mg (NDC 0378-5168-93),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
998,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 150mg (NDC 0378-5169-91),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
999,Lamivudine Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Lamivudine Tablets 300mg (NDC 0378-5170-93),New,3/16/18,,,,,Antiviral,To be Discontinued,3/16/18,3/16/18
1000,Lamotrigine Tablets,Teva Pharmaceuticals,800-545-8800,25 mg tablets (NDCs 0093-0032-05 and 0093-0039-01),New,12/21/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,12/21/18,12/21/18
1001,Lamotrigine Tablets,Cipla Limited,844-247-5287,25 mg bottles of 100 (NDC 69097-148-07),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1002,Lamotrigine Tablets,Cipla Limited,844-247-5287,25 mg bottles of 500 (NDC NDC 69097-148-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1003,Lamotrigine Tablets,Cipla Limited,844-247-5287,25 mg bottles of 1000 (NDC 69097-148-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1004,Lamotrigine Tablets,Cipla Limited,844-247-5287,100 mg bottles of 100 (NDC 69097-149-07),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1005,Lamotrigine Tablets,Cipla Limited,844-247-5287,100 mg bottles of 500 (NDC 69097-149-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1006,Lamotrigine Tablets,Cipla Limited,844-247-5287,100 mg bottles of 1000 (NDC 69097-149-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1007,Lamotrigine Tablets,Cipla Limited,844-2547-5287,150 mg bottles of 60 (NDC 69097-151-03),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1008,Lamotrigine Tablets,Cipla Limited,844-247-5287,150 mg bottles of 500 (NDC 69097-151-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1009,Lamotrigine Tablets,Cipla Limited,844-247-5287,150 mg bottles of 1000 (NDC 69097-151-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1010,Lamotrigine Tablets,Cipla Limited,844-247-5287,200 mg bottles of 60 (NDC 69097-152-03),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1011,Lamotrigine Tablets,Cipla Limited,844-247-5287,200 mg bottles of 500 (NDC 69097-152-12),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1012,Lamotrigine Tablets,Cipla Limited,844-247-5287,200 mg bottles of 1000 (NDC 69097-152-15),New,9/20/19,,,,,Neurology,To be Discontinued,9/20/19,9/20/19
1013,Lamotrigine Tablets,Teva Pharmaceuticals,800-545-8800,100 mg (NDCs 0093-0463-01 and 0093-0463-05),New,10/15/19,,This product is being discontinued due to a business decision.,,,Neurology,To be Discontinued,10/15/19,10/15/19
1014,Lanoxin (digoxin) Tablets,Concordia Pharmaceuticals Inc.,866-243-5382,Lanoxin (digoxin) 187.5 mcg (0.1875 mg) tablets; 100-count bottles (NDC 59212-245-55),New,5/22/18,,"A business decision was made to discontinue manufacture and supply of the Lanoxin 187.5 mcg (0.1875 mg) strength tablets.  All existing lots on the market are good through expiry. The anticipated final date of availability for sale is June 30, 2018 (NDC 59212-245-55).",,,Cardiovascular,To be Discontinued,5/22/18,5/22/18
1015,Latanoprost Ophthalmic Solution 0.005%,Sandoz,800-525-8747,2.5 mL Bottle (NDC 61314-547-01),Reverified,12/18/19,Available,,,,Ophthalmology,Current,,
1016,Latanoprost Ophthalmic Solution 0.005%,Pfizer Pharmaceuticals,800-533-4535,"2.5 mL fill, 0.005% (50 mcg/mL): Package of 1 bottle (NDC 59762-0333-2)",Reverified,12/20/19,Next Delivery: December 2019;  Estimated Recovery: March 2020,Limited Supply Available.  Please check with your wholesaler for available inventory,,Demand increase for the drug,Ophthalmology,Current,,
1017,Latanoprost Ophthalmic Solution 0.005%,Bausch Health,800-321-4576,"2.5 mL fill, 0.005% (50 mcg/mL): Package of 1 bottle (NDC 24208-463-25)",Reverified,12/13/19,Available,"Distributed by: Bausch & Lomb Incorporated, a division of  Bausch Health Americas, Inc, Bridgewater, NJ 08807 USA",,,Ophthalmology,Current,,
1018,Lesinurad (ZURAMPIC) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,ZURAMPIC® (lesinurad) 200 mg tablets 5 count bottle (NDC 70785-011-05),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Zurampic.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
1019,Lesinurad (ZURAMPIC) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,ZURAMPIC® (lesinurad) 200 mg tablets 30 count bottle (NDC 70785-011-30),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Zurampic.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
1020,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/200mg tablets 5 count bottle (NDC 70785-021-05),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
1021,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/200 mg tablets 30 count bottle (NDC 70785-021-30),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,Endocrinology/Metabolism,To be Discontinued,4/15/19,4/15/19
1022,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/200 mg tablets 90 count bottle (NDC 70785-021-90),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
1023,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/300 mg tablets 5 count bottle (NDC 70785-022-05),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
1024,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/300 mg tablets 30 count bottle (NDC 70785-022-30),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
1025,Lesinurad/Allopurinol (DUZALLO®) Tablets,Ironwood Pharmaceuticals Inc.,844-374-4793,200/300 mg tablets 90 count bottle (NDC 70785-022-90),New,4/15/19,,"Ironwood Pharmaceuticals, Inc. has made a business-related decision to discontinue Duzallo.",,,,To be Discontinued,4/15/19,4/15/19
1026,Letermovir (Prevymis) Injection,Merck Sharp & Dohme Corp.,800-672-6372,480 mg injection (NDC 0006-5004-01),Revised,12/2/19,Available,,,Other,Antiviral,Current,,
1027,Letermovir (Prevymis) Injection,Merck Sharp & Dohme Corp.,800-672-6372,240 mg injection (NDC 0006-5003-01),Revised,12/2/19,Available,,,Other,Antiviral,Current,,
1028,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,500mg vial (NDC 25021-828-50),Reverified,12/20/19,On allocation. Estimated availability Mar-2020,,,Manufacturing delay,Oncology;Pediatric,Current,,
1029,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mg SDV (NDC 63323-710-50),Revised,12/20/19,Available,Check Wholesaler Inventory,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
1030,Leucovorin Calcium Lyophilized Powder for Injection,"Fresenius Kabi USA, LLC",888-386-1300,500 mg SDV (NDC 63323-711-00),Revised,12/20/19,Backordered. Next release January 2020.,Check Wholesaler Inventory,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
1031,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,50 mg vial (NDC 25021-813-10),Reverified,12/20/19,Backordered. Estimated availability May-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
1032,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,100mg vial (NDC 25021-814-30),Reverified,12/20/19,Backordered. Estimated availability May-2021,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
1033,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,200mg vial (NDC 25021-815-30),Reverified,12/20/19,On allocation. Estimated availability Mar-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
1034,Leucovorin Calcium Lyophilized Powder for Injection,Sagent Pharmaceuticals,866-625-1618,350mg vial (NDC 25021-816-30),Reverified,12/20/19,On allocation. Estimated availability Mar-2020,,,Manufacturing delay,Oncology;Pediatric,Current,9/25/13,
1035,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,"100mg/vial, 20mL (NDC 0703-5140-01)",Reverified,12/16/19,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
1036,Leucovorin Calcium Lyophilized Powder for Injection,Teva Pharmaceuticals,800-545-8800,350mg/vial 30mL (NDC 0703-5145-01),Reverified,12/16/19,Available,,,Demand increase for the drug,Oncology;Pediatric,Current,9/25/13,
1037,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,Lupron Depot 3.75 mg PDS kit (NDC 0074-3641-03),Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1038,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,"Lupron Depot Ped, 3Month, 11.25 mg kit (NDC 0074-3379-03)",Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1039,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,"Lupron Depot Ped, 3Month, 30 mg kit (NDC 0074-9694-03)",Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1040,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,"Lupron Depot, 3Month, 11.25 mg PDS kit (NDC 0074-3663-03)",Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1041,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,"Lupron Depot, 3Month, 22.5 mg PDS kit (NDC 0074-3346-03)",Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1042,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,"Lupron Depot, 4Month, 30 mg PDS kit (NDC 0074-3683-03)",Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1043,Leuprolide Acetate (Lupron Depot; Lupron Depot Ped) Injection,Abbvie,800-621-1020,"Lupron Depot, 6Month 45 mg PDS kit (NDC 0074-3473-03)",Revised,12/17/19,Available,,,Other,Endocrinology/Metabolism;Oncology,Current,12/9/19,12/9/19
1044,Leuprolide Acetate Injection,Sandoz,800-525-8747,Leuprolide Acetate Injection 1mg/0.2ml (14mg/2.8ml)(NDC 0781-4003-32),Revised,5/10/19,,,Available,,Oncology,Resolved,5/10/19,
1045,"Levetiracetam Extended-Release Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra XR) Extended-Release Tablets, 500 mg 60 ct. bottle; (NDC 69102-200-60)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
1046,"Levetiracetam Extended-Release Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra XR) Extended-Release Tablets, 750 mg 60 ct. bottle; (NDC 69102-201-60)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
1047,"Levetiracetam Extended-Release Oral Tablets, USP",Teva Pharmaceuticals,800-545-8800,500mg (NDC 0591-3635-60),New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Neurology,To be Discontinued,6/7/19,6/7/19
1048,"Levetiracetam Extended-Release Oral Tablets, USP",Teva Pharmaceuticals,800-545-8800,750mg (NDC 0591-3699-60),New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Neurology,To be Discontinued,6/7/19,6/7/19
1049,"Levetiracetam Extended-Release Oral Tablets, USP",Apotex Corp.,800-706-5575,Levetiracetam Extended-Release Tablets 500 mg (60 ct. bottle)(NDC 60505-3280-06),Revised,11/27/19,"Backorder, Estimated Resupply February 2020",,,Demand increase for the drug,Neurology,Current,,
1050,"Levetiracetam Extended-Release Oral Tablets, USP",Apotex Corp.,800-706-5575,Levetiracetam Extended-Release Tablets 750 mg (60 ct. bottle)(NDC 60505-3517-06),Revised,11/27/19,"Backorder, Estimated Resupply February 2020",,,Demand increase for the drug,Neurology,Current,,
1051,"Levetiracetam Extended-Release Oral Tablets, USP",Sun Pharmaceutical Industries Inc.,800-818-4555,500mg tablet 60 count bottle (NDC 4733557386),Revised,12/3/19,"Back-order, Estimated re-supply: TBD",,,Demand increase for the drug,Neurology,Current,,
1052,"Levetiracetam Extended-Release Oral Tablets, USP",Sun Pharmaceutical Industries Inc.,800-818-4555,750mg tablet 60 count bottle (NDC 4733557686),Revised,12/3/19,"Back-order, Estimated re-supply: TBD",,,Demand increase for the drug,Neurology,Current,,
1053,"Levetiracetam Extended-Release Oral Tablets, USP",Lupin,866-587-4617,500mg  60 count bottle (NDC 68180-117-07),Reverified,12/17/19,Continuous production but will be on/off backorder,,,Shortage of active ingredient,Neurology,Current,,
1054,"Levetiracetam Extended-Release Oral Tablets, USP",Lupin,866-587-4617,750mg 60 count bottle (NDC 68180-118-07),Reverified,12/17/19,Continuous production but will be on/off backorder,,,Shortage of active ingredient,Neurology,Current,,
1055,"Levetiracetam Extended-Release Oral Tablets, USP",UCB Inc.,919-767-3210,500mg extended-release (NDC 50474-598-66),Reverified,12/3/19,Available,,,,Neurology,Current,,
1056,"Levetiracetam Extended-Release Oral Tablets, USP",UCB Inc.,919-767-3210,750mg extended-release (NDC 50474-599-66),Reverified,12/3/19,Available,,,,Neurology,Current,,
1057,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 500mg, 60’s (NDC 43547-0345-06)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1058,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 500mg, 500’s (NDC 43547-0345-50)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1059,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 750mg, 60’s (NDC 43547-0346-06)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1060,"Levetiracetam Extended-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam ER Tablets, 750mg, 500’s (NDC 43547-0346-50)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1061,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"250mg, 120 count bottle (NDC 13668-014-12)",Revised,12/13/19,Available,,,,Neurology,Current,,
1062,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"500mg, 120 count bottle (NDC 13668-015-12)",Revised,12/13/19,Available,,,,Neurology,Current,,
1063,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"750 mg, 120 count bottle (NDC 13668-016-12)",Revised,12/13/19,Available,,,,Neurology,Current,,
1064,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"750 mg, 500 count bottle (NDC 13668-016-05)",Revised,12/13/19,Available,,,,Neurology,Current,,
1065,"Levetiracetam Immediate-Release Oral Tablets, USP",Torrent Pharma Inc.,888-544-2299 option 4,"1000 mg, 60 count bottle (NDC 13668-017-60)",Revised,12/13/19,Available,,,Shortage of Active Ingredient,Neurology,Current,,
1066,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,919-767-3210,"250MG, (NDC 50474-594-40)",Reverified,12/3/19,Available,,,,Neurology,Current,,
1067,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,919-767-3210,"500MG, (NDC 50474-595-40)",Reverified,12/3/19,Available,,,,Neurology,Current,,
1068,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,919-767-3210,"750MG, (NDC 50474-596-40)",Reverified,12/3/19,Available,,,,Neurology,Current,,
1069,"Levetiracetam Immediate-Release Oral Tablets, USP",UCB Inc.,919-767-3210,"1000MG, (NDC 50474-597-66)",Reverified,12/3/19,Available,,,,Neurology,Current,,
1070,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"250mg, 120 count (NDC 65862024508)",Reverified,12/13/19,Available,,,,Neurology,Current,,
1071,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"500mg , 120 count (NDC 65862024608)",Reverified,12/13/19,Available,,,,Neurology,Current,,
1072,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"1000mg, 60 count (NDC 65862031560)",Reverified,12/13/19,Available,,,,Neurology,Current,,
1073,"Levetiracetam Immediate-Release Oral Tablets, USP",Aurobindo Pharma,866-850-2876,"750mg, 120 count (NDC 65862024708)",Reverified,12/13/19,Available,,,,Neurology,Current,,
1074,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 90 Count Bottes (68180-112-09)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1075,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 120 Count Bottes (68180-112-16)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1076,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 250 mg – 500 Count Bottes (68180-112-02)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1077,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 90 Count Bottes (68180-113-09)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1078,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 90 Count Bottes (68180-114-09)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1079,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 500 Count Bottes (68180-114-02)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1080,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 120 Count Bottes (68180-113-16)",Reverified,12/17/19,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
1081,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 500 mg – 500 Count Bottes (68180-113-02)",Reverified,12/17/19,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
1082,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 750 mg – 120 Count Bottes (68180-114-16)",Reverified,12/17/19,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
1083,"Levetiracetam Immediate-Release Oral Tablets, USP",Lupin,866-587-4617,"Levetiracetam Tablets, 1000 mg – 60 Count Bottes (68180-115-07)",Reverified,12/17/19,Will remain on backorder for few months,"Due to shortage, API is being allocated between the different strengths",,Shortage of active Ingredient,Neurology,Current,,
1084,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"250mg, 120 count (NDC 31722053612)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1085,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"250mg, 500 count (NDC 31722053605)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1086,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"500mg, 120 count (NDC 31722053712)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1087,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"500mg, 500 count (NDC 31722053705)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1088,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"750mg, 120 count (NDC 31722053812)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1089,"Levetiracetam Immediate-Release Oral Tablets, USP",Camber Pharmaceuticals Inc.,732-529-0430,"750mg, 500 count (NDC 31722053805)",Reverified,12/17/19,Available,,,,Neurology,Current,,
1090,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 250mg – 120’s (NDC 43547-0221-15)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1091,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 500mg – 120’s (NDC 43547-0222-15)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1092,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 500mg – 1000’s (NDC 43547-0222-11)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1093,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 750mg – 120’s (NDC 43547-0223-15)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1094,"Levetiracetam Immediate-Release Oral Tablets, USP","Solco Healthcare US, LLC",866-931-9829,"Levetiracetam Tablets, 1000mg – 60’s (NDC 43547-0224-06)",Reverified,12/11/19,Long-term backorder for all skus. No estimated release date at this time.,,,,Neurology,Current,,
1095,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 250 mg, 120 count (NDC 0378-5613-78)",Revised,11/26/19,"Unavailable, recovery in January 2020",,,Shortage of active ingredient,Neurology,Current,,
1096,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 250 mg, 500 count (NDC 0378-5613-05)",Revised,11/26/19,"Unavailable, recovery in January 2020",,,Shortage of active ingredient,Neurology,Current,,
1097,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 500 mg, 500 count (NDC 0378-5615-05)",Revised,11/26/19,"Unavailable, recovery in January 2020",,,Shortage of active ingredient,Neurology,Current,,
1098,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 500 mg, 120 count (NDC 0378-5615-78)",Revised,11/26/19,Available,,,Shortage of active ingredient,Neurology,Current,,
1099,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 750 mg, 120 count (NDC 0378-5617-78)",Revised,11/26/19,Available,,,Shortage of active ingredient,Neurology,Current,,
1100,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 750 mg, 500 count (NDC 0378-5617-05)",Revised,11/26/19,Available,,,Shortage of active ingredient,Neurology,Current,,
1101,"Levetiracetam Immediate-Release Oral Tablets, USP",Mylan Pharmaceuticals Inc.,1-800-796-9526,"Levetiracetam Tablets, 1000 mg, 60 count (NDC 0378-5619-91)",Revised,11/26/19,Available,,,Shortage of active ingredient,Neurology,Current,,
1102,"Levetiracetam Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra) Tablets, 500 mg (120 count; (NDC 69102-104-01)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
1103,"Levetiracetam Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra) Tablets, 750 mg (120 count; (NDC 69102-102-01)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
1104,"Levetiracetam Oral Tablets, USP",Lotus Pharmaceutical Co. Ltd.,866-770-3024,"Levetiracetam (Roweepra) Tablets, 1000 mg 60 count; (NDC  69102-103-01)",New,9/3/19,,The discontinuation of this product is a business decision.,,,Neurology,To be Discontinued,9/3/19,9/3/19
1105,Levoleucovorin Calcium Injection,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/1 mL (17.5 mL)(NDC 67457-600-20),New,6/25/19,,,,,Oncology,To be Discontinued,6/25/19,6/25/19
1106,Levoleucovorin Calcium Injection,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg/1 mL (25 mL)(NDC 67457-601-30),New,6/25/19,,,,,Oncology,To be Discontinued,6/25/19,6/25/19
1107,Levonorgestrel and Ethinyl Estradiol Tablets 0.1mg/0.02mg,Mylan Pharmaceuticals Inc.,800-796-9526,"0.1mg/0.02mg Tablets, NDC (0378-7298-53)",New,1/2/19,,,,,Reproductive,To be Discontinued,1/2/19,1/2/19
1108,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 5 mL (NDC 0591-3012-26)",New,4/27/18,,This was a business-related decision to discontinue manufacturing these products,,,Anesthesia,To be Discontinued,4/27/18,4/27/18
1109,Lidocaine HCl Topical Jelly,Teva Pharmaceuticals,800-545-8800,"Lidocaine HCl Topical Jelly, 20 mg/1 mL (2%), 30 mL (NDC 0591-3012-30)",New,4/27/18,,This was a business-related decision to discontinue manufacturing these products,,,Anesthesia,To be Discontinued,4/27/18,4/27/18
1110,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/500 mL (4mg/mL) in VIAFLEX Plus container. Product code 2B0973 (NDC 0338-0409-03)",Reverified,12/11/19,Available,,,,Cardiovascular,Current,,
1111,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,Baxter Healthcare,888-229-0001,"Lidocaine Hydrochloride and 5% Dextrose Injection USP, 2 gram/250 mL (8mg/mL) in VIAFLEX Plus container. Product code 2B0962 (NDC 0338-0411-02)",Reverified,12/11/19,Available,,,,Cardiovascular,Current,,
1112,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.8% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5982 (NDC 00264-9598-20),Revised,12/11/19,Product available,,,Other,Cardiovascular,Current,,
1113,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 250mL Excel Plastic container P5942 (NDC 00264-9594-20),Revised,12/11/19,Product available,,,Other,Cardiovascular,Current,,
1114,Lidocaine Hydrochloride (Xylocaine) and Dextrose Injection Solution-Premix Bags,B. Braun Medical Inc.,800-227-2862,0.4% Lidocaine Hydrochloride and 5% Dextrose in 500mL Excel Plastic container P5941 (NDC 00264-9594-10),Revised,12/11/19,Product on allocation to contracted customers,,,Other,Cardiovascular,Current,,
1115,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 2 mL Ampoule (NDC 55150-158-72),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1116,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 5 mL Ampoule (NDC 55150-159-74),Revised,12/11/19,Currently on backorder,Next shipment expected Jan. 2020,,Demand increase for the drug,Anesthesia,Current,,
1117,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 2 mL Ampoule (NDC 55150-160-72),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1118,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 2 mL Single Dose Vial (NDC 55150-161-02),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1119,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 5 mL Single Dose Vial (NDC 55150-162-05),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1120,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 30 mL Single Dose Vial (NDC 55150-163-30),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1121,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 2 mL Single Dose Vial (NDC 55150-164-02),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1122,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 5 mL Single Dose Vial (NDC 55150-165-05),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1123,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial, sterile pack (NDC 63323-0492-31)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1124,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Ansyr Plastic Syringe (NDC 0409-9137-05),Revised,12/20/19,Next Delivery: April 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1125,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,1.5%; 20mL Sterile Pack Amp (NDC 0409-4056-01),Revised,12/20/19,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
1126,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,20 mg/2 mL (10 mg/mL); Glass Ampul (NDC 0409-4713-32),Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1127,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-01, pack of 25; NDC 0409-4276-16, individual)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1128,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/30 mL (10 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4279-02),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: April 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1129,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,500 mg/50 mL (10 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4276-02),Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1130,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,1%; 30 mL Sterile Pack vial (NDC 0409-4270-01),Revised,12/20/19,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
1131,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,40 mg/2 mL (20 mg/mL); Glass Ampul (NDC 0409-4282-01),Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1132,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); Glass Ampul (NDC 0409-4282-02),Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1133,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4904-34),Revised,12/20/19,Next Delivery and Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1134,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (20 mg/mL); LifeShield Abboject Glass Syringe (NDC 0409-4903-34),Revised,12/20/19,Next Delivery: January 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1135,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/5 mL (20 mg/mL); Single Dose Glass Fliptop Vial (NDC 0409-2066-05),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: January 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1136,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-01, pack of 25; NDC 0409-4277-16, individual)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1137,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,"1,000 mg/50 mL (20 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4277-02)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1138,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,200 mg/5 mL (40 mg/mL); Glass Ampul (NDC 0409-4283-01),Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1139,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,Xylocaine Cardiac 100 mg/5 mL (20 mg/mL); Ansyr Plastic Syringe (NDC 0409-1323-05),Revised,12/20/19,Next Delivery: March 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1140,Lidocaine Hydrochloride (Xylocaine) Injection,"Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"2%, 5mL Luer-Jet Prefilled Syringe (NDC 76329-3390-1)
(old NDC 0548-3390-00)",Reverfied,12/16/19,Intermittent supply,"IMS is releasing product, but market demand continues to exceed our capacity",,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1141,Lidocaine Hydrochloride (Xylocaine) Injection,American Regent/Luitpold,800-645-1706,"1%, 50 mL vial package of 25 (NDC 00517-0625-25)",Reverified,11/27/19,Unavailable-No product available for release. No plan to manufacture.,"American Regent/Luitpold has discontinued manufacturing Lidocaine HCl Injection, USP",,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
1142,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 10 mL ampule (NDC 63323-0493-97)",Reverified,12/20/19,Backordered. Next release date not available at this time.,All lidocaine and Xylocaine presentations are on intermittent back order and will be released as the product becomes available. Shortage per Manufacturer: Increase in demand,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1143,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1.5% Xylocaine 1.5% - MPF injection 15 mg/mL, 20 mL ampule (NDC 63323-0493-91)",Reverified,12/20/19,Backordered. Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1144,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% Lidocaine 2% injection 20 mg/mL, 2 mL vial (NDC 63323-0202-02)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1145,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 2% injection 20 mg/mL, 5 mL SD Tear Top vial, preservative-free (NDC 63323-0208-05)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1146,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-17)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1147,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 20 mL vial (NDC 63323-0486-27)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1148,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-57)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1149,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 10 mL vial (NDC 63323-0486-10)
discontinued",Reverified,12/20/19,No release date available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1150,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection NDC discontinued 20 mg/mL, 20 mL vial (NDC 63323-0486-20)-NDC discontinued",Reverified,12/20/19,No release date available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1151,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% injection 20 mg/mL, 50 mL vial (NDC 63323-0486-50)-NDC discontinued",Reverified,12/20/19,No release date available at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1152,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 2 mL vial (NDC 63323-0495-27)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1153,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 5 mL vial (NDC 63323-0495-07)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1154,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 2% - MPF injection 20 mg/mL, 10 mL ampule (NDC 63323-0496-97)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1155,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Multiple Dose Plastic Fliptop Vial (NDC 0409-4275-01),Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1156,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,100 mg/2 mL (50 mg/mL); Glass Ampul (NDC 0409-4712-01),Revised,12/20/19,Next Delivery and Estimated Recovery: March 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1157,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,250 mg/50 mL (5 mg/mL); Single Dose Glass Teartop Vial (NDC 0409-4278-01),Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1158,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,50 mg/5 mL (10 mg/mL); Glass Ampul (NDC 0409-4713-02),Revised,12/20/19,Next Delivery and  Estimated Recovery: March 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1159,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 0.5% Xylocaine 0.5% injection 5 mg/mL, 50 mL vial (NDC 63323-0484-57)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1160,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 0.5% - MPF injection, APP 5 mg/mL, 50 mL vial (NDC 63323-0491-57)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1161,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 2 mL vial (NDC 63323-0201-02)",Reverified,12/20/19,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1162,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Lidocaine 1% Lidocaine 1% injection 10 mg/mL, 10 mL vial (NDC 63323-0201-10)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1163,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 20 mL vial (NDC 63323-0485-27)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1164,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% injection 10 mg/mL, 50 mL vial (NDC 63323-0485-57)",Reverified,12/20/19,Backordered. Next release December 2019.,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1165,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL vial (NDC 63323-0492-27)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1166,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 2 mL glass ampule (NDC 63323-0492-80)",Reverified,12/20/19,Backordered. No release expectations at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1167,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL glass ampule (NDC 63323-0492-89)",Reverified,12/20/19,Backordered. No release expectations at this time.,,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1168,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 5 mL vial (NDC 63323-0492-57)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1169,Lidocaine Hydrochloride (Xylocaine) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine 1% - MPF injection 10 mg/mL, 30 mL vial (NDC 63323-0492-37)",Reverified,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anesthesia;Pediatric,Current,,
1170,Lidocaine Hydrochloride (Xylocaine) Injection,"Hospira, Inc.",844-646-4398,300 mg/20 mL (15 mg/mL); Glass Ampul (NDC 0409-4776-01),Revised,12/20/19,Next Delivery and Estimated Recovery: February 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1171,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 10 mL Multi Dose Vial (NDC 55150-251-10),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1172,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 20 mL Multi Dose Vial (NDC 55150-252-20),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1173,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 10 mL Multi Dose Vial (NDC 55150-254-10),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1174,Lidocaine Hydrochloride (Xylocaine) Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,2% 20 mL Multi Dose Vial (NDC 55150-255-20),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1175,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 5 mL vial, Preservative Free (NDC 0143-9595-25)",Revised,12/13/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
1176,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 5 mL vial, Preservative Free (NDC 0143-9594-25)",Revised,12/13/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
1177,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1% 50 mL vial, Preserved (NDC 0143-9577-10)",Revised,12/13/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
1178,Lidocaine Hydrochloride (Xylocaine) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2% 50 mL vial, Preserved (NDC 0143-9575-10)",Revised,12/13/19,Available,,,Demand increase for the drug,Anesthesia,Current,,
1179,Lidocaine Hydrochloride (Xylocaine) Injection,"Spectra Medical Devices, Inc.",978-657-0889 ext. 5231,1% 5 mL ampule (NDC 65282-1605-1),New,6/14/18,"Currently available, in stock Production is ongoing",,,Other,Anesthesia,Current,,
1180,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100 mg MDV (NDC 63323-0482-17)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
1181,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 100mg SDV, MPF (NDC 63323-0487-17)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
1182,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 150 mg, SDV, MPF (NDC 63323-0488-17)",Revised,12/20/19,Available,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
1183,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Fresenius Kabi USA, LLC",888-386-1300,"Xylocaine w/EPI 10 mL, 200 mg, SDV, MPF (NDC 63323-0489-17)",Revised,12/20/19,Backordered. Next release not available at this time.,Check wholesalers for inventory.,,Manufacturing delay,Anesthesia;Pediatric,Current,,
1184,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"0.5% w/EPI 1:100,000; 1.8 mL Carpule (NDC 00409-0996-01)",Revised,12/20/19,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
1185,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2.5 g/50 mL (0.5%; 1:200,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3177-01)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1186,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"200 mg/20 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-01)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1187,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"300 mg/30 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 00409-3178-02)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1188,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"500 mg/50 mL (1%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3178-03)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1189,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"75 mg/5 mL (1.5%; 1:200,000); Glass Ampul (NDC 0409-1209-01)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1190,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"450 mg/30 mL (1.5%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3181-01)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1191,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-01)",Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1192,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"600 mg/30 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-02)",Revised,12/20/19,Available,,,Other,Anesthesia;Pediatric,Current,,
1193,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"1 g/50 mL (2%; 1:100,000); Multiple Dose Glass Fliptop Vial (NDC 0409-3182-03)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1194,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"400 mg/20 mL (2%; 1:200,000); Single Dose Glass Fliptop Vial (NDC 0409-3183-01)",Revised,12/20/19,Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia;Pediatric,Current,,
1195,Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine,"Hospira, Inc.",844-646-4398,"2% w/EPI 1:50,000; 1.8mL syringe (NDC 00409-7263-01)",Revised,12/20/19,Discontinued,,,Discontinuation of the manufacture of the drug,Anesthesia;Pediatric,Current,,
1196,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 5mcg tablets (NDC 0378-3611-01),New,3/28/18,,The discontinuation of this product is a business decision,,,Endocrinology/Metabolism,To be Discontinued,3/28/18,3/28/18
1197,Liothyronine Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Liothyronine Sodium 25mcg tablets (NDC 0378-3612-01),New,3/28/18,,The discontinuation of this product is a business decision,,,Endocrinology/Metabolism,To be Discontinued,3/28/18,3/28/18
1198,Liotrix (Thyrolar) Tablets,Allergan,800-678-1605,Thyrolar-1/4 (NDC 0456-0040-01),New,12/6/18,,"The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains",,,Endocrinology/Metabolism,To be Discontinued,12/6/18,12/6/18
1199,Liotrix (Thyrolar) Tablets,Allergan,800-678-1605,Thyrolar-1/2 (NDC 0456-0045-01),New,12/6/18,,"The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains",,,Endocrinology/Metabolism,To be Discontinued,12/6/18,12/6/18
1200,Liotrix (Thyrolar) Tablets,Allergan,800-678-1605,Thyrolar-1 (NDC 0456-0050-01),New,12/6/18,,"The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains",,,Endocrinology/Metabolism,To be Discontinued,12/6/18,12/6/18
1201,Liotrix (Thyrolar) Tablets,Allergan,800-678-1605,Thyrolar-2 (NDC 0456-0055-01),New,12/6/18,,"The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains",,,Endocrinology/Metabolism,To be Discontinued,12/6/18,12/6/18
1202,Liotrix (Thyrolar) Tablets,Allergan,800-678-1605,Thyrolar-3 (NDC 0456-0060-01),New,12/6/18,,"The company has made a business decision to discontinue manufacturing of Thyrolar® (Liotrix tablets, USP) ¼, ½, 1, 2 and 3 grains",,,Endocrinology/Metabolism,To be Discontinued,12/6/18,12/6/18
1203,Lisinopril (Prinivil) Tablets,Merck Sharp & Dohme Corp.,800-672-6372,"5-mg tablets, unit-of-use bottle/90 (NDC 0006-0019-54)",New,3/11/19,,To be discontinued on or near April 2019.,,,Cardiovascular,To be Discontinued,3/11/19,
1204,Lisinopril Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2.5 mg (NDC 0378-2072-01); 5 mg (NDC 0378-2073-01); 5 mg (NDC 0378-2073-10); 10 mg (NDC 0378-2074-01); 10 mg (NDC 0378-2074-10); 20 mg (NDC 0378-2075-01); 20 mg (NDC 0378-2075-10); 30 mg (NDC 0378-2077-01); 40 mg (NDC 0378-2076-01; 40 mg (NDC 0378-2076-05),New,4/11/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,4/11/18,4/11/18
1205,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL; Carpuject Luer Lock Glass Syringe (NDC 00409-1539-31),Reverified,12/20/19,Next delivery: January 2020 Estimated Recovery: December 2020,Shortage per manufacturer: Manufacturing Delay,,Other,Neurology,Current,,
1206,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL; Carpuject Luer Lock Glass Syringe  (NDC 00409-1985-30),Reverified,12/20/19,Available,,,Other,Neurology,Current,,
1207,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6778-02),Reverified,12/20/19,Available,,,Other,Neurology,Current,,
1208,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL; 1 mL Multiple Dose Glass Fliptop Vial (NDC 00409-6779-02),Reverified,12/20/19,Available,,,Other,Neurology,Current,,
1209,"Lorazepam Injection, USP","Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-6780-02),Reverified,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Neurology,Current,,
1210,"Lorazepam Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"LORAZEPAM INJECTION, USP, C IV [2 mg/ mL](NDC 76329-8261-1)",Reverified,12/16/19,Available,,,Other,Neurology,Current,,
1211,"Lorazepam Injection, USP",Akorn Pharmaceuticals,800-932-5676,Lorazepam Injection 2 mg/mL (NDC 17478-040-01),Revised,12/2/19,Available,,,Demand increase for the drug,Neurology,Current,,
1212,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 1 mL vial (NDC 0641-6001-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1213,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 2 mg/mL, 10 mL vial (NDC 0641-6000-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1214,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 1 mL vial (NDC 0641-6003-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1215,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Ativan (lorazepam) Injection 4 mg/mL, 10 mL vial ((NDC 0641-6002-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1216,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 1 mL vial (NDC 0641-6044-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1217,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 2 mg/mL, 10 mL vial (NDC 0641-6046-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1218,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 1 mL vial (NDC 0641-6045-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1219,"Lorazepam Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Lorazepam Injection, USP 4 mg/mL, 10 mL vial (NDC 0641-6002-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Neurology,Current,,
1220,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
1221,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
1222,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
1223,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",New,11/25/19,,,,,Psychiatry,To be Discontinued,11/25/19,11/25/19
1224,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 100 count bottle (NDC 0527-1394-01)",New,11/25/19,"Out of stock, estimated availability in January/February 2020",Additional lots are scheduled for release in the January/February timeframe. Product will be made available as it is released.,,Other,Psychiatry,Current,,
1225,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"5 mg, 1000 count bottle (NDC 0527-1394-10)",New,11/25/19,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
1226,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 100 count bottle (NDC 0527-1395-01)",New,11/25/19,Allocating inventory,Additional lots are scheduled for release in the January/February timeframe.,,Other,Psychiatry,Current,,
1227,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"10 mg, 1000 count bottle (NDC 0527-1395-10)",New,11/25/19,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
1228,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 100 count bottle (NDC 0527-1396-01)",New,11/25/19,Allocating Inventory,Additional lots are scheduled for release in the January/February timeframe.,,Other,Psychiatry,Current,,
1229,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"25 mg, 1000 count bottle (NDC 0527-1396-10)",New,11/25/19,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
1230,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 100 count bottle (NDC 0527-1397-01)",New,11/25/19,Allocating Inventory,Additional lots are scheduled for release in the January/February timeframe.,,Other,Psychiatry,Current,,
1231,Loxapine Capsules,"Lannett Company, Inc.",215-333-9000 ext. 4,"50 mg, 1000 count bottle (NDC 0527-1397-10)",New,11/25/19,Unavailable,,,Discontinuation of the manufacture of the drug,Psychiatry,Current,,
1232,Loxapine Capsules,Mylan,800-796-9526,"5 mg, 100 count bottle (NDC 0378-7005-01)",New,11/25/19,End Q1 2020,,,Other,Psychiatry,Current,,
1233,Loxapine Capsules,Mylan,800-796-9526,"10 mg, 100 count bottle (NDC 0378-7010-01)",New,11/25/19,End Q1 2020,,,Other,Psychiatry,Current,,
1234,Loxapine Capsules,Mylan,800-796-9526,"25 mg, 100 count bottle (NDC 0378-7025-01)",New,11/25/19,End Q1 2020,,,Other,Psychiatry,Current,,
1235,Loxapine Capsules,Mylan,800-796-9526,"50 mg, 100 count bottle (NDC 0378-7050-01)",New,11/25/19,End Q1 2020,,,Other,Psychiatry,Current,,
1236,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"5 mg, 100 count bottle (NDC 0591-0369-01)",Reverified,12/16/19,Product is available,,,,Psychiatry,Current,,
1237,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"10 mg, 100 count bottle (NDC 0591-0370-01)",Reverified,12/16/19,Availability and estimated duration of supply interruption is unknown,,,Other,Psychiatry,Current,,
1238,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"25 mg, 100 count bottle (NDC 0591-0371-01)",Reverified,12/16/19,Product is available,,,,Psychiatry,Current,,
1239,Loxapine Capsules,Teva Pharmaceuticals,800-545-8800,"50 mg, 100 count bottle (NDC 0591-0372-01)",Reverified,12/16/19,Product is available,,,,Psychiatry,Current,,
1240,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,718-276-8607,"12.5mg tablets, 100 count (NDC 42806-012-01)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
1241,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"12.5mg tablets, 1000 count (NDC 42806-012-10)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
1242,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 100 count (NDC 42806-014-01)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
1243,Meclizine Hydrochloride Tablets,Epic Pharmaceuticals,716-276-8607,"25mg tablets, 1000 count (NDC 42806-014-10)",New,2/28/18,,This discontinuation is due to a business decision.,,,Gastroenterology,To be Discontinued,2/28/18,2/28/18
1244,Megestrol Acetate (Megace) Oral Suspension,"Endo Pharmaceuticals, Inc.",800-462-3636,MEGACE®ES 625mg/5ml Suspension (NDC 63481-160-38),New,8/21/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,8/21/19,8/21/19
1245,Megestrol Acetate (Megace) Oral Suspension,Bristol Myers Squibb Co.,800-332-2056,40 mg/mL Oral Suspension (NDC 00015-508-42),New,5/6/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/6/19,5/6/19
1246,Mesna Injection,Teva Pharmaceuticals,800-545-8800,100 mg/mL (NDC 0703-4805-03),New,6/21/19,,This product discontinuation is a business related decision.,,,Oncology,To be Discontinued,6/21/19,6/21/19
1247,"Metaproterenol Sulfate Tablets, USP",Par Pharmaceutical,"800-828-9393 option 5, then option 2","10mg, 100 count (NDC 49884-0258-01)",New,7/12/19,,Business decision to discontinue marketing in the US.,,,Pulmonary/Allergy,To be Discontinued,7/12/19,7/12/19
1248,"Metaproterenol Sulfate Tablets, USP",Par Pharmaceutical,"800-828-9393 option 5, then option 2","20mg, 100 count (NDC 49884-0259-01)",New,7/12/19,,Business decision to discontinue marketing in the US.,,,Pulmonary/Allergy,To be Discontinued,7/12/19,7/12/19
1249,Metformin Hydrochloride (Glucophage XR) Tablets Extended Release,Bristol Myers Squibb Co.,800-332-2056,"500mg 100/bottle, (NDC 0087-6063-13)",New,2/27/19,,This was a business-related decision to discontinue manufacturing these products,,,Endocrinology/Metabolism,To be Discontinued,2/27/19,2/27/19
1250,Metformin Hydrochloride (Glucophage XR) Tablets Extended Release,Bristol Myers Squibb Co.,800-332-2056,750mg 100/bottle (NDC 0087-6064-13),New,2/27/19,,This was a business-related decision to discontinue manufacturing these products,,,Endocrinology/Metabolism,To be Discontinued,2/27/19,2/27/19
1251,Metformin Hydrochloride (Glucophage) Tablets,Bristol Myers Squibb Co.,800-332-2056,"500mg 100/bottle, (NDC  0087-6060-05)",New,2/27/19,,This was a business-related decision to discontinue manufacturing these products,,,Endocrinology/Metabolism,To be Discontinued,2/27/19,2/27/19
1252,Metformin Hydrochloride (Glucophage) Tablets,Bristol Myers Squibb Co.,800-332-2056,"500mg 500/bottle, (NDC 0087-6060-10)",New,2/27/19,,This was a business-related decision to discontinue manufacturing these products,,,Endocrinology/Metabolism,To be Discontinued,2/27/19,2/27/19
1253,Metformin Hydrochloride (Glucophage) Tablets,Bristol Myers Squibb Co.,800-332-2056,"850mg 100/bottle, (NDC 0087-6070-05)",New,2/27/19,,This was a business-related decision to discontinue manufacturing these products,,,Endocrinology/Metabolism,To be Discontinued,2/27/19,2/27/19
1254,Metformin Hydrochloride (Glucophage) Tablets,Bristol Myers Squibb Co.,800-332-2056,"1000mg 100/bottle, (NDC 0087-6071-11)",New,2/27/19,,This was a business-related decision to discontinue manufacturing these products,,,Endocrinology/Metabolism,To be Discontinued,2/27/19,2/27/19
1255,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,"Metformin Hydrochloride Tablet Extended Release, 750 mg per tablet, (NDC 0093-7212-01), 100 count per bottle",New,7/22/19,,Teva made a business decision to discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,7/22/19,7/22/19
1256,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,"Metformin Hydrochloride Tablet Extended Release, 500 mg per tablet, (NDC 0093-7267-01), 100 count per bottle",New,7/22/19,,Teva made a business decision to discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,7/22/19,7/22/19
1257,Metformin Hydrochloride Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,"Metformin Hydrochloride Tablet Extended Release, 500 mg per tablet, (NDC 0093-7267-10), 1000 count per bottle",New,7/22/19,,Teva made a business decision to discontinue the drug product.,,,Endocrinology/Metabolism,To be Discontinued,7/22/19,7/22/19
1258,Methadone Hydrochloride Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),Methadone Hydrochloride Injection (Solution in Multi Dose Vials) [200 mg / 20 ml](NDC 67457-217-20),Reverified,11/26/19,Available,,,Other,Analgesia/Addiction;Anesthesia,Current,,
1259,Methadone Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"Methadone Hydrochloride Injection USP, 200 mg/20 mL (10 mg/mL) , 20 mL multidose vials (NDC 17478-380-20)",Revised,12/11/19,Backordered. Estimated recovery February/March 2020,,,Other,Analgesia/Addiction;Anesthesia,Current,,
1260,"Methocarbamol Tablet, USP","Endo Pharmaceuticals, Inc.",800-462-3636,"Robaxin® 500mg, 100 Tablets (NDC 52244-429-10)",New,8/21/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction;Musculoskeletal,To be Discontinued,8/21/19,8/21/19
1261,Methocarbamol Tablets,"Oxford Pharmaceuticals, LLC",256-759-6905,"500 mg, 100 ct (NDC 69584-611-10); 500 ct (NDC 69584-611-50); 1000 ct (NDC 69584-611-90)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1262,Methocarbamol Tablets,"Oxford Pharmaceuticals, LLC",256-759-6905,"750 mg, 100 ct (NDC 69584-612-10); 500 ct (NDC 69584-612-50); 1000 ct (NDC 69584-612-90)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1263,Methocarbamol Tablets,"Solco Healthcare US, LLC",866-931-9829,"500 mg, 100 ct (NDC 43547-0405-10); 500 ct (NDC 43547-0405-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1264,Methocarbamol Tablets,"Solco Healthcare US, LLC",866-931-9829,"750 mg, 100 ct (NDC 43547-0226-10); 500 ct (NDC 43547-0226-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1265,Methocarbamol Tablets,Granules Pharmaceuticals Inc.,877-770-3183,"500 mg, 100 ct (NDC 70010-754-01); 500 ct (NDC 70010-754-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1266,Methocarbamol Tablets,Granules Pharmaceuticals Inc.,877-770-3183,"750 mg, 100 ct (NDC 70010-770-01); 500 ct (NDC 70010-770-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1267,Methocarbamol Tablets,"AustarPharma, LLC",805-447-9866 ext. 259,"Distributed by Golden State Medical Supply, Inc.: 500 mg, 100 ct (NDC 60429-118-01); 500 ct (NDC 60429-118-05) Distributed by Virus Pharmaceuticals: 500 mg, 100 ct (NDC 69543-134-10); 500 ct (NDC 69543-134-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1268,Methocarbamol Tablets,"AustarPharma, LLC",805-477-9866 ext. 259,"Distributed by Golden State Medical Supply, Inc.: 750 mg, 100 ct (NDC 60429-119-01); 500 ct (NDC 60429-119-05) Distributed by Virtus Pharmaceuticals: 750 mg, 100 ct (NDC 69543-135-10); 500 ct (NDC 69543-135-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1269,Methocarbamol Tablets,Camber Pharmaceuticals Inc.,866-827-3647,"500 mg, 100 ct (NDC 31722-533-01); 500 ct (NDC 31722-533-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1270,Methocarbamol Tablets,Camber Pharmaceuticals Inc.,866-827-3647,"750 mg, 100 ct (NDC 31722-534-01); 500 ct (NDC 31722-534-05)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1271,Methocarbamol Tablets,Bayshore Pharmaceuticals,973-315-1819,"500 mg, 100 ct (NDC 76385-123-01); 500 ct (NDC 76385-123-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1272,Methocarbamol Tablets,Bayshore Pharmaceuticals,973-315-1819,"750 mg, 100 ct (NDC 76385-124-01); 500 ct (NDC 76385-124-50)",Revised,12/13/19,,,,,Analgesia/Addiction,Resolved,12/13/19,
1273,Methotrexate Sodium Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 2 mL vial (NDC 0143-9519-10)",Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1274,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML 1X40ML (NDC 00703-3678-01),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1275,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML 1X40ML Premier label  (NDC 00703-3678-81),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1276,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML 1X10ML (NDC 00703-3675-01),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1277,Methotrexate Sodium Injection,Teva Pharmaceuticals,800-545-8800,25MG/ML SDV 10X2ML (NDC 00703-3671-03),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1278,Methotrexate Sodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 gram per vial, 50 mL vial, SDV (NDC 63323-122-50)",Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1279,Methotrexate Sodium Injection,"Fresenius Kabi USA, LLC",888-386-1300,"250 mg per 10 mL, vial (NDC 63323-123-10)",Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1280,Methotrexate Sodium Injection,"Hospira, Inc.",844-646-4398,50 mg/2 mL (25 mg/mL); Glass Fliptop Vial (NDC 61703-0350-38),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1281,Methotrexate Sodium Injection,"Hospira, Inc.",844-646-4398,1 g/40 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 61703-0408-41),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1282,Methotrexate Sodium Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),1000 mg/40 mL (NDC 67457-480-40),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1283,Methotrexate Sodium Injection,Accord Healthcare Inc.,800-843-7477,25 mg/mL; 2mL (NDC 16729-277-30),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1284,Methotrexate Sodium Injection,Accord Healthcare Inc.,800-843-7477,25 mg/mL; 40 mL (NDC 16729-277-35),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1285,Methotrexate Sodium Injection,Accord Healthcare Inc.,800-843-7477,25 mg/mL; 10 mL (NDC 16729-277-03),Revised,12/17/19,,,,,Oncology,Resolved,12/17/19,
1286,Methotrexate Sodium Injection,Mylan,800-796-9526,"250 mg in 10 mL (25 mg/mL), single dose vial (NDC 67457-466-10)",New,12/16/19,,Expected Discontinuation April 2020,,,Dermatology;Oncology;Pediatric;Rheumatology,To be Discontinued,12/16/19,12/16/19
1287,"Methotrexate Tablets, USP","Endo Pharmaceuticals, Inc.",800-462-3636,"Methotrexate Sodium 2.5 mg Tablet, 36 count (NDC 67253-320-36)",New,9/13/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Dermatology;Oncology;Rheumatology,To be Discontinued,9/13/19,9/13/19
1288,"Methotrexate Tablets, USP","Endo Pharmaceuticals, Inc.",800-462-3636,"Methotrexate Sodium 2.5 mg Tablet, 100 count (NDC 67253-320-10)",New,9/13/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Dermatology;Oncology;Rheumatology,To be Discontinued,9/13/19,9/13/19
1289,"Methscopolamine Bromide, Tablets, USP",Par Pharmaceutical,800-828-9393,"2.5 mg, 100 count (NDC  64376-603-01)",New,7/18/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,7/18/19,7/18/19
1290,"Methscopolamine Bromide, Tablets, USP",Par Pharmaceutical,800-828-9393,"5 mg, 60 count (NDC 64376-604-61)",New,7/18/19,,Par has made a business decision to permanently discontinue the drug product.,,,Gastroenterology,To be Discontinued,7/18/19,7/18/19
1291,Methyclothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-0160-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1292,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,500 mg/1 unit (NDC 0093-2932-05),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
1293,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,500 mg/1 unit (NDC 0093-2932-01),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
1294,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,250 mg/1 unit (NDC 0093-2931-10),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
1295,Methyldopa Tablets,Teva Pharmaceuticals,800-545-8800,250 mg/1 unit (NDC 0093-2931-01),New,6/10/19,,"The discontinuation of these products is a business decision and not related to product quality, safety or efficacy.",,,Cardiovascular,To be Discontinued,6/10/19,6/10/19
1296,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 100s (16729-03-001),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
1297,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 250 mg 500s (16729-03-016),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
1298,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 100s (16729-03-101),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
1299,Methyldopa Tablets,Accord Healthcare Inc.,866-941-7875,Methyldopa 500 mg 500s (16729-03-116),Reverified,12/13/19,Limited availability; Estimated shortage until March 2020,,,API procurement delay,Cardiovascular,Current,,
1300,Methyldopa Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,250 mg (NDC 0378-0611-01),Reverified,11/26/19,Unavailable. Estimated recovery: Q1 2020,,,Other,Cardiovascular,Current,,
1301,Methyldopa Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,500 mg (NDC 0378-0421-01),Reverified,11/26/19,Unavailable. Estimated recovery: Q1 2020,,,Other,Cardiovascular,Current,,
1302,Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets,"Tris Pharma, Inc.",732-940-0358,20 mg (NDC 24478-074-01),Revised,8/9/19,,,,,Pediatric;Psychiatry,Resolved,8/9/19,
1303,Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets,"Tris Pharma, Inc.",732-940-0358,30 mg (NDC 24478-075-01),Revised,8/9/19,,,,,Pediatric;Psychiatry,Resolved,8/9/19,
1304,Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets,"Tris Pharma, Inc.",732-940-0358,40 mg (NDC 24478-076-01),Revised,8/9/19,,,,,Pediatric;Psychiatry,Resolved,8/9/19,
1305,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,300 mg/60 mL (NDC 24478-321-02),Reverified,12/13/19,Available,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,Other,Pediatric;Psychiatry,Current,,
1306,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,600 mg/120mL (NDC 24478-322-04),Reverified,12/13/19,Available,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,Other,Pediatric;Psychiatry,Current,,
1307,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,750 mg/150 mL (NDC 24478-323-05),Reverified,12/13/19,Available,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,Other,Pediatric;Psychiatry,Current,,
1308,Methylphenidate Hydrochloride (QUILLIVANT XR) for Extended-Release Oral Suspension,"Tris Pharma, Inc.",732-940-0358,900 mg/180 mL (NDC 24478-324-06),Reverified,12/13/19,Available,"Effective September 21, 2018, Tris Pharma, Inc. acquired NextWave Pharmaceuticals, previously a wholly owned subsidiary of Pfizer Inc., including this product",,Other,Pediatric;Psychiatry,Current,,
1309,"Methylphenidate Hydrochloride Extended-Release Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,36 mg 30 count (NDC 0591-2717-30),New,5/17/19,,Teva made a business related decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
1310,"Methylphenidate Hydrochloride Extended-Release Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,54 mg 30 count (NDC 0591-2718-30),New,5/17/19,,Teva made a business related decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
1311,"Methylphenidate Hydrochloride Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,5 mg 100 count (NDC 0591-5882-01),New,5/17/19,,Teva made a business decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
1312,"Methylphenidate Hydrochloride Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,10 mg 100 count (NDC 0591-5883-01),New,5/17/19,,Teva made a business decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
1313,"Methylphenidate Hydrochloride Tablets, USP CII",Teva Pharmaceuticals,800-545-8800,20 mg 100 count (NDC 0591-5884-01),New,5/17/19,,Teva made a business decision to discontinue the product.,,,Pediatric;Psychiatry,To be Discontinued,5/17/19,5/17/19
1314,Methylprednisolone Tablets,Teva Pharmaceuticals,800-545-8800,4 mg tablets (NDC 0591-0790-01),New,12/5/19,,,,,Neurology,To be Discontinued,12/5/19,12/5/19
1315,"Metoclopramide Injection, USP",Heritage Pharma,855-228-9470,10mg/2mL (NDC 23155-240-41),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
1316,"Metoclopramide Injection, USP","Hospira, Inc.",844-646-4398,10 mg/2 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3414-01),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
1317,"Metoclopramide Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 2 mL, single use, prefilled syringe (NDC 76045-101-20)",Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
1318,"Metoclopramide Injection, USP",Teva Pharmaceuticals,800-545-8800,5 mg/ 1 ml (NDC 0703-4502-04),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
1319,"Metoclopramide Injection, USP",Teva Pharmaceuticals,800-545-8800,5 mg/ 1 ml (NDC 0703-4502-84),Revised,10/18/19,,,,,Gastroenterology,Resolved,10/18/19,
1320,"Metoprolol Tartrate Injection, USP",Gland Pharma,609-250-7990,"1 mg/mL, 5 mL vial (NDC 72266-122-25)",Reverified,12/16/19,Available,Distributed by Fosun Pharma USA Inc. (Company Contact Information:  833-291-9645),,Available,Cardiovascular,Current,,
1321,"Metoprolol Tartrate Injection, USP",Gland Pharma,609-250-7990,1 mg/mL 5mL vial (NDC 70860-300-05 and 70860-300-41),Reverified,12/16/19,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Cardiovascular,Current,,
1322,"Metoprolol Tartrate Injection, USP",Gland Pharma,609-250-7990,5 mg per 5 mL Single Dose Vial (NDC 47781-587-17),Reverified,12/16/19,Available,Distributed by Alvogen Inc. (Company Contact Information:  973-532-7840),,Available,Cardiovascular,Current,,
1323,"Metoprolol Tartrate Injection, USP",Baxter Healthcare,888-229-0001,1 mg/mL - 5 mL Sterile Single Use Glass Vial (10 x 5 mL). For Intravenous Use (NDC 36000-033-10),Reverified,12/11/19,Available,,,,Cardiovascular,Current,,
1324,"Metoprolol Tartrate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 5 mL, SDV, PF (NDC 63323-660-05)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Manufacturing delays,Cardiovascular,Current,,
1325,"Metoprolol Tartrate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"1mg/mL – 10mL vials, (NDC 0143-9660-10)",Reverified,12/13/19,Available,,,Demand increase for the drug,Cardiovascular,Current,,
1326,"Metoprolol Tartrate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,1mg/mL – 5ml vials (NDC 0143-9873-25),Reverified,12/13/19,This presentation is temporarily on backorder.,,,Demand increase for the drug,Cardiovascular,Current,,
1327,"Metoprolol Tartrate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/5 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1778-05),Reverified,12/20/19,Available,,,Other,Cardiovascular,Current,,
1328,"Metoprolol Tartrate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/5 mL (1 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1778-35),Reverified,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
1329,"Metoprolol Tartrate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/5 mL (1 mg/mL); Glass Ampul (NDC 00409-2285-05),Reverified,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular,Current,,
1330,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,50 mg tablets (NDCs 0591-0462-01 and 0591-0462-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,12/16/19,12/16/19
1331,Metoprolol Tartrate Tablets,Teva Pharmaceuticals,800-545-8800,100 mg tablets (NDCs 0591-0463-01 and 0591-0463-10),New,12/16/19,,,,,Cardiovascular,To be Discontinued,12/16/19,12/16/19
1332,"Metronidazole Injection, USP",Baxter Healthcare,888-229-0001,"Metronidazole Injection, USP, 500 mg/100 mL, in VIAFLEX Plus Container (NDC 0338-1055-48)",Reverified,12/11/19,Available,,,,Anti-Infective,Current,,
1333,"Metronidazole Injection, USP","Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 00409-7811-24),Reverified,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective,Current,,
1334,"Metronidazole Injection, USP","Hospira, Inc.",844-646-4398,500 mg/100 mL (5 mg/mL); Flexible Container (NDC 00409-7811-37),Reverified,12/20/19,Available,,,Other,Anti-Infective,Current,,
1335,"Metronidazole Injection, USP",B. Braun Medical Inc.,800-227-2862,Metronidazole Injection 500mg (5mg/mL) 100mL D5353-5224 (NDC 0264-5535-32),Revised,1/22/19,Product available for contracted  customers,,,Manufacturing interruptions and demand increase,Anti-Infective,Current,,
1336,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,15mg tablets (NDC 0591-2469-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
1337,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,30mg tablets (NDC 0591-2470-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
1338,Mirtazapine Orally Disintegrating Tablets,"Actavis LLC, an indirect wholly owned subsidiary of Teva Pharmaceuticals USA, Inc.",800-545-8800,45mg tablets (NDC 0591-2471-15),New,5/29/18,,This product discontinuation is a business related decision,,,Psychiatry,To be Discontinued,5/29/18,5/29/18
1339,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,15 mg 30 count bottle (NDC 0093-7206-56),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1340,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,15 mg 30 count bottle (NDC 0591-1117-30),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1341,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,15 mg 1000 count bottle (NDC 0591-1117-10),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1342,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,30 mg 30 count bottle (NDC 0093-7207-56),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1343,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,30 mg 30 count bottle (NDC 0591-1118-30),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1344,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,30 mg 1000 count bottle (NDC 0591-1118-10),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1345,"Mirtazapine Tablets, USP",Teva Pharmaceuticals,800-545-8800,45 mg 30 count bottle (NDC 0591-1119-30),New,5/2/19,,Discontinuation of the manufacture of the drug.,,,Psychiatry,To be Discontinued,5/2/19,5/2/19
1346,Modafinil Tablets,Par Pharmaceutical,800-828-9393,"100 mg, bottle of 30 (NDC 49884-534-11)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,4/19/19,4/19/19
1347,Moexipril Hydrochloride/Hydrochlorothiazide Tablets,Teva Pharmaceuticals,800-545-8800,7.5 mg; 12.5 mg tablets (NDC 0093-5213-01),New,11/6/18,,This product discontinuation is a business-related decision.,,,Cardiovascular,To be Discontinued,11/6/18,11/6/18
1348,Moexipril Hydrochloride/Hydrochlorothiazide Tablets,Teva Pharmaceuticals,800-545-8800,15 mg; 12.5 mg tablets (NDC 0093-5214-01),New,11/6/18,,This product discontinuation is a business-related decision.,,,Cardiovascular,To be Discontinued,11/6/18,11/6/18
1349,Moexipril Hydrochloride/Hydrochlorothiazide Tablets,Teva Pharmaceuticals,800-545-8800,15 mg; 25 mg tablets (NDC 0093-5215-01),New,11/6/18,,This product discontinuation is a business-related decision.,,,Cardiovascular,To be Discontinued,11/6/18,11/6/18
1350,Mometasone Furoate (Elocon) Topical Cream,Merck Sharp & Dohme Corp.,800-672-6372,0.1% 15 gram tube  (NDC 0085-3149-01),New,7/29/19,,,,,Dermatology,To be Discontinued,7/29/19,7/29/19
1351,Mometasone Furoate (Elocon) Topical Cream,Merck Sharp & Dohme Corp.,800-672-6372,0.1% 50 gram tube  (NDC 0085-3149-03),New,7/29/19,,,,,Dermatology,To be Discontinued,7/29/19,7/29/19
1352,Montelukast Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-5201-93),New,3/20/18,,The discontinuation of this product is a business decision,,,Pediatric;Pulmonary/Allergy,To be Discontinued,3/20/18,3/20/18
1353,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,20 mg/0.8 mg; 30 capsules per bottle (NDC 60793-430-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
1354,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,30 mg/1.2 mg; 30 capsules per bottle (NDC 60793-431-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
1355,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,50 mg/2 mg; 30 capsules per bottle (NDC 60793-433-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
1356,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,60 mg/2.4 mg; 30 capsules per bottle (NDC 60793-434-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
1357,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,80 mg/3.2 mg; 30 capsules per bottle (NDC 60793-435-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
1358,Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules,Pfizer Pharmaceuticals,800-533-4535,100 mg/4 mg; 30 capsules per bottle (NDC 60793-437-20),New,10/7/19,,Stop sale date 15Nov2019.  Anticipated unavailability of product is early 2020.,,,Analgesia/Addiction,To be Discontinued,10/7/19,10/7/19
1359,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"15 mg, bottle of 100 (NDC 60951-652-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
1360,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"30 mg, bottle of 100 (NDC 60951-653-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
1361,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"60 mg, bottle of 100 (NDC 60951-655-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
1362,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"100 mg, bottle of 100 (NDC 60951-658-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
1363,Morphine Sulfate Extended-Release Tablets,Par Pharmaceutical,800-828-9393,"200 mg, bottle of 100 (NDC 60951-659-70)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Analgesia/Addiction,To be Discontinued,4/19/19,4/19/19
1364,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100s (NDC 0378-2658-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
1365,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"30 mg, 100s (NDC 0378-2659-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
1366,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"60 mg, 100s (NDC 0378-2660-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
1367,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg, 100s (NDC 0378-2661-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
1368,Morphine Sulfate Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg, 100s (NDC 0378-2662-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Analgesia/Addiction,To be Discontinued,5/8/18,5/8/18
1369,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single dose vial, (NDC 63323-452-01)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1370,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single dose vial, (NDC 63323-454-01)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1371,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single dose vial, (NDC 63323-455-01)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1372,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single dose vial, (NDC 63323-458-01)",Reverified,12/20/19,Available,,,Demand increase for the drug,Analgesia/Addiction,Current,,
1373,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single dose vial, (NDC 63323-451-01)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1374,"Morphine Sulfate Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,Morphine Sulfate 1 mg/mL 30 mg in 30 mL PUMP-JET®  SUITABLE FOR USE WITH COMPATIBLE I.V. INFUSION PUMPS,Revised,12/16/19,Available,,,,Analgesia/Addiction,Current,,
1375,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"4 mg/mL, 1 mL vial (NDC 0641-6125-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1376,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"8 mg/mL, 1 mL vial (NDC 0641-6126-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1377,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"10 mg/mL, 1 mL vial (NDC 0641-6127-25)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1378,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,250 mg/10 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1135-02),Revised,12/20/19,Next Delivery: March 2020; Estimated Recovery: April 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1379,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1890-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
1380,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,2 mg/mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1890-11),Revised,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1381,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1891-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
1382,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,4 mg/mL (4 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1891-11),Revised,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1383,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1892-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
1384,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,8 mg/mL (8 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1892-11),Revised,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1385,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1893-01),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
1386,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,10 mg/mL (10 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1893-11),Revised,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1387,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,5 mg/10 mL (0.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3814-12),Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
1388,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,10 mg/10 mL (1 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-3815-12),Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1389,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,"1,000 mg/20 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-03)",Revised,12/20/19,Available,,,Other,Analgesia/Addiction,Current,,
1390,"Morphine Sulfate Injection, USP","Hospira, Inc.",844-646-4398,"2,500 mg/50 mL (50 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-1134-05)",Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1391,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"2 mg per 1 mL, Single-use prefilled syringe (NDC 76045-004-10)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1392,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4 mg per 1 mL, Single-use prefilled syringe (NDC 76045-005-10)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1393,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"5 mg per 1 mL, Single-use prefilled syringe (NDC 76045-006-10)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Analgesia/Addiction,Current,,
1394,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"8 mg per 1 mL, Single-use prefilled syring (NDC 76045-007-10)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
1395,"Morphine Sulfate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"10 mg per 1 mL, Single-use prefilled syringe (NDC 76045-008-10)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,,,Demand increase for the drug,Analgesia/Addiction,Current,,
1396,"Morphine Sulfate Injection, USP","ICU Medical, Inc.",877-946-7747,1mg/mL 30mL PCA glass vial (NDC 0409-2029-02),Reverified,12/16/19,Unavailable,"ICU Medical acquired these products from Hospira, a Pfizer company. For questions or inquiries regarding these Hospira labeled products, please contact ICU Medical.",,Other,Analgesia/Addiction,Current,,
1397,"Morphine Sulfate Injection, USP","ICU Medical, Inc.",877-946-7747,5mg/mL 30mL PCA GLASS VIAL (CII)(NDC 0409-6028-04),New,10/2/19,,Discontinuation of the manufacture of the drug,,,Analgesia/Addiction,To be Discontinued,10/2/19,10/2/19
1398,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 1 mg/mL, 10 mL ampul (NDC 0641-6019-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1399,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Duramorph (Preservative-Free) 0.5 mg/mL, 10 mL ampul (NDC 0641-6020-10)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1400,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 10 mg/mL, 20 mL ampul (NDC 0641-6039-01)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1401,"Morphine Sulfate Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"Infumorph (Preservative-free Morphine Sulfate Sterile Solution) 25 mg/mL, 20 mL ampul (NDC 0641-6040-01)",Revised,12/13/19,Inventory is currently available.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction,Current,,
1402,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 10 mL Single Dose Dual Glass Fliptop Vials (NDC 61703-0434-82),Revised,12/20/19,Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1403,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Adult; 2 x 50 mL Pharmacy Bulk Package Dual Glass Fliptop Vials (NDC 61703-0422-83),Revised,12/20/19,Next Delivery: November 2020; Estimated Recovery: December 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1404,Multi-Vitamin Infusion (Adult and Pediatric),"Hospira, Inc.",844-646-4398,MVI Pediatric; Single Dose Glass Fliptop Vial (NDC 61703-0421-53),Revised,12/20/19,Next Delivery: November 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1405,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Pediatric, Multiple Vitamins for Injection. Single Dose package. (NDC 54643-5646-1)",Reverified,12/11/19,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1406,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Adult, Multiple Vitamins for Injection. Single dose package. (NDC 54643-5649-1)",Reverified,12/11/19,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1407,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Adult, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5650-2)",Reverified,12/11/19,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1408,Multi-Vitamin Infusion (Adult and Pediatric),Baxter Healthcare,888-229-0001,"INFUVITE Pediatric, Multiple Vitamins for Injection. Bulk package. (NDC 54643-5647-0)",Reverified,12/11/19,Available,"For detailed clinical recommendations to use during this shortage, please see information posted by the American Society of Parenteral and Enteral Nutrition.",,,Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1409,Mupirocin Calcium Nasal Ointment,GlaxoSmithKline,908-293-5330,2% Nasal Ointment 1 gram tube Package of 10 (NDC 0029152611),Revised,12/13/19,,,,,Anti-Infective,To be Discontinued,12/13/19,12/13/19
1410,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-3124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1411,Nafcillin Sodium Injection,Sandoz,800-525-8747,2 gram vial packaged in 10s (NDC 0781-3125-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1412,Nafcillin Sodium Injection,Sandoz,800-525-8747,Pharmacy Bulk Package bottle (NDC 0781-3126-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1413,Nafcillin Sodium Injection,Sandoz,800-525-8747,1 gram vial packaged in 10s (NDC 0781-9124-95),New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1414,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9224-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1415,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-9225-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1416,Nafcillin Sodium Injection,Sandoz,800-525-8747,"1 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3128-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1417,Nafcillin Sodium Injection,Sandoz,800-525-8747,"2 gram ADD-Vantage Vial, packed in 10s (NDC 0781-3129-92)",New,12/23/19,,,,,Anti-Infective,To be Discontinued,12/23/19,12/23/19
1418,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 1% 60 gm (NDC 40085-201-60),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
1419,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 1% 90 gm (NDC 40085-201-90),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
1420,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 2% 45 gm (NDC 40085-203-45),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
1421,Naftifine Hydrochloride Cream,Mylan Pharmaceuticals Inc.,800-796-9526,Naftifine HCl Cream 2% 60 gm (NDC 40085-203-60),New,5/15/19,,Discontinuation of the manufacture of the drug,,,Dermatology,To be Discontinued,5/15/19,5/15/19
1422,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 1 mL Glass Ampul (NDC 00409-1463-01),Reverified,12/20/19,Next Delivery: June 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1423,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/mL; 1 mL Glass Ampul (NDC 00409-1465-01),Reverified,12/20/19,Next Delivery: June 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1424,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1464-01),Reverified,12/20/19,Limited Supply Available. Next Delivery: June 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1425,Nalbuphine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/10 mL (20 mg/mL); 10 mL Multiple Dose Glass Fliptop Vial (NDC 00409-1467-01),Reverified,12/20/19,Limited Supply Available. Next Delivery: June 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Analgesia/Addiction,Current,,
1426,Naratriptan Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg  (NDC 0378-4450-59),New,7/17/19,,,,,Neurology,To be Discontinued,7/17/19,7/17/19
1427,Nebivolol Hydrochloride and Valsartan (BYVALSAN) Tablets,Allergan,800-678-1605,"5 mg, 80 mg per tablet; (NDCs 0023-5874-90; 0023-5874-84; 0023-5874-32; 0023-5874-31; 0023-5874-30; 0023-5874-07)",New,12/19/18,,,,,Cardiovascular,To be Discontinued,12/19/18,12/19/18
1428,Nelarabine (Arranon) Injection,Novartis,888-669-6682,250 mg/50 mL (NDC 0078-0683-06),Reverified,12/11/19,Available,,,Demand increase for the drug,Hematology,Current,,
1429,"Neomycin and Polymyxin B Sulfates Solution For Irrigation, USP",Teva Pharmaceuticals,800-545-8800,"40 mg and 200,000 units (1 mL ampule) (NDC 0591-2190-45)",New,6/10/19,,Discontinuation of the manufacture of the drug.,,,Anti-Infective;Urology,To be Discontinued,6/10/19,6/10/19
1430,Nesiritide Powder (NATRECOR) for Injection,Janssen Pharmaceuticals,800-526-7736,1.5 mg (NDC 65847-205-25),New,2/5/18,,Discontinuation of the manufacture of the drug,,,Cardiovascular,To be Discontinued,2/5/18,2/5/18
1431,Nevirapine Extended Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg tablets (NDC 0378-6950-77),New,1/31/19,,,,,Antiviral,To be Discontinued,1/31/19,1/31/19
1432,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"30mg, 100 count bottle (NDC 10370-677-01)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
1433,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"30mg, 500 count bottle (NDC 10370-677-05)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
1434,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"60mg, 100 count bottle (NDC 10370-678-01)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
1435,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"60mg, 500 count bottle (NDC 10370-678-05)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
1436,"Nifedipine Extended-Release Tablet, USP",Par Pharmaceutical,800-828-9393,"90 mg, 100 count bottle (NDC 10370-679-01)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/15/19,4/15/19
1437,"Nifedipine Extended-Release Tablet, USP",Teva Pharmaceuticals,800-545-8800,"Nifedipine extended-release tablets, 90 mg, 500 count (NDC 45963-152-50)",New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,6/7/19,6/7/19
1438,"Nifedipine Extended-Release Tablet, USP",Teva Pharmaceuticals,800-545-8800,"Nifedipine extended-release tablets, 90 mg, 100 count (NDC 45963-152-02)",New,6/7/19,,This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,6/7/19,6/7/19
1439,Nizatidine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 60 count bottle (NDC 0378-5150-91)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
1440,Nizatidine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg, 30 count bottle (NDC 0378-5300-93)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
1441,Norethindrone (NOR QD) Tablets,Allergan,800-678-1605,"Nor QD, 0.35 mg norethindrone, Tablets, (NDC  52544-235-28)",New,2/23/18,,"An authorized generic of the product is currently available as Nora-BE, NDC 52544-629-28.",,,Reproductive,To be Discontinued,2/23/18,2/23/18
1442,Norethindrone Acetate and Ethinyl Estradiol plus Ferrous Fumarate Chewable Tablets 0.1mg/0.02mg + 75mg (Minastrin 24Fe),Mylan Pharmaceuticals Inc.,800-796-9526,"0.1mg/0.02mg + 75mg Tablets, NDC (0378-7315-53)",New,1/2/19,,,,,Reproductive,To be Discontinued,1/2/19,1/2/19
1443,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate) (NDC 0023-5970-05) 5 Blister Pack in 1 Carton > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1444,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)(NDC 0430-0010-05) 5 Blister Pack in 1 Carton > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1445,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)(NDC 0430-0482-14) 72 Carton in 1 Case > 5 Cello Pack in 1 Carton > 1 Blister Pack in 1 Cello Pack > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1446,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)(NDC 0430-0482-95) 30 Tray in 1 Case > 6 Carton in 1 Tray > 1 Cello Pack in 1 Carton > 1 Blister Pack in 1 Cello Pack > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1447,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)(NDC 54868-6161-0) 1 Blister Pack in 1 Cello Pack > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1448,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)(NDC 68180-897-13) 5 Pouch in 1 Carton > 1 Blister Pack in 1 Pouch > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1449,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)( NDC 68180-898-13) 72 Carton in 1 Case > 5 Cello Pack in 1 Carton > 1 Blister Pack in 1 Cello Pack > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1450,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Allergan,800-678-1605,"Norethindrone, Ethinyl Estradiol Tablet (0.4 mg norethindrone / 0.035 mg ethinyl estradiol) Ferrous Fumarate Placebo Tablet (75 mg ferrous fumarate)( NDC68180-899-13) 5 Blister Pack in 1 Carton > 1 Kit in 1 Blister Pack",New,1/11/19,,The company has made a business decision to discontinue manufacturing of these items,,,Reproductive,To be Discontinued,1/11/19,1/11/19
1451,Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"0.02 mg norethindrone acetate / 1 mg ethinyl estradiol / 75 mg ferrous fumarate; 28 tablets per blister pack, 3 blisters per carton (NDC 0378-7301-53)",New,5/23/19,,,,,Reproductive,To be Discontinued,5/23/19,5/23/19
1452,Normosol-M and 5% Dextrose Injection,"ICU Medical, Inc.",877-946-7747,Normosol-M and 5% Dextrose Injection (NDC 0409-7965-03),New,12/6/18,,Discontinuation of the manufacture of the drug.,,,Gastroenterology;Pediatric;Total Parenteral Nutrition,To be Discontinued,12/6/18,12/6/18
1453,"Nystatin Cream, USP",Par Pharmaceutical,800-828-9393,"100,000 USP units per gram, 15 g (NDC 0603-7818-74)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology,To be Discontinued,4/15/19,4/15/19
1454,"Nystatin Cream, USP",Par Pharmaceutical,800-828-9393,"100,000 USP units per gram, 30 g (NDC 0603-7818-78)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology,To be Discontinued,4/15/19,4/15/19
1455,"Nystatin Cream, USP",Par Pharmaceutical,800-828-9393,"100,000 USP units per gram, 60 g (NDC 0603-7818-88)",New,4/15/19,,Par has made a business decision to permanently discontinue the drug product.,,,Dermatology,To be Discontinued,4/15/19,4/15/19
1456,"Nystatin Cream, USP",Teva Pharmaceuticals,800-545-8800,"100,000 USP units per gram, 15 g (NDC 0472-0163-15)",New,11/15/19,,Teva made a business decision to discontinue the product.,,,Dermatology,To be Discontinued,11/15/19,11/15/19
1457,"Nystatin Cream, USP",Teva Pharmaceuticals,800-545-8800,"100,000 units per gram, 30 g (NDC 0472-0163-30)",New,11/15/19,,Teva made a business decision to discontinue the product.,,,Dermatology,To be Discontinued,11/15/19,11/15/19
1458,Nystatin Oral Suspension,Wockhardt,800-346-6854 ext. 2,"Nystatin Oral Solution 100,000 units/1mL; 473 mL bottles (NDC 60432-0537-16)",Reverified,12/10/19,Available,,,Other,Anti-Infective;Pediatric,Current,,
1459,Nystatin Oral Suspension,Wockhardt,800-346-6854 ext. 2,"Nystatin Oral Solution 100,000 units/1mL; 60 mL bottles (NDC 60432-0537-60)",Reverified,12/10/19,Available,,,Other,Anti-Infective;Pediatric,Current,,
1460,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 500,000 units/5 ml; 5mL unit dose cup; 50 unit dose cups/ case (NDC 66689-037-50)",Revised,11/13/19,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective;Pediatric,Current,,
1461,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 500,000 units/5 ml; 5mL unit dose cup; 100 unit dose cups/ case (NDC 66689-037-99)",Revised,11/13/19,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective;Pediatric,Current,,
1462,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 100,000 units/ml; 60 mL Bottle (NDC 66689-008-02)",Revised,11/13/19,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective;Pediatric,Current,,
1463,Nystatin Oral Suspension,"VistaPharm, Inc.",877-530-1633,"Nystatin Oral Suspension, USP 100,000 units/ml; 480 mL Bottle (NDC 66689-008-16)",Revised,11/13/19,Available,,,Requirements related to complying with good manufacturing practices,Anti-Infective;Pediatric,Current,,
1464,Nystatin Oral Suspension,"Pharmaceutical Associates, Inc",800-845-8210,"Nystatin Oral Suspension, USP 500,000 Units/5 mL 5 mL Unit Dose Cups Case of 40 – 5 mL UDC (NDC 00121-4810-40); Case of 100 – 5 mL UDC (NDC 00121-4810-00); 2 oz. Bottles (NDC 00121-0810-02); 16 oz. Bottles (NDC 00121-0810-16)",New,1/8/19,Product availability will be limited as we resume production.,Resolution of product quality and manufacturing concerns.,,Requirements related to complying with good manufacturing practices,Anti-Infective;Pediatric,Current,,
1465,Olaratumab (Lartruvo) Injection,Eli Lilly and Co.,800-545-5979,500mg/50 ML x 1 vial (NDC 0002-8926-01),New,10/2/19,,Market withdrawal of Lartruvo. There is no safety or quality issue related to the withdrawal.,,,Oncology,To be Discontinued,10/2/19,10/2/19
1466,Olaratumab (Lartruvo) Injection,Eli Lilly and Co.,800-545-5979,190mg/19 ML x 1 vial (NDC 0002-7190-01),New,10/2/19,,Market withdrawal of Lartruvo. There is no safety or quality issue related to the withdrawal.,,,Oncology,To be Discontinued,10/2/19,10/2/19
1467,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20mg/12.5mg, 30 count bottle (NDC 0378-1413-93)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1468,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20mg/12.5mg, 90 count bottle (NDC 0378-1413-77)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1469,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/12.5mg, 30 count bottle (NDC 0378-1422-93)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1470,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/12.5mg, 90 count bottle (NDC 0378-1422-77)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1471,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/25mg, 30 count bottle (NDC 0378-1425-93)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1472,Olmesartan Medoxomil and Hydrochlorothiazide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"40mg/25mg, 90 count bottle (NDC 0378-1425-77)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
1473,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"5mg, 30 ct. (NDC 65852-0741-30)",Revised,12/13/19,Temporarily discontinued,,,,Cardiovascular,Current,,
1474,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"20mg, 30 ct. (NDC 65862-0742-30)",Revised,12/13/19,Temporarily discontinued,,,API Supply Issue,Cardiovascular,Current,,
1475,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"20mg, 90 ct. (NDC 65862-0742-90)",Revised,12/13/19,Temporarily discontinued,,,API Supply Issue,Cardiovascular,Current,,
1476,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"40mg, 30 ct. (NDC 65862-0743-30)",Revised,12/13/19,Temporarily discontinued,,,API Supply Issue,Cardiovascular,Current,,
1477,Olmesartan Medoxomil Tablets,Aurobindo Pharma,866-850-2876,"40mg., 90 ct. (NDC 65862-0743-90)",Revised,12/13/19,Temporarily discontinued,,,API Supply Issue,Cardiovascular,Current,,
1478,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"5mg, Bottle of 30 counts (NDC 62332-131-30)",Reverified,12/18/19,Available,,,,Cardiovascular,Current,,
1479,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"20mg, Bottle of 30 counts (NDC 62332-132-30)",Reverified,12/18/19,Available,,,,Cardiovascular,Current,,
1480,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"20mg, Bottle of 90 counts (NDC 62332-132-90)",Reverified,12/18/19,Available,,,,Cardiovascular,Current,,
1481,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"40mg, Bottle of 30 counts (NDC 62332-133-30)",Reverified,12/18/19,Available,,,,Cardiovascular,Current,,
1482,Olmesartan Medoxomil Tablets,Alembic Pharmaceuticals,908-393-9604,"40mg, Bottle of 90 counts (NDC 62332-133-90)",Reverified,12/18/19,Available,,,,Cardiovascular,Current,,
1483,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,5mg (NDC 68462-0436-30),Revised,12/12/19,Temporarily on backorder. Supply available mid-December 2019,,,API shortage,Cardiovascular,Current,,
1484,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,20mg (NDC 68462-0437-30),Revised,12/12/19,Available,,,API shortage,Cardiovascular,Current,,
1485,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,20mg (NDC 68462-0437-90),Revised,12/12/19,Available,,,API shortage,Cardiovascular,Current,,
1486,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,40mg (NDC 68462-0438-30),Revised,12/12/19,Temporarily on backorder. Estimated availability: mid-December 2019,,,API shortage,Cardiovascular,Current,,
1487,Olmesartan Medoxomil Tablets,Glenmark Pharmaceuticals,888-721-7115,40mg (NDC 68462-0438-90),Revised,12/12/19,Available,,,API shortage,Cardiovascular,Current,,
1488,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil  5mg T 30s (NDC 0378-7012-93),Reverified,11/26/19,Out of Stock. Resupply is Q1 2020.,,,,Cardiovascular,Current,,
1489,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 20mg T 30s (NDC 0378-7112-93),Reverified,11/26/19,Out of Stock. Resupply is Q1 2020.,,,Other,Cardiovascular,Current,,
1490,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 20mg T 90s (NDC 0378-7112-77),Reverified,11/26/19,Out of Stock. Resupply is Q1 2020.,,,Other,Cardiovascular,Current,,
1491,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 40mg T 30s (NDC 0378-7124-93),Reverified,11/26/19,Out of Stock. Resupply is Q1 2020.,,,,Cardiovascular,Current,,
1492,Olmesartan Medoxomil Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,Olmesartan Medoxomil 40mg T 90s (NDC 0378-7124-77),Reverified,11/26/19,Out of Stock. Resupply is Q1 2020.,,,Other,Cardiovascular,Current,,
1493,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"5mg, 30T (NDC 1672-9320-10)",Revised,12/11/19,Stocks available to support current customer demand,,,Limited API availability,Cardiovascular,Current,,
1494,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"5mg, 90T (NDC 1672-9320-15)",Revised,12/11/19,Stocks available to support current customer demand,,,Limited API availability,Cardiovascular,Current,,
1495,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"20mg, 30T (NDC 1672-9321-10)",Revised,12/11/19,Stocks available to support current customer demand,,,Limited API availability,Cardiovascular,Current,,
1496,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"20mg, 90T (NDC 1672-9321-15)",Revised,12/11/19,Stocks available to support current customer demand,,,Limited API availability,Cardiovascular,Current,,
1497,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"40mg, 30T (NDC 1672-9322-10)",Revised,12/11/19,Stocks available to support current customer demand,,,Limited API availability,Cardiovascular,Current,,
1498,Olmesartan Medoxomil Tablets,Accord Healthcare Inc.,866-941-7875,"40mg, 90T (NDC 1672-9322-15)",Revised,12/11/19,Stocks available to support current customer demand,,,Limited API availability,Cardiovascular,Current,,
1499,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,5mg tablet (NDC 13668-248-30),Reverified,12/13/19,Available,,,,Cardiovascular,Current,,
1500,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,20mg tablet (NDC 13668-249-30),Reverified,12/13/19,Available,,,,Cardiovascular,Current,,
1501,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,20mg tablet (NDC 13668-249-90),Reverified,12/13/19,Available,,,,Cardiovascular,Current,,
1502,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,40mg tablet (NDC 13668-250-30),Reverified,12/13/19,Available,,,,Cardiovascular,Current,,
1503,Olmesartan Medoxomil Tablets,Torrent Pharma Inc.,888-544-2299 option 4,40mg tablet (NDC 13668-250-90),Reverified,12/13/19,Available,,,,Cardiovascular,Current,,
1504,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"5mg, 30 Unit (NDC 65597-101-30)",Reverified,12/10/19,Available,,,Other,Cardiovascular,Current,,
1505,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"20mg, 30 Unit (NDC 65597-103-30)",Reverified,12/10/19,Available,,,Other,Cardiovascular,Current,,
1506,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"20mg, 90 Unit (NDC 65597-103-90)",Reverified,12/10/19,Available,,,Other,Cardiovascular,Current,,
1507,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"40mg, 30 Unit (NDC 65597-104-30)",Reverified,12/10/19,Available,,,Other,Cardiovascular,Current,,
1508,Olmesartan Medoxomil Tablets,"Daiichi Sankyo, Inc.",908-992-7001,"40mg, 90 Unit (NDC 65597-104-90)",Reverified,12/10/19,Available,,,Other,Cardiovascular,Current,,
1509,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 20mg 30 Tabs (NDC 67877-0446-30),New,3/12/19,Availability: TBD,,,Other,Cardiovascular,Current,,
1510,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 20mg 90 Tabs (NDC 67877-0446-90),New,3/12/19,Availability: TBD,,,Other,Cardiovascular,Current,,
1511,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 40mg 30 Tabs (NDC 67877-0447-30),New,3/12/19,Availability: TBD,,,Other,Cardiovascular,Current,,
1512,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 40mg 90 Tabs (NDC 67877-0447-90),New,3/12/19,Availability: TBD,,,Other,Cardiovascular,Current,,
1513,Olmesartan Medoxomil Tablets,Alkem Laboratories,201-476-9445,Olmesartan Medoxomil 5mg 30 Tabs (NDC 67877-0445-30),New,3/12/19,Availability: TBD,,,Other,Cardiovascular,Current,,
1514,Ombitasvir; Paritaprevir; Ritonavir (Technivie) Tablets,Abbvie,800-255-5162,212.5mg; 75mg; 50mg (NDC 0074-3082-28),New,5/22/18,,"Estimated product availability until January 1, 2019. The product discontinuation is voluntary",,,Antiviral,To be Discontinued,5/22/18,5/22/18
1515,Omega-3-Acid Ethyl Esters,Par Pharmaceutical,800-828-9393,"900 mg/1 unit capsule, liquid filled (NDC 49884-019-08)",New,5/10/19,,Par has made a business decision to discontinue the drug product.,,,Gastroenterology,To be Discontinued,5/10/19,5/10/19
1516,Omega-3-Acid Ethyl Esters,Par Pharmaceutical,800-828-9393,900mg/1 unit capsule (NDC 0254-3010-08),New,5/10/19,,Par has made a business decision to discontinue the drug product.,,,Gastroenterology,To be Discontinued,5/10/19,5/10/19
1517,Omeprazole Delayed-Release 40 mg Capsules,Teva Pharmaceuticals,800-545-8800,"Omeprazole 40 mg Capsule, Delayed Release Pellets (NDC 0093-5294-56), (30 count Bottle)",New,7/17/19,,Teva made a business decision to discontinue product.,,,Gastroenterology,To be Discontinued,7/17/19,7/17/19
1518,Omeprazole Delayed-Release 40 mg Capsules,Teva Pharmaceuticals,800-545-8800,"Omeprazole 40 mg Capsule, Delayed Release Pellets (NDC (0093-5294-98) (90 count Bottle)",New,7/17/19,,Teva made a business decision to discontinue product.,,,Gastroenterology,To be Discontinued,7/17/19,7/17/19
1519,Omeprazole Delayed-Release 40 mg Capsules,Teva Pharmaceuticals,800-545-8800,"Omeprazole 40 mg Capsule, Delayed Release Pellets (NDC 0093-5294-10) (1000 count Bottle )",New,7/17/19,,Teva made a business decision to discontinue product.,,,Gastroenterology,To be Discontinued,7/17/19,7/17/19
1520,Ondansetron Hydrochloride Injection,Gland Pharma,609-250-7990,"2 mg/mL, 2 mL vial (NDC 72266-123-25)",Reverified,12/16/19,Available,Distributed by Fosun Pharma USA Inc. Company Contact Information:  833-291-9645,,Available,Gastroenterology,Current,,
1521,Ondansetron Hydrochloride Injection,Gland Pharma,609-250-7990,"2 mg/mL, 20 mL vial (NDC 72266-124-01)",Reverified,12/16/19,Available,Distributed by Fosun Pharma USA Inc. Company Contact Information:  833-291-9645,,Available,Gastroenterology,Current,,
1522,Ondansetron Hydrochloride Injection,Baxter Healthcare,800-229-0001,"Ondansetron Injection, USP (2 mg/mL) 2 mL Single Use Glass Vial (25 x 2 mL) (NDC 36000-012-25)",Reverified,12/11/19,Available,For IV or IM injection,,,Gastroenterology,Current,,
1523,Ondansetron Hydrochloride Injection,Gland Pharma,609-250-7990,2 mg/mL 2mL vial (NDC 70860-776-02),Reverified,12/16/19,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Gastroenterology,Current,,
1524,Ondansetron Hydrochloride Injection,Gland Pharma,609-250-7990,2 mg/mL 20mL vial (NDC 70860-777-20),Reverified,12/16/19,Available,"Marketed by Athenex. To order, contact Athenex at 855-273-0154",,Available,Gastroenterology,Current,,
1525,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, amber vial, 4 mg per 2 mL (NDC 63323-373-02)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
1526,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Multi dose, amber vial, 40 mg per 20 mL (NDC 63323-374-20)",Reverified,12/20/19,Backordered.  Next release January 2020.,,,Demand increase for the drug,Gastroenterology,Current,,
1527,Ondansetron Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, Simplist syringe, 4 mg per 2 mL (NDC 76045-103-20)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
1528,Ondansetron Hydrochloride Injection,Apotex Corp.,800-706-5575,Ondansetron 2mg/mL 2mL vials Box of 25 vials (NDC 60505-6130-05),Reverified,11/27/19,Available,,,Available,Gastroenterology,Current,,
1529,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"Inj4mg/2mL, 25 (NDC 23155-549-31)",Revised,11/20/19,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
1530,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,PPRx4mg/2mL (NDC 23155-548-41),Revised,11/20/19,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
1531,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,PPRx4mg/2mL (NDC 23155-548-42),Revised,11/20/19,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
1532,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 20 mL vial (NDC 0143-9890-01)",Revised,10/9/19,Inventory is currently available.,Additional lots are scheduled for manufacturing in the October – November 2019 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
1533,Ondansetron Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 2 mL vial, 25 count (NDC 55150-125-02)",Reverified,12/11/19,"Currently on backorder, next shipment expected Dec. 2019",Intermittent availability expected,,Demand increase for the drug,Gastroenterology,Current,,
1534,Ondansetron Hydrochloride Injection,Heritage Pharma,866-901-1230,"4mg/2mL, 10 (NDC 23155-547-41 )",Revised,11/20/19,Product is available,,,Demand increase for the drug,Gastroenterology,Current,,
1535,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-4759-01),Reverified,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: December 2019,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1536,Ondansetron Hydrochloride Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"2 mg/mL, 2 mL vial (NDC 0641-6078-25)",Revised,10/9/19,Inventory is currently available,Additional lots are scheduled for manufacturing in the October – November 2019 timeframe.  Product will be made available as it is released.,,Demand increase for the drug,Gastroenterology,Current,,
1537,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-4755-03),Reverified,12/20/19,Available,,,Other,Gastroenterology,Current,,
1538,Ondansetron Hydrochloride Injection,"Hospira, Inc.",844-646-4398,4 mg/2 mL (2 mg/mL); iSecure Luer Lock Glass Syringe (NDC 00409-1120-12),Reverified,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1539,Ondansetron Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,"2 mg/mL, 20 mL vial, 1 count (NDC 55150-126-20)",Reverified,12/11/19,"Currently on backorder, next shipment expected Dec. 2019",Intermittent availability expected,,Demand increase for the drug,Gastroenterology,Current,,
1540,Ondansetron Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"EQ 2MG BASE/ML, INJECTION, SOLUTION,20 mL Vials, (NDC 0703-7226-03)",New,10/12/18,,This was a business-related decision to discontinue manufacturing these products,,,Gastroenterology,To be Discontinued,10/12/18,10/12/18
1541,Ondansetron Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"EQ 2MG BASE/ML, INJECTION, SOLUTION, 20 mL Vial, (NDC 0703-7226-01)",New,10/12/18,,This was a business-related decision to discontinue manufacturing these products,,,Gastroenterology,To be Discontinued,10/12/18,10/12/18
1542,Ondansetron Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"EQ 2MG BASE/ML, INJECTION, SOLUTION, 2 mL Vial, (NDC 0703-7221-04)",New,10/12/18,,This was a business-related decision to discontinue manufacturing these products,,,Gastroenterology,To be Discontinued,10/12/18,10/12/18
1543,Ondansetron Hydrochloride Injection,Teva Pharmaceuticals,800-545-8800,"EQ 2MG BASE/ML, INJECTION, SOLUTION,  2 mL Vial, (NDC 0703-7221-01)",New,10/12/18,,This was a business-related decision to discontinue manufacturing these products,,,Gastroenterology,To be Discontinued,10/12/18,10/12/18
1544,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,40mg/20mL EA 1 Vial (NDC 25021-782-20),Reverified,12/20/19,Available,,,,Gastroenterology,Current,,
1545,Ondansetron Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,4mg/2mL PK 25 Vials (NDC 25021-777-02),Reverified,12/20/19,Available,,,,Gastroenterology,Current,,
1546,Orphenadrine Citrate Injection,Teva Pharmaceuticals,800-545-8800,30mg/mL injection (NDCs 0591-3222-47 and 0591-3222-02),New,10/25/18,,This product discontinuation is a business-related decision.,,,Analgesia/Addiction,To be Discontinued,10/25/18,10/25/18
1547,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-6605-01)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
1548,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 500 count bottle (NDC 0378-6605-05)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
1549,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-6610-01)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
1550,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 500 count bottle (NDC 0378-6610-05)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
1551,Oxybutynin Chloride Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"15 mg, 100 count bottle (NDC 0378-6615-01)",New,5/2/19,,,,,Neurology;Pediatric;Urology,To be Discontinued,5/2/19,5/2/19
1552,Oxybutynin Chloride Extended-Release Tablets,Impax Laboratories,877-835-5472,"5 mg, 100 count bottle (NDC 0093-5206-01)",New,3/29/19,,"Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.",,,Neurology;Pediatric;Urology,To be Discontinued,3/29/19,3/29/19
1553,Oxybutynin Chloride Extended-Release Tablets,Impax Laboratories,877-835-5472,"10 mg, 100 count bottle (NDC 0093-5207-01)",New,3/29/19,,"Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.",,,Neurology;Pediatric;Urology,To be Discontinued,3/29/19,3/29/19
1554,Oxybutynin Chloride Extended-Release Tablets,Impax Laboratories,877-835-5472,"15 mg, 100 count bottle (NDC 0093-5208-01)",New,3/29/19,,"Distributed by Teva Pharmaceuticals, 1-800-545-8800. Teva made a business decision to discontinue product.",,,Neurology;Pediatric;Urology,To be Discontinued,3/29/19,3/29/19
1555,Oxycodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,30 mg/1 unit (NDC 0228-2879-11),New,11/7/19,,Teva made a business decision to discontinue manufacture of the drug product.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,11/7/19,11/7/19
1556,Oxycodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,15 mg/1 unit (NDC 0228-2878-11),New,11/7/19,,Teva made a business decision to discontinue manufacture of the drug product.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,11/7/19,11/7/19
1557,Oxycodone Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,5 mg/1 unit (NDC 0228-2876-11),New,11/7/19,,Teva made a business decision to discontinue manufacture of the drug product.,,,Analgesia/Addiction;Anesthesia,To be Discontinued,11/7/19,11/7/19
1558,Oxymorphone Hydrochloride,Teva Pharmaceuticals,800-545-8800,5 mg/1 unit (NDC 0093-5861-01),New,6/10/19,,Business related decision to discontinue these products,,,Analgesia/Addiction;Anesthesia,To be Discontinued,6/10/19,6/10/19
1559,Oxymorphone Hydrochloride,Teva Pharmaceuticals,800-545-8800,10 mg/1 unit (NDC 0093-5862-01),New,6/10/19,,Business related decision to discontinue these products,,,Analgesia/Addiction;Anesthesia,To be Discontinued,6/10/19,6/10/19
1560,"Oxytocin (Pitocin) Synthetic Injection, USP",Par Pharmaceutical,800-828-9393,Pitocin Single Pack 10 mL Vial (NDC 42023-116-01),New,11/1/19,,Par has made a business decision to permanently discontinue the drug product.,,,Reproductive,To be Discontinued,11/1/19,11/1/19
1561,"Oxytocin Injection, USP Synthetic","Fresenius Kabi USA, LLC",888-386-1300,100 USP Units per 10 mL (10 USP units per mL); Multiple dose vial;  (NDC 63323-012-10),Revised,12/20/19,Available,Check wholesalers for inventory,,Delay in manufacturing,Reproductive,Current,,
1562,"Oxytocin Injection, USP Synthetic","Fresenius Kabi USA, LLC",888-386-1300,300 USP Units per 30 mL (10 USP Units per mL); Multiple dose vial; (NDC 63323-012-30),Revised,12/20/19,Backordered.  Next release January 2020.,,,Delay in manufacturing,Reproductive,Current,,
1563,"Oxytocin Injection, USP Synthetic","Fresenius Kabi USA, LLC",888-386-1300,10 USP Units per mL (10 USP units per mL); (NDC 63323-012-01)( NDC 63323-0012-11),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory for both NDC's,,Delay in manufacturing,Reproductive,Current,,
1564,"Oxytocin Injection, USP Synthetic",Par Pharmaceutical,800-828-9393,"Packages of six 50 mL Pharmacy Bulk Packages, each containing 10 units of oxytocin per mL (total = 500 units of oxytocin per vial), (NDC 42023-130-06)",Revised,12/16/19,Available,,,,Reproductive,Current,,
1565,"Oxytocin Injection, USP Synthetic",Par Pharmaceutical,800-828-9393,"Packages of twenty-five oversized 1-mL vials, each containing 10 units of oxytocin, (NDC 42023-116-25)",Revised,12/16/19,"On backorder at this time due to increased demand, new material will be released in January 2020",,,,Reproductive,Current,,
1566,"Oxytocin Injection, USP Synthetic",Par Pharmaceutical,800-828-9393,"Packages of twenty-five 10 mL multiple-dose vial, each containing 10 units of oxytocin per mL (total = 100 units of oxytocin per vial) (NDC 42023-116-02)",Revised,12/16/19,"On backorder at this time due to increased demand, new material will be released in January 2020.",,,,Reproductive,Current,,
1567,"Paclitaxel Injection, USP",Mylan Institutional,800-796-9526,"100 mg in 16.7 mL (6 mg/mL), multi-dose vial (NDC 67457-449-17)",New,11/22/19,,19-Dec,,,Oncology,To be Discontinued,11/22/19,11/22/19
1568,"Paclitaxel Injection, USP",HQ Specialty Pharma,201-857-8290,30 mg/5 mL (NDC 44567-504-1),New,7/3/19,,Distributed by WG Critical Care. Discontinuance: no longer commercially viable,,,Oncology,To be Discontinued,7/3/19,7/3/19
1569,"Paclitaxel Injection, USP",HQ Specialty Pharma,201-857-8290,100 mg/16.7 mL (NDC 44567-505-1),New,7/3/19,,Distributed by WG Critical Care. Discontinuance: no longer commercially viable,,,Oncology,To be Discontinued,7/3/19,7/3/19
1570,"Paclitaxel Injection, USP",HQ Specialty Pharma,201-857-8290,300 mg/50 mL (6 mg/mL)(NDC 44567-506-1),New,7/3/19,,Distributed by WG Critical Care. Discontinuance: no longer commercially viable,,,Oncology,To be Discontinued,7/3/19,7/3/19
1571,Pantoprazole Sodium for Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"40 mg, 10 vials (NDC 0143-9284-10)",Revised,12/13/19,Available,,,Demand increase for the drug,Gastroenterology,Current,,
1572,Pantoprazole Sodium for Injection,Aurobindo Pharma,888-238-7880,"40 mg, 10 vials (NDC 55150-202-10)",Reverified,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology,Current,,
1573,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-0923-55)",Reverified,12/20/19,Next delivery: December 2019; Estimated recovery: March 2020,Please check with wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1574,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-0923-60)",Reverified,12/20/19,Next delivery: December 2019; Estimated recovery: March 2020,Please check with wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1575,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-2001-10; Amerinet)",Reverified,12/20/19,Next delivery: December 2019; Estimated recovery: March 2020,Please check with wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1576,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-2001-25; Amerinet)",Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: March 2020,Please check with wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1577,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 10 vials (NDC 0008-4001-10; PremierPro)",Reverified,12/20/19,Next delivery: December 2019; Estimated recovery: March 2020,Please check with wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1578,Pantoprazole Sodium for Injection,Pfizer Pharmaceuticals,800-533-4535,"40 mg, 25 vials (NDC 0008-4001-25; PremierPro)",Reverified,12/20/19,Next delivery: December 2019; Estimated recovery: March 2020,Please check with wholesaler for available inventory. Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology,Current,,
1579,Pantoprazole Sodium for Injection,Sun Pharmaceutical Industries Inc.,800-818-4555,"40 mg, 10 vials (NDC 62756-129-44)",New,10/29/19,Available,,,,Gastroenterology,Current,,
1580,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,25mcg Cartridge: (NDC 68875-0202-1); Carton: (NDC 68875-0202-2) (contains 2 cartridges),Reverified,12/18/19,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
1581,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,50mcg   Cartridge: (NDC 68875-0203-1); Carton: (NDC 68875-0203-2) (contains 2 cartridges),Reverified,12/18/19,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
1582,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,75mcg   Cartridge: (NDC 68875-0204-1); Carton: (NDC 68875-0204-2) (contains 2 cartridges),Reverified,12/18/19,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
1583,Parathyroid Hormone (Natpara) Injection,Takeda Pharmaceuticals USA Inc.,866-888-0660,100mcg   Cartridge: (NDC 68875-0205-1); Carton: (NDC 68875-0205-2) (contains 2 cartridges),Reverified,12/18/19,To be determined.  Takeda is actively working to resolve the issue and resume supply.  Updates will be provided on an ongoing basis.,Important Information Regarding a Temporary Special Use Program for Obtaining and Using NATPARA® (Parathyroid Hormone) for Injection,,Requirements related to complying with good manufacturing processes,Endocrinology/Metabolism,Current,,
1584,Pegademase bovine (Adagen) Injection,"Leadiant Biosciences, Inc.",301-670-5450,ADAGEN (pegademase bovine) Injection 250 units per mL (NDC 57665-001-01),New,1/18/19,,"The discontinuation of the manufacture of Adagen is due to the permanent shortage of the active ingredient. The discontinuation of the product is not due to product quality, safety, or efficacy concerns. Based on the demand in mid-January 2019, the inventory is estimated to runout by late-March 2019. Physicians can continue to treat ADA-SCID patients with another approved treatment for ADA-SCID.",,,Other;Pediatric,To be Discontinued,1/18/19,1/18/19
1585,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 200 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4347-01)",New,2/28/18,,This presentation will be discontinued on or near December 2019. For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
1586,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 300 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4348-01)",New,2/28/18,,This presentation will be discontinued on or near December 2019. For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
1587,Peginterferon alfa-2b (Sylatron),Merck Sharp & Dohme Corp.,800-672-6372,"SYLATRON (peginterferon alfa-2b) A box containing one 600 mcg per vial of SYLATRON powder and one 5 mL vial of Sterile Water for Injection, USP, 2 B-D Safety Lok syringes with a safety sleeve and 2 alcohol swabs. (NDC 0085-4349-01)",New,2/28/18,,This presentation will be discontinued on or near December 2018.  For additional information please contact the Merck National Service Center Telephone Number: 1-800-672-6372,,,Oncology,To be Discontinued,2/28/18,2/28/18
1588,PEGINTRON (peginterferon alfa-2b) Injection,Merck Sharp & Dohme Corp.,800-672-6372,"PEGINTRON injection (peginterferon alfa-2b) 50 mcg per 0.5 mL; box containing one 50 mcg per 0.5 mL vial of PEGINTRON Powder for Injection and one 5 mL vial of Diluent (Sterile Water for Injection USP), 2 BD Safety Lok syringes with a safety sleeve and 2 alcohol swabs (NDC 00085-4353-01)",New,9/12/19,,To be discontinued on or near May 2021,,,Antiviral;Oncology,To be Discontinued,9/12/19,9/12/19
1589,Penicillamine (Depen) Titratable Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"Penicillamine tablets, 250 mg (NDC 0037-4401-01)",Revised,10/1/19,,,,,Endocrinology/Metabolism;Gastroenterology;Inborn Errors;Pediatric;Renal;Rheumatology,Resolved,10/1/19,
1590,Pentamidine Isethionate (Nebupent) For Inhalation Solution,"Fresenius Kabi USA, LLC",888-386-1300,"300 mg per vial, SDV, PF (NDC 63323-877-15)",Revised,9/13/19,,,,,Anti-Infective,Resolved,9/13/19,
1591,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 100s (NDC 0378-0357-01)",New,5/8/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/8/18,5/8/18
1592,Pentoxifylline Extended-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"400 mg, 500s (NDC 0378-0357-05)",New,5/8/18,,The discontinuation of this product is a business decision,,,Cardiovascular,To be Discontinued,5/8/18,5/8/18
1593,Peritoneal Dialysis Solutions,Baxter Healthcare,888-229-0001,Peritoneal Dialysis Solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD) therapy (Dianeal and Extraneal),Reverified,12/11/19,Available.  Please see link.,,,,Pediatric;Renal,Current,,
1594,Peritoneal Dialysis Solutions,Baxter Healthcare,888-229-0001,Peritoneal Dialysis Solutions for Automated Peritoneal Dialysis (APD) therapy (Dianeal and Extraneal),Reverified,12/11/19,Available. Please see link.,,,,Pediatric;Renal,Current,,
1595,Peritoneal Dialysis Solutions,Fresenius Medical Care North America,800-323-5188,Peritoneal Dialysis Solutions (Delflex and Stay Safe),New,8/8/14,Available,,,Other,Pediatric;Renal,Current,,
1596,Phenobarbital Oral Solution,Torrent Pharma Inc.,908-280-3333,1 pint 473mL (NDC 16571-330-16),New,11/25/19,,,,,Neurology,To be Discontinued,11/25/19,11/25/19
1597,"Phenytoin Sodium Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 2 mL vial (NDC 0641-0493-25)",Revised,9/3/19,,,Available,,Neurology,Resolved,9/3/19,
1598,"Phenytoin Sodium Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 5 mL vial (NDC 0641-2555-45)",Revised,9/3/19,,,Available,,Neurology,Resolved,9/3/19,
1599,"Physostigmine Salicylate Injection, USP",Akorn Pharmaceuticals,800-932-5676,"Physostigmine Salicylate Injection, USP  1mg/mL (10amps/box, 2mL each) (NDC 17478-510-02)",Revised,12/2/19,Available,,,Other,Neurology,Current,,
1600,Pimozide (Orap) Tablets,Teva Pharmaceuticals,800-545-8800,1 mg tablet (NDC 57844-151-01),New,12/18/18,,This was a business-related decision to discontinue manufacturing this product.,,,Psychiatry,To be Discontinued,12/18/18,12/18/18
1601,Pimozide (Orap) Tablets,Teva Pharmaceuticals,800-545-8800,2 mg tablet (NDC 57844-198-01),New,12/18/18,,This was a business-related decision to discontinue manufacturing this product.,,,Psychiatry,To be Discontinued,12/18/18,12/18/18
1602,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0781-9210-95) Novaplus",Reverified,12/18/19,Available,,,,Anti-Infective;Pediatric,Current,,
1603,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0781-9214-95) Novaplus",Reverified,12/18/19,Available,,,,Anti-Infective;Pediatric,Current,,
1604,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0781-9213-95) Novaplus",Reverified,12/18/19,Available,,,,Anti-Infective;Pediatric,Current,,
1605,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"3.375 g, single dose vial, box of 10 (NDC 0781-9350-95) Novaplus",Reverified,12/16/19,Permanently discontinued,"Marketed by Sandoz, Inc.",,,Anti-Infective;Pediatric,Current,,
1606,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 2.25 g/50 mL, frozen IV bag (NDC 0206-8860-02)",Reverified,12/20/19,Available,,,,Anti-Infective;Pediatric,Current,,
1607,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 3.375 g/50 mL, frozen IV bag (NDC 0206-8861-02)",Reverified,12/20/19,Available,,,,Anti-Infective;Pediatric,Current,,
1608,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 4.5 g/100 mL, frozen IV bag (NDC 0206-8862-02)",Reverified,12/20/19,Next Delivery and Estimated Recovery: December 2019,,,,Anti-Infective;Pediatric,Current,,
1609,Piperacillin and Tazobactam (Zosyn) Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),"3.375 g, single dose vial, box of 10 (NDC 67457-522-37)",Reverified,11/26/19,Available,,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
1610,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"2.25 g, single dose vial, box of 10 (NDC 55150-119-30)",Reverified,12/10/19,Available,Marketed by AuroMedics Pharma LLC. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1611,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"3.375 g, single dose vial, box of 10 (NDC 55150-120-30)",Reverified,12/10/19,Available,Marketed by AuroMedics Pharma LLC. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1612,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"4.5 g, single dose vial, box of 10 (NDC 55150-121-50)",Reverified,12/10/19,Available,Marketed by AuroMedics Pharma LLC. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1613,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 63323-309-20)",Reverified,12/16/19,Available,"Marketed by Fresenius Kabi USA, LLC. Check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1614,Piperacillin and Tazobactam (Zosyn) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"3.375 g, single dose vial, box of 10 (NDC 63323-983-21)",Revised,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
1615,Piperacillin and Tazobactam (Zosyn) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"4.5 g, single dose vial, box of 10 (NDC 63323-0982-52)",Revised,12/20/19,Available,Check wholesalers for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
1616,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"40.5 g, pharmacy bulk bottle (NDC 63323-304-74)",Reverified,12/16/19,Available,"Marketed by Fresenius Kabi USA, LLC. Check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1617,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0409-3374-02) ADD-Vantage",Reverified,12/18/19,Next Delivery: September 2019; Estimated Recovery: October 2019,Marketed by Hospira. Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
1618,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn 2.25 g, single dose vial, box of 10 (NDC 0206-8852-16)",Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2020,Shortage per manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
1619,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 3.375 g, single dose vial, box of 10 (NDC 0206-8854-16)",Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
1620,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 4.5 g, single dose vial, box of 10 (NDC 0206-8855-16)",Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
1621,Piperacillin and Tazobactam (Zosyn) Injection,Pfizer Pharmaceuticals,800-533-4535,"Zosyn; 40.5 g, pharmacy bulk vial (NDC 0206-8859-10)",Reverified,12/20/19,Next Delivery and Estimated Recovery: March 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Anti-Infective;Pediatric,Current,,
1622,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"2.25 g, single dose vial, box of 10 (NDC 25021-164-30)",Reverified,12/10/19,Available,"Marketed by Sagent Pharmaceuticals. To order, contact Sagent at 1-866-625-1618.",,,Anti-Infective;Pediatric,Current,,
1623,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"3.375 g, single dose vial, box of 10 (NDC 25021-165-30)",Reverified,12/10/19,Available,"Marketed by Sagent Pharmaceuticals. To order, contact Sagent at 1-866-625-1618.",,,Anti-Infective;Pediatric,Current,,
1624,Piperacillin and Tazobactam (Zosyn) Injection,Aurobindo Pharma,888-238-7880,"4.5 g, single dose vial, box of 10 (NDC 25021-166-48)",Reverified,12/10/19,Available,"Marketed by Sagent Pharmaceuticals. To order, contact Sagent at 1-866-625-1618.",,Manufacturing delay,Anti-Infective;Pediatric,Current,,
1625,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 44567-801-10)",Reverified,12/16/19,Available,"Marketed by WG Critical Care. Product continues to be manufactured, please check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1626,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"3.375 g, single dose vial, box of 10 (NDC 44567-802-10)",Reverified,12/16/19,Available,"Marketed by WG Critical Care. Product continues to be manufactured, please check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1627,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"4.5 g, single dose vial, box of 10 (NDC 44567-803-10)",Reverified,12/16/19,Available,"Marketed by WG Critical Care. Product continues to be manufactured, please check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1628,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"40.5 g, pharmacy bulk bottle (NDC 44567-804-01)",Reverified,12/16/19,Available,"Marketed by WG Critical Care. Product continues to be manufactured, please check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1629,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0781-3114-95)",Reverified,12/18/19,Available,,,,Anti-Infective;Pediatric,Current,,
1630,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0781-3113-95)",Reverified,12/18/19,Available,,,,Anti-Infective;Pediatric,Current,,
1631,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0781-3110-95)",Reverified,12/18/19,Available,,,,Anti-Infective;Pediatric,Current,,
1632,Piperacillin and Tazobactam (Zosyn) Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),"4.5 g, single dose vial, box of 10 (NDC 67457-523-45)",Reverified,11/26/19,Available,,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
1633,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 0781-3344-95)",Reverified,12/16/19,Permanently discontinued,"Marketed by Sandoz, Inc.",,,Anti-Infective;Pediatric,Current,,
1634,Piperacillin and Tazobactam (Zosyn) Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),"2.25 g, single dose vial, box of 10 (NDC 67457-521-22)",Reverified,11/26/19,Available,,,,Anti-Infective;Pediatric,Current,,
1635,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"3.375 g, single dose vial, box of 10 (NDC 0781-3350-95)",Reverified,12/16/19,Permanently discontinued,"Marketed by Sandoz, Inc.",,,Anti-Infective;Pediatric,Current,,
1636,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"4.5 g, single dose vial, box of 10 (NDC 0781-3367-95)",Reverified,12/16/19,Permanently discontinued,"Marketed by Sandoz, Inc.",,,Anti-Infective;Pediatric,Current,,
1637,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"4.5 g, single dose vial, box of 10 (NDC 0781-9367-95) Novaplus",Reverified,12/16/19,Permanently discontinued,"Marketed by Sandoz, Inc.",,,Anti-Infective;Pediatric,Current,,
1638,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 0781-9344-95) Novaplus",Reverified,12/16/19,Permanently discontinued,"Marketed by Sandoz, Inc.",,,Anti-Infective;Pediatric,Current,,
1639,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"2.25 g, single dose vial, box of 10 (NDC 39822-0123-2)",Revised,12/11/19,Available - Less than one year dating,"Marketed by X-GEN Pharmaceuticals, Inc. Check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1640,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"4.5 g, single dose vial, box of 10 (NDC 39822-0127-6)",Revised,12/11/19,Available - Less than one year dating,"Marketed by X-GEN Pharmaceuticals, Inc. Check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1641,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"40.5 g, pharmacy bulk vial (NDC 39822-0139-7)",Revised,12/11/19,Available - Less than one year dating,"Marketed by X-GEN Pharmaceuticals, Inc. To order, contact X-GEN at 1-866-390-4411",,,Anti-Infective;Pediatric,Current,,
1642,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"3.375 g, single dose vial, box of 10 (NDC 39822-0125-4)",Revised,12/11/19,Available - Less than one year dating,"Marketed by X-GEN Pharmaceuticals, Inc. Check wholesalers for inventory.",,,Anti-Infective;Pediatric,Current,,
1643,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"4.5 g, single dose vial, box of 10 (NDC 64679-012-01)",Revised,12/12/19,Stock sold out and new batches on backorder until week of 12/23/2019,,,,Anti-Infective;Pediatric,Current,,
1644,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"4.5 g, single dose vial (NDC 64679-012-02)",Revised,12/12/19,Stock sold out and new batches on backorder until week of 12/23/2019,,,,Anti-Infective;Pediatric,Current,,
1645,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"2.25 g, single dose vial, box of 10 (NDC 64679-034-01)",Revised,12/12/19,"Stock sold out. Product has arrived, will be available for sale wk of 12/9/19",,,,Anti-Infective;Pediatric,Current,,
1646,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"2.25 g, single dose vial (NDC 64679-034-02)",Revised,12/12/19,"Stock sold out. Product has arrived, will be available for sale wk of 12/9/19",,,,Anti-Infective;Pediatric,Current,,
1647,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"3.375 g, single dose vial, box of 10 (NDC 61990-0120-2)",Revised,12/11/19,Available,Marketed by Apollo Pharmaceuticals Inc. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1648,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"13.5 g, pharmacy bulk vial (NDC 61990-0140-2)",Revised,12/11/19,Available,Marketed by Apollo Pharmaceuticals Inc. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1649,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"40.5 g, pharmacy bulk vial (NDC 61990-0150-2)",Revised,12/11/19,Available,Marketed by Apollo Pharmaceuticals Inc. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1650,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"3.375 g, single dose vial, box of 10 (NDC 70860-121-30)",Reverified,12/16/19,Available,"To order, contact Athenex at 855-273-0154",,,Anti-Infective;Pediatric,Current,,
1651,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"4.5 g, single dose vial, box of 10 (NDC 70860-122-50)",Reverified,12/16/19,Available,"To order, contact Athenex at 855-273-0154",,,Anti-Infective;Pediatric,Current,,
1652,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"40.5 g, pharmacy bulk bottle (NDC 70860-123-99)",Reverified,12/16/19,Available,"To order, contact Athenex at 855-273-0154",,,Anti-Infective;Pediatric,Current,,
1653,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0409-3378-13) ADD-Vantage",Reverified,12/18/19,Available,Marketed by Hospira.,,,Anti-Infective;Pediatric,Current,,
1654,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0409-3379-04) ADD-Vantage",Reverified,12/18/19,Available,Marketed by Hospira.,,,Anti-Infective;Pediatric,Current,,
1655,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"2.25 g, single dose vial, box of 10 (NDC 0409-3383-02)",Reverified,12/18/19,Available,Marketed by Hospira.,,,Anti-Infective;Pediatric,Current,,
1656,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"3.375 g, single dose vial, box of 10 (NDC 0409-3385-13)",Reverified,12/18/19,Available,Marketed by Hospira.,,,Anti-Infective;Pediatric,Current,,
1657,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"4.5 g, single dose vial, box of 10 (NDC 0409-3390-04)",Reverified,12/18/19,Available,Marketed by Hospira.,,,Anti-Infective;Pediatric,Current,,
1658,Piperacillin and Tazobactam (Zosyn) Injection,Sandoz,800-525-8747,"13.5 g, pharmacy bulk bottle (NDC 0409-2999-14)",Reverified,12/18/19,Available,Marketed by Hospira.,,,Anti-Infective;Pediatric,Current,,
1659,Piperacillin and Tazobactam (Zosyn) Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2.25 g, single-dose vial (NDC 63323-981-21)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory.,,Demand increase for the drug,Anti-Infective;Pediatric,Current,,
1660,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"3.375 g, single dose vial, box of 10 (NDC 64679-056-01)",Revised,12/12/19,"Stock sold out. Product has arrived, will be available for sale wk of 12/9/19",,,,Anti-Infective;Pediatric,Current,,
1661,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"3.375 g, single dose vial (NDC 64679-056-02)",Revised,12/12/19,"Stock sold out. Product has arrived, will be available for sale wk of 12/9/19",,,,Anti-Infective;Pediatric,Current,,
1662,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"40.5 g, pharmacy bulk vial (NDC 64679-0679-01)",Revised,12/12/19,No backorder,,,,Anti-Infective;Pediatric,Current,,
1663,Piperacillin and Tazobactam (Zosyn) Injection,Wockhardt,800-346-6854,"40.5 g, pharmacy bulk vial, box of 10 (NDC 64679-0679-02)",Revised,12/12/19,No backorder,,,,Anti-Infective;Pediatric,Current,,
1664,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"2.25 g, single dose vial, box of 10 (NDC 61990-0110-2)",Revised,12/11/19,Available,Marketed by Apollo Pharmaceuticals Inc. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1665,Piperacillin and Tazobactam (Zosyn) Injection,Apollo Pharmaceuticals Inc.,800-881-3550,"4.5 g, single dose vial, box of 10 (NDC 61990-0130-2)",Revised,12/11/19,Available,Marketed by Apollo Pharmaceuticals Inc. Check wholesalers for inventory.,,,Anti-Infective;Pediatric,Current,,
1666,Piperacillin and Tazobactam (Zosyn) Injection,Istituto Biochimico Italiano SpA,information pending,"2.25 g, single dose vial, box of 10 (NDC 70860-120-20)",Reverified,12/16/19,Available,"To order, contact Athenex at 855-273-0154",,,Anti-Infective;Pediatric,Current,,
1667,Piperacillin and Tazobactam (Zosyn) Injection,"Qilu Tianhe Pharmaceutical Co., Ltd.",,"2.25 g, single dose vial, box of 10 (NDC 60505-6156-4)",Reverified,10/30/19,Available,"Marketed by Apotex Corp. To order, contact Apotex at 800-706-5575.",,,Anti-Infective;Pediatric,Current,,
1668,Piperacillin and Tazobactam (Zosyn) Injection,"Qilu Tianhe Pharmaceutical Co., Ltd.",,"3.375 g, single dose vial, box of 10 (NDC 60505-6157-4)",Reverified,10/30/19,Available,"Marketed by Apotex Corp. To order, contact Apotex at 800-706-5575.",,,Anti-Infective;Pediatric,Current,,
1669,Piperacillin and Tazobactam (Zosyn) Injection,"Qilu Tianhe Pharmaceutical Co., Ltd.",,"4.5 g, single dose vial, box of 10 (NDC 60505-6159-4)",Reverified,10/30/19,Available,"Marketed by Apotex Corp. To order, contact Apotex at 800-706-5575.",,,Anti-Infective;Pediatric,Current,,
1670,"Polyethylene Glycol 3350 Powder, for Oral Solution",Perrigo Pharmaceuticals,866-634-9120,"Polyethylene Glycol Powder for solution 17G  (NDC 0574-0412-07, 0574-0412-05, 0574-0412-02)",New,12/6/18,,,,,Gastroenterology,To be Discontinued,12/6/18,12/6/18
1671,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3294-51)",Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1672,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"40 mEq/mL (2 mEq/mL), Single Dose Plastic Fliptop Vial (NDC 00409-8183-01)",Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1673,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"100 mEq/50 mL (2 mEq/mL), Pharmacy Bulk Package Glass Fliptop Vial NovaPlus (NDC 00409-3294-25)",Revised,12/20/19,Limited Supply Available. Next Delivery and Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1674,"Potassium Acetate Injection, USP","Hospira, Inc.",844-646-4398,"40 mEq/mL (2 mEq/mL), Single Dose Plastic Fliptop Vial NovaPlus (NDC 00409-8183-25)",Revised,12/20/19,Next Delivery: February 2020; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1675,"Potassium Acetate Injection, USP","Exela Pharma Sciences, LLC",828-758-5474,Potassium Acetate Inj. 40mEq (2mEq/ml) 20mL (NDC 51754-2001-4),Revised,12/10/19,On allocation due to increased demand.,"Please check with wholesaler for availability. Additional production underway. Direct shipment to hospitals at 200 vials max per week are available from Exela. Customer Service # 828-758-5474, then press #2",,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Current,,
1676,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,10 mEq/50 mL (Legacy Hospira NDC 0409-7075-14) (ICU Medical NDC 0990-7075-14),Revised,6/21/19,,,Available,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1677,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,"20 mEq/100 mL (Legacy Hospira NDC 0409-7075-26)
(ICU Medical NDC 0990-7075-26)",Revised,6/21/19,,,Available,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1678,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 0.45% NaCl (NDC 0409-9257-39),Revised,6/21/19,,,Available,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1679,Potassium Chloride Injection,"Hospira, Inc.",844-646-4398,10 mEq/5 mL (2 mEq/mL); Single Dose Glass Fliptop Vial (NDC 00409-6635-01),Revised,6/21/19,,,Available,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1680,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,30 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0673-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1681,Potassium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mEq/mL, 5 mL vials, (NDC 63323-0965-05)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1682,Potassium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mEq/mL, 10 mL vials, (NDC 63323-0965-10)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1683,Potassium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mEq/mL, 15 mL vials, (NDC 63323-0965-15)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1684,Potassium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mEq/mL, 20 mL vials, (NDC 63323-0965-20)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1685,Potassium Chloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mEq/mL, 30 mL vials, (NDC 63323-0967-30)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1686,Potassium Chloride Injection,B. Braun Medical Inc.,800-227-2862,250mL Potassium Chloride Injection Concentrate (2 mEq K/mL)(NDC 0264-1940-20),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1687,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,10 mEq/100 mL in sterile water (NDC 00338-0709-48),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1688,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/100 mL in sterile water (NDC 00338-0705-48),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1689,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,40 mEq/100 mL in sterile water (NDC 00338-0703-48),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1690,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/50 mL in sterile water (NDC 00338-0703-41),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1691,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,10 mEq/50 mL in sterile water (NDC 00338-0705-41),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1692,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in lactated ringers and dextrose 5% (NDC 00338-0811-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1693,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0803-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1694,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0691-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1695,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,40 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0675-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1696,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in 5% dextrose (NDC 00338-0683-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1697,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,40 mEq/1000 mL in 0.9% sodium chloride (NDC 00338-0695-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1698,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0671-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1699,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,"20 mEq/L in 5% dextrose and 0.45% sodium chloride, 500 mL (NDC 00338-0671-03)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1700,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in 0.45% sodium chloride (NDC 00338-0704-34),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1701,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,40 mEq/1000 mL in 5% dextrose and 0.9% sodium chloride (NDC 00338-0807-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1702,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,"20 mEq/L in 5% dextrose and 0.2% sodium chloride, 500 mL (NDC 00338-0663-03)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1703,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,20 mEq/1000 mL in 5% dextrose and 0.2% sodium chloride (NDC 00338-0663-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1704,Potassium Chloride Injection,Baxter Healthcare,888-229-0001,10 mEq/1000 mL in 5% dextrose and 0.45% sodium chloride (NDC 00338-0669-04),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1705,Potassium Chloride Injection,"Hospira, Inc.",844-646-4398,20 mEq/10 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6651-06),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1706,Potassium Chloride Injection,"Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-6653-05),Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1707,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,"10 mEq/100 mL (Legacy Hospira NDC 0409-7074-26)
(ICU Medical NDC 0990-7074-26)",Revised,6/21/19,,,Available,,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1708,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/50 mL (NDC 0409-7077-14),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1709,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,40 mEq/100 mL (NDC 0409-7077-26),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1710,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,40 mEq/1000 mL (NDC 0409-7116-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1711,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 0.9% NaCl (NDC 0409-7115-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1712,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 5% dextrose (NDC 0409-7905-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1713,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 5% Dex/Lact Ringers (NDC 0409-7111-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1714,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,"10 mEq/ 500 mL in 5% dex 0.45% NaCl
(NDC 0409-7902-03)",Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1715,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,"20 mEq/1000 mL in 5% dex& 0.225% NaCl
(NDC 0409-7901-09)",Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1716,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7902-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1717,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,30 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7903-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1718,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,40 mEq/1000 mL in 5% dex& 0.45% NaCl (NDC 0409-7904-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1719,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,10 mEq/1000 mL in 5% dex & 0.45% NaCl (NDC 0409-7993-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1720,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,20 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7107-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1721,Potassium Chloride Injection,"ICU Medical, Inc.",877-946-7747,40 mEq/1000 mL in 5% dex & 0.9% NaCl (NDC 0409-7109-09),Revised,6/21/19,,,Available,Other,Gastroenterology;Endocrinology/Metabolism;Pediatric;Total Parenteral Nutrition,Resolved,6/21/19,
1722,Potassium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 15 mmol per 5 mL, Potassium 22 mEq per 5 mL,single dose vial (NDC 63323-086-05)",Revised,5/23/19,,,Available,,Endocrinology/Metabolism;Gastroenterology,Resolved,5/23/19,
1723,Potassium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 45 mmol per 15 mL, Potassium 66 mEq per 15 mL, single dose vial (NDC 63323-086-15)",Revised,5/23/19,,,Available,,Endocrinology/Metabolism;Gastroenterology,Resolved,5/23/19,
1724,Potassium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 150 mmol per 50 mL, Potassium 220 mEq per 50 mL, single dose vial (NDC 63323-086-50)",Revised,5/23/19,,,Available,,Endocrinology/Metabolism;Gastroenterology,Resolved,5/23/19,
1725,Potassium Phosphate Injection,"Hospira, Inc.",844-646-4398,Phosphorus 45mM per 15mL; Single Dose Glass Fliptop Vial (NDC 00409-7295-01),Revised,5/29/19,,,Available,,Endocrinology/Metabolism;Gastroenterology,Resolved,5/29/19,
1726,Pramipexole Dihydrochloride (Mirapex) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.25 mg tablets (NDCs 0597-0184-61 and 0597-0184-90),New,11/6/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,11/6/18,11/6/18
1727,Pramipexole Dihydrochloride (Mirapex) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.125 mg tablets (NDC 0597-0183-90),New,11/6/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,11/6/18,11/6/18
1728,Pramipexole Dihydrochloride (Mirapex) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.5 mg tablets (NDCs 0597-0185-61 and 0597-0185-90),New,11/6/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,11/6/18,11/6/18
1729,Pramipexole Dihydrochloride (Mirapex) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,0.75 mg tablets (NDC 0597-0101-90),New,11/6/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,11/6/18,11/6/18
1730,Pramipexole Dihydrochloride (Mirapex) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,1 mg tablets (NDCs 0597-0190-61 and 0597-0190-90),New,11/6/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,11/6/18,11/6/18
1731,Pramipexole Dihydrochloride (Mirapex) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",800-542-6257,1.5 mg tablets (NDCs 0597-0191-61 and 0597-0191-90),New,11/6/18,,This product discontinuation is a business related decision.,,,Neurology,To be Discontinued,11/6/18,11/6/18
1732,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (Pred Forte) (NDC 11980-180-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1733,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1734,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,10 mL in 15 mL bottle (NDC 60758-119-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1735,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (NDC 60758-119-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1736,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 5mL in 1 bottle (NDC 61314-637-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1737,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 10mL in 1 bottle (NDC 61314-637-10),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1738,Prednisolone Acetate 1% Ophthalmic Suspension,Novartis,888-669-6682,Prednisolone Acetate Suspension 1% 15mL in 1 bottle (NDC 61314-637-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1739,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,15 mL in 15 mL bottle (Pred Forte) (NDC 11980-180-15),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1740,Prednisolone Acetate 1% Ophthalmic Suspension,Allergan,800-678-1605,5 mL in 10 mL bottle (NDC 60758-119-05),Revised,10/31/19,,,,,Ophthalmology,Resolved,10/31/19,
1741,"Primaquine Phosphate Tablet, EQ 15mg Base",Sanofi,800-633-1610,"Primaquine; Film-coated tablet, 15 mg/1 unit, bottles of 100, (NDC 0024-1596-01)",Revised,12/10/19,,,,,Anti-Infective,Resolved,12/10/19,
1742,"Primaquine Phosphate Tablet, EQ 15mg Base",Bayshore Pharmaceuticals,973-315-1819,"Primaquine Phosphate USP,  26.3 mg (15mg base)Tablets, (NDC 76385-102-01), 100 Count Bottle",Revised,12/10/19,,,,,Anti-Infective,Resolved,12/10/19,
1743,"Primidone Tablets, USP",Par Pharmaceutical,800-828-9393,"50mg, count bottle (NDC 0603-5371-21)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,4/9/19,4/9/19
1744,"Primidone Tablets, USP",Par Pharmaceutical,800-828-9393,"50mg, count bottle (NDC 0603-5371-28)",New,4/9/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Neurology,To be Discontinued,4/9/19,4/9/19
1745,"Procainamide Hydrochloride Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,100 mg/1 mL injection; 10 mL Luer-Jet Prefilled Syringe (NDC 76329-3399-5),Reverified,12/16/19,Available,,,Other,Cardiovascular;Renal,Current,,
1746,"Procainamide Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,"1,000 mg/10 mL (100 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1902-01)",Reverified,12/20/19,Available,,,Other,Cardiovascular;Renal,Current,,
1747,"Procainamide Hydrochloride Injection, USP","Hospira, Inc.",844-646-4398,"1,000 mg/2 mL (500 mg/mL); Multiple Dose Glass Fliptop Vial (NDC 00409-1903-01)",Reverified,12/20/19,Next Delivery and Estimated Recovery: January 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Cardiovascular;Renal,Current,,
1748,"Procainamide Hydrochloride Injection, USP","Nexus Pharmaceuticals, Inc.",888-806-4606,"500 mg/mL, 2 mL (NDC 14789-900-02)",New,10/19/17,Available,,,Other,Cardiovascular;Renal,Current,,
1749,"Procainamide Hydrochloride Injection, USP","Nexus Pharmaceuticals, Inc.",888-806-4606,"100 mg/mL, 10 mL (NDC 14789-900-10)",New,10/19/17,Available,,,Other,Cardiovascular;Renal,Current,,
1750,"Progesterone Injection, USP",Teva Pharmaceuticals,800-545-8800,50MG 1X10ML (NDC 0591-3128-79),Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
1751,"Progesterone Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"500 mg per 10 mL, MDV (NDC 63323-0261-10)",Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
1752,"Progesterone Injection, USP","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 10 mL (NDC 0143-9725-01)",Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
1753,"Progesterone Injection, USP",AuroMedics Pharma LLC (mfd. by Eugia Pharmaceutical Specialities Ltd.),888-238-7880,500 mg/10 mL multiple dose vial (NDC 55150-306-10),Revised,9/23/19,,,,,Endocrinology/Metabolism,Resolved,9/23/19,
1754,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL vial (NDC 0641-0928-25)",Revised,12/13/19,Available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1755,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL ,1 mL vial (NDC 0641-0929-25)",Revised,12/13/19,Available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1756,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"25 mg/mL, 1 mL ampul (NDC 0641-1495-35)",Revised,12/13/19,Available,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1757,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"50 mg/mL, 1 mL ampul (NDC 0641-1496-35)",Revised,12/13/19,On backorder.,Additional lots are scheduled to be manufactured.  Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1758,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL vial (NDC 0641-6084-25)",Revised,12/13/19,Available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1759,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL ,1 mL vial (NDC 0641-6085-25)",Revised,12/13/19,Available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1760,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 25 mg/mL, 1 mL ampul (NDC 0641-6082-25)",Revised,12/13/19,Available,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1761,Promethazine (Phenergan) Injection,"Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"PHENERGAN Injection 50 mg/mL, 1 mL ampul (NDC 0641-6083-25)",Revised,12/13/19,On backorder.,Additional lots are scheduled to be manufactured. Product will be made available as it is released.,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1762,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"25 mg/mL, Carton of 25 ampuls (NDC 39822-5525-3)",Reverified,12/11/19,Available,,,Demand increase for the drug,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1763,Promethazine (Phenergan) Injection,"X-GEN Pharmaceuticals, Inc.",866-390-4411,"50 mg/mL, Carton of 25 ampuls (NDC 39822-5550-6)",Reverified,12/11/19,Available,,,Other,Analgesia/Addiction;Gastroenterology;Pediatric;Pulmonary/Allergy,Current,,
1764,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 1 vial Single-Dose (NDC 0703-2191-01)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
1765,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL Injection, 1 Vial Single-Dose (NDC 0703-2201-01)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
1766,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"25 mg/1 mL, 25 in 1 tray (NDC 0703-2191-04)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
1767,"Promethazine Hydrochloride Injection, Solution",Teva Pharmaceuticals,800-545-8800,"50 mg/1 mL, 25 in 1 tray (NDC 0703-2201-04)",New,12/19/19,,Teva made a business decision to discontinue this product.,,,Anesthesia;Gastroenterology;Pulmonary/Allergy,To be Discontinued,12/19/19,12/19/19
1768,Promethazine Suppository,Mylan Pharmaceuticals Inc.,800-796-9526,Promethazine Suppositories 12.5mg Bx12 (NDC 40085-218-12),New,12/13/18,,A business decision was made to discontinue manufacture of the drug product,,,Anesthesia;Gastroenterology;Pediatric;Pulmonary/Allergy,To be Discontinued,12/13/18,12/13/18
1769,Promethazine Suppository,Mylan Pharmaceuticals Inc.,800-796-9526,Promethazine Suppositories 25mg Bx12 (NDC 40085-219-12),New,12/13/18,,A business decision was made to discontinue manufacture of the drug product,,,Anesthesia;Gastroenterology;Pediatric;Pulmonary/Allergy,To be Discontinued,12/13/18,12/13/18
1770,Promethazine Suppository,Mylan Pharmaceuticals Inc.,800-796-9526,Promethazine Suppositories 50mg Bx12,New,12/13/18,,A business decision was made to discontinue manufacture of the drug product,,,Anesthesia;Gastroenterology;Pediatric;Pulmonary/Allergy,To be Discontinued,12/13/18,12/13/18
1771,Quinapril Hydrochloride (Accupril) Tablets,Pfizer Pharmaceuticals,800-533-4535,5 mg tablets; 10 x 10 unit dose blisters (NDC 0071-0527-40),New,11/12/19,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,11/12/19,11/12/19
1772,Quinapril Hydrochloride (Accupril) Tablets,Pfizer Pharmaceuticals,800-533-4535,10 mg tablets; 10 x 10 unit dose blisters (NDC 0071-0530-40),New,11/12/19,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,11/12/19,11/12/19
1773,Quinapril Hydrochloride (Accupril) Tablets,Pfizer Pharmaceuticals,800-533-4535,20 mg tablets; 10 x 10 unit dose blisters (NDC 0071-0532-40),New,11/12/19,,Discontinuation of the manufacture of the drug.,,,Cardiovascular,To be Discontinued,11/12/19,11/12/19
1774,Quinidine Gluconate Injection,Eli Lilly and Co.,800-545-5979,"QUINIDINE GLUCONATE, 80 mg/1 mL,10 mL/vial Injectable (NDC 0002-1407-01)",Revised,9/19/19,,Discontinuation of the manufacture of the drug. The product distribution has ceased given the product's labeled expiry of March 2019. FDA and CDC are developing a strategy to ensure continued access to essential medicine for the treatment of severe malaria in the United States.,,,Anti-Infective;Cardiovascular,To be Discontinued,9/19/19,9/19/19
1775,Rabeprazole Sodium Delayed-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 30 count bottle (NDC 0378-6709-93)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
1776,Rabeprazole Sodium Delayed-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 90 count bottle (NDC 0378-6709-77)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
1777,Rabeprazole Sodium Delayed-Release Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 500 count bottle (NDC 0378-6709-05)",New,5/2/19,,,,,Gastroenterology,To be Discontinued,5/2/19,5/2/19
1778,"Ranitidine Injection, USP",Mylan Institutional,800-796-9526,"Ranitidine Injection 25 mg/mL, 2ml vial; 10 pack; (NDC 67457-397-99)",Revised,12/19/19,Unavailable.,,,,Gastroenterology,Current,,
1779,"Ranitidine Injection, USP",Mylan Institutional,800-796-9526,"Ranitidine Injection 25 mg/mL, 6 mL vial; 1 pack; (NDC 67457-398-62)",Revised,12/19/19,Unavailable.,,,,Gastroenterology,Current,,
1780,"Ranitidine Injection, USP",Zydus Pharmaceuticals USA Inc.,609-730-1900,Ranitidine HCl Injection 25mg/mL (10x2mL SD vials)(NDC 68382-422-02),Reverified,12/18/19,Available,,,Other,Gastroenterology,Current,,
1781,"Ranitidine Injection, USP",Zydus Pharmaceuticals USA Inc.,609-730-1900,Ranitidine HCl Injection 25mg/mL (6mL MD vial)(NDC 68382-423-06),Reverified,12/18/19,Unavailable,,,Other,Gastroenterology,Current,,
1782,"Ranitidine Injection, USP","Teligent Pharma, Inc.",856-697-1441,ZANTAC INJECTABLE 25MG/ML 2ML VIAL (NDC 52565-101-01),Reverified,10/29/19,Unavailable,,,Demand increase for the drug,Gastroenterology,Current,,
1783,"Ranitidine Injection, USP","Teligent Pharma, Inc.",856-697-1441,ZANTAC INJECTABLE 25MG/ML 40ML VIAL (NDC 52565-096-01),Reverified,10/29/19,Unavailable,,,Demand increase for the drug,Gastroenterology,Current,,
1784,"Ranitidine Injection, USP","Teligent Pharma, Inc.",856-697-1441,ZANTAC INJECTABLE 25MG/ML 6ML VIAL (NDC 52565-102-01),Reverified,10/29/19,Unavailable,,,Demand increase for the drug,Gastroenterology,Current,,
1785,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,"Fresenius Kabi USA, LLC",888-386-1300,"1 mg per vial, SDV (NDC 63323-723-03)",Reverified,12/20/19,Available,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
1786,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per vial, SDV (NDC 63323-724-05)",Reverified,12/20/19,Available,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
1787,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per vial, SDV (NDC 63323-725-10)",Reverified,12/20/19,Available,Check wholesaler inventory,,Demand increase for the drug,Analgesia/Addiction;Pediatric,Current,,
1788,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),1 mg (NDC 67457-198-03),Reverified,11/26/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
1789,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),2 mg (NDC 67457-198-05),Reverified,11/26/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
1790,Remifentanil (Ultiva) Lyophilized Powder for Solution Injection,Mylan Institutional,800-RXMYLAN (1-800-796- 9526),5 mg (NDC 67457-198-10),Reverified,11/26/19,Available,,,Other,Analgesia/Addiction;Pediatric,Current,,
1791,Repaglinide Tablets,Sandoz,800-525-8747,1mg tablets (NDC 0781-5149-01),New,2/2/18,,,,,Endocrinology/Metabolism,To be Discontinued,2/2/18,2/2/18
1792,Ribavirin (Rebetol) Oral Solution,Merck Sharp & Dohme Corp.,800-672-6372,40 mg/mL (NDC 0085-1318-01),New,4/16/19,,To be discontinued on or near June 2019.,,,Antiviral,To be Discontinued,4/16/19,4/16/19
1793,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,"200 mg (NDCs 66435-101-14, 66435-101-16, 66435-101-18, 66435-101-42, 66435-101-56, 66435-101-70, 66435-101-84, 66435-102-16, 66435-102-95, 54738-950-16)",New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1794,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,400 mg (NDCs 66435-103-56 and 66435-103-95),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1795,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,"600 mg (NDCs 66435-104-56, 66435-104-92, 54738-952-56)",New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1796,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,600 mg dose pack (NDCs 66435-108-56 and 66435-108-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1797,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,800 mg dose pack (NDCs 66435-105-56 and 66435-105-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1798,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,1000 mg dose pack (NDCs 66435-106-56 and 66435-106-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1799,Ribavirin Capsules and Tablets,"Kadmon Pharmaceuticals, LLC",800-405-8506,1200 mg dose pack (NDCs 66435-107-56 and 66435-107-99),New,7/12/19,,,,,Antiviral,To Be Discontinued,7/12/19,7/12/19
1800,Risedronate Sodium Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"150 mg, 1 count blister card (NDC 0378-4150-32)",New,5/2/19,,,,,Other,To be Discontinued,5/2/19,5/2/19
1801,Risedronate Tablets,Allergan Sales LLC,800-678-1605,5 mg tablets (NDC 0430-0471-15),New,12/9/19,,,,,Musculoskeletal,To be Discontinued,12/9/19,12/9/19
1802,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1803,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 4 mg (NDC 50458-595-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1804,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1805,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 3 mg (NDC 50458-594-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1806,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1807,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1808,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 2 mg (NDC 50458-593-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1809,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1810,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1811,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 1 mg (NDC 50458-592-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1812,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1813,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1814,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.5 mg (NDC 50458-591-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1815,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-60),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1816,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1817,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperidone 0.25 mg (NDC 50458-590-10),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1818,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 3 mg (NDC 50458-330-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1819,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 2 mg (NDC 50458-320-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1820,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 1 mg (NDC 50458-300-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1821,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.5 mg (NDC 50458-302-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1822,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-50),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1823,Risperidone Tablets,Janssen Pharmaceuticals,800-526-7736,Risperdal 0.25 mg (NDC 50458-301-01),New,5/24/18,,"Janssen has made a business decision to discontinue all Risperidone Tablet strengths, Risperdal 0.25 mg and various Risperdal pack sizes.",,,Pediatric;Psychiatry,To be Discontinued,5/24/18,5/24/18
1824,Rizatriptan Benzoate Orally Disintegrating Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 9 count bottle (NDC 0378-3701-59)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
1825,Rizatriptan Benzoate Orally Disintegrating Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 9 count bottle (NDC 0378-3702-59)",New,5/2/19,,,,,Neurology;Pediatric,To be Discontinued,5/2/19,5/2/19
1826,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 5mL vial (NDC 70860-651-05),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,11/2/18,
1827,Rocuronium Bromide Injection,"Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,10 mg/mL 10mL vial (NDC 70860-651-10),Revised,11/2/18,Available,,,Available,Anesthesia,Resolved,11/2/18,
1828,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) Tablets, 0.25 mg, 100 count bottles (NDC 0007-4890-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately April 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1829,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) QUIP Tablets, 0.5 mg, 100 count bottles (NDC 0007-4891-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately May 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1830,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) Tablets, 1 mg, 100 count bottles (NDC 0007-4892-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately January 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1831,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) Tablets, 2 mg, 100 count bottles (NDC 0007-4893-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately January 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1832,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) Tablets, 3 mg, 100 count bottles (NDC 0007-4895-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately April 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1833,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) Tablets, 4 mg, 100 count bottles (NDC 0007-4896-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately May 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1834,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) Tablets, 5 mg, 100 count bottles (NDC 0007-4894-20)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately March 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1835,Ropinirole Hydrochloride (Requip) Tablets,GlaxoSmithKline,908-293-5330,"Ropinirole Hydrochloride (Requip) XL Tablets, 2 mg, 30 count bottles (NDC 0007-4885-13)",New,12/19/18,,A business decision was made to discontinue manufacture of the drug product. The anticipated final date of availability to patients is approximately March 2019.,,,Neurology,To be Discontinued,12/19/18,12/19/18
1836,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,4 mg  (NDC 0007-4887-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
1837,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,6 mg  (NDC 0007-4883-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
1838,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,8 mg  (NDC 0007-4888-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
1839,Ropinirole Hydrochloride Extended Release (Requip XL) Tablets,GlaxoSmithKline,888-825-5249,12 mg  (NDC 0007-4882-13),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of REQUIP XL 4 mg is approximately November 2019. The anticipated date that GSK will cease distribution of REQUIP XL 6 mg is approximately April 2020. The anticipated date that GSK will cease distribution of REQUIP XL 8 mg is approximately February 2020. The anticipated date that GSK will cease distribution of REQUIP XL 12 mg is approximately April 2020.,,,Neurology,To be Discontinued,6/28/19,6/28/19
1840,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,0.2% 2mg/mL 10x100mL (NDC 25021-671-82),Reverified,12/20/19,Available,,,,Anesthesia,Current,,
1841,Ropivacaine Hydrochloride Injection,Sagent Pharmaceuticals,866-625-1618,0.2% 2mg/mL 10x200mL (NDC 25021-671-87),Reverified,12/20/19,Available,,,,Anesthesia,Current,,
1842,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,20 mg/10 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-10),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
1843,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,40 mg/20 mL (2 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9300-20),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
1844,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/30 mL (5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9301-30),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
1845,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,150 mg/20 mL (7.5 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9302-20),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: February 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Anesthesia,Current,,
1846,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,100 mg/10 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-10),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
1847,Ropivacaine Hydrochloride Injection,"Hospira, Inc.",844-646-4398,200 mg/20 mL (10 mg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9303-20),Revised,12/20/19,Available,,,Other,Anesthesia,Current,,
1848,Ropivacaine Hydrochloride Injection,Akorn Pharmaceuticals,800-932-5676,"0.5% 5mg/mL, 30mL, 1 Vial (NDC 17478-0081-30)",Reverified,12/2/19,Available,,,Other,Anesthesia,Current,,
1849,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.2% 20 mL Single Dose Vials (NDC 55150-195-20),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1850,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.2% 100 mL Single Dose Infusion Bottles (NDC 55150-196-99),Revised,12/11/19,Currently on backorder,Next shipment expected Feb. 2020,,Demand increase for the drug,Anesthesia,Current,,
1851,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 20 mL Single Dose Vials (NDC 55150-197-20),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1852,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.5% 30 mL Single Dose Vials (NDC 55150-198-30),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1853,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,0.75% 20 mL Single Dose Vials (NDC 55150-199-20),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1854,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 10 mL Single Dose Vials (NDC 55150-200-10),Revised,12/11/19,Short-dated product available exp. Aug. 2020,Next shipment TBD,,Demand increase for the drug,Anesthesia,Current,,
1855,Ropivacaine Hydrochloride Injection,AuroMedics Pharma LLC (mfd. by Aurobindo Pharma Ltd.),888-238-7880,1% 20 mL Single Dose Vials (NDC 55150-201-20),Revised,12/11/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Anesthesia,Current,,
1856,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-10)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1857,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-285-20)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1858,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-286-20)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1859,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-287-20)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1860,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Plastic Ampule, Sterile-Pak (63323-288-10)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1861,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Plastic Ampule, Sterile-Pak (NDC 63323-288-20)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1862,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Free Flex Bag (NDC 63323-285-61)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1863,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Free Flex Bag (NDC 63323-285-63)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1864,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (200 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-285-65)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1865,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (400 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-285-64)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1866,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (500 mg per 100 mL), Single Dose Infusion Bottle (NDC 63323-286-00)",Revised,12/20/19,Backordered. Next release January 2020.,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1867,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (1,000 mg per 200 mL), Single Dose Infusion Bottle (NDC 63323-286-63)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1868,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (20 mg per 10 mL), Single Dose Vial (NDC 63323-285-13)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1869,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"2 mg per mL / 0.2% (40 mg per 20 mL), Single Dose Vial (NDC 63323-285-23)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1870,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Single Dose Vial (NDC 63323-286-35)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1871,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (100 mg per 20 mL), Single Dose Vial (NDC 63323-286-23)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1872,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"7.5 mg per mL / 0.75% (150 mg per 20 mL), Single Dose Vial (NDC 63323-287-21)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1873,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (100 mg per 10 mL), Single Dose Vial (NDC 63323-288-11)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1874,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"10 mg per mL / 1% (200 mg per 20 mL), Single Dose Vial (NDC 63323-288-21)",Revised,12/20/19,Available,Check wholesaler for inventory,,Manufacturing Delay,Anesthesia,Current,,
1875,Ropivacaine Hydrochloride Injection,"Fresenius Kabi USA, LLC",888-386-1300,"5 mg per mL / 0.5% (150 mg per 30 mL), Sterile-Pack, Single Dose Vial (NDC 63323-286-31)",Revised,12/20/19,Backordered. Next release date not available at this time.,,,Manufacturing Delay,Anesthesia,Current,,
1876,Sacrosidase (Sucraid) Oral Solution,"QOL Medical, LLC",772-584-3640,"8,500 I.U./mL 118 mL per bottle, 2 bottles/box  (NDC  67871-111-04)",Revised,5/6/19,,,Available,,Gastroenterology;Inborn Errors,Resolved,5/6/19,
1877,Saquinavir Mesylate (Invirase) 200mg Capsules,"Genentech, Inc",877-436-3683,200 mg capsules (NDC 0004-0245-15),New,2/6/18,,"Roche intends to stop-shipping Saquinavir Mesylate (Invirase) 200 mg Capsules on March 31, 2018 with product availability continuing until the September 2018 expiry date.  Saquinavir Mesylate (Invirase) 500mg Tablets are still available.",,,Antiviral,To be Discontinued,2/6/18,2/6/18
1878,Sclerosol Intrapleural Aerosol,Lymol Medical Corp.,781-935-0004,Sclerosol 4 GM (NDC 63256-100-30),Reverified,12/11/19,Unavailable,,,Other,Pulmonary/Allergy,Current,,
1879,Scopolamine Transdermal System,GlaxoSmithKline,908-293-5330,Transderm (Scopolamine) 1.5 mg Patch 10 count (NDC 10019-553-03),Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1880,Scopolamine Transdermal System,GlaxoSmithKline,908-293-5330,Transderm (Scopolamine) 1.5 mg Patch 24 count (NDC 10019-553-04),Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1881,Scopolamine Transdermal System,GlaxoSmithKline,908-293-5330,Transderm (Scopolamine) 1.5 mg Patch 4 count (NDC 66758-208-54),Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1882,Scopolamine Transdermal System,Perrigo Pharmaceuticals,866-634-9120,"Scopolamine Transdermal System, 1mg/3days 4-Count Pack (NDC 45802-580-84)",Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1883,Scopolamine Transdermal System,Perrigo Pharmaceuticals,866-634-9120,"Scopolamine Transdermal System, 1mg/3days 10-Count Pack (NDC 45802-580-46)",Revised,12/11/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1884,Scopolamine Transdermal System,Perrigo Pharmaceuticals,866-634-9120,"Scopolamine Transdermal System, 1mg/3days 24-Count Pack (NDC 45802-580-62)",Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1885,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 4s (NDC 0378-6470-99),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1886,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 10s (NDC 0378-6470-97),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1887,Scopolamine Transdermal System,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/3 days 24s (NDC 0378-6470-44),Revised,12/10/19,,,,,Endocrinology/Metabolism;Neurology,Resolved,12/11/19,
1888,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/12.5 mL; vial (NDC 0069-0338-01),Revised,10/24/19,, ,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
1889,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,20 mg; tablets (NDC 0069-4190-68),Revised,10/24/19,, ,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
1890,Sildenafil Citrate (REVATIO),Pfizer Pharmaceuticals,800-533-4535,10 mg/mL (powder); bottle (NDC 0069-0336-21),Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
1891,Sildenafil Citrate (REVATIO),Novitium Pharma LLC,845-652-0377,"10 mg/mL, (NDC 70954-168-10)",Revised,10/24/19,,,,,Cardiovascular;Pediatric;Pulmonary/Allergy,Resolved,10/24/19,
1892,Simeprevir Capsules,Janssen Pharmaceuticals,800-526-7736,150mg capsules (NDC 59676-225-28),New,5/23/18,,,,,Antiviral,To be Discontinued,5/23/18,5/23/18
1893,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,5 mg (NDC 0093-7152-98),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
1894,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,10 mg (NDCs 0093-7153-93 / 0093-7153-56 / 0093-7153-19 / 0093-7153-31 / 0093-7153-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
1895,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,20 mg (NDCs 0093-7154-93 / 0093-7154-56 / 0093-7154-31 / 0093-7154-19 / 0093-7154-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
1896,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,40 mg (NDCs 0093-7155-93 / 0093-7155-56 / 0093-7155-31 / 0093-7155-19 / 0093-7155-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
1897,Simvastatin (Zocor) Tablets,Teva Pharmaceuticals,800-545-8800,80 mg (NDCs 0093-7156-98 / 0093-7156-93 / 0093-7156-56 / 0093-7156-19 / 0093-7156-10),New,2/6/18,,Product discontinuation will occur the second quarter of 2018.  This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
1898,Simvastatin (Zocor) Tablets,Merck Sharp & Dohme Corp.,800-637-2579,5 mg Tablets bottles of 30 (NDC 0006-0726-31),New,2/6/18,,,,,Cardiovascular,To be Discontinued,2/6/18,2/6/18
1899,Sincalide (Kinevac) Lyophilized Powder for Injection,Bracco Diagnostics,877-272-2269,Supplied in packages of 10 single dose vials containing 5 mcg of sincalide per vial (NDC 0270-0556-15),Revised,9/18/19,Available,,,Delay in shipping of the drug,Medical Imaging;Other,Current,12/17/15,
1900,"Sodium Acetate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,32.8% 400 mEq 100mL PBP (NDC 63323-0032-00),Revised,12/20/19,Backordered. Next release January 2020.,Check wholesalers for inventory,,Demand increase for the drug,Total Parenteral Nutrition,Current,,
1901,"Sodium Acetate Injection, USP","Hospira, Inc.",844-646-4398,100 mEq/50 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3299-05),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Total Parenteral Nutrition,Current,,
1902,"Sodium Acetate Injection, USP","Hospira, Inc.",844-646-4398,200 mEq/100 mL (2 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-3299-06),Revised,12/20/19,Limited Supply Available. Next Delivery: January 2020; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Total Parenteral Nutrition,Current,,
1903,"Sodium Acetate Injection, USP","Hospira, Inc.",844-646-4398,40 mEq/20 mL (2 mEq/mL); Single Dose Plastic Fliptop Vial (NDC 00409-7299-73),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: March 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Total Parenteral Nutrition,Current,,
1904,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,Neut (Sodium Bicarbonate Additive Solution); 200 mg/5 mL (4%); Single Dose Glass Fliptop Vial (NDC 0409-6609-02),Revised,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1905,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,Infant; 5 mEq/10 mL (4.2%; 0.5 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-5534-34),Revised,12/20/19,Next Delivery: February 2020; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1906,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,44.6 mEq/50 mL (7.5%; 0.9 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-4916-34),Revised,12/20/19,Next Delivery: November 2020; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1907,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,50 mEq/50 mL (8.4%; 1 mEq/mL); Single Dose Glass Fliptop Vial (NDC 0409-6625-02),Revised,12/20/19,Available,,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1908,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,50 mEq/50 mL (8.4%; 1 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-6637-34),Revised,12/20/19,Next Delivery: December 2019; Estimated Recovery: December 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1909,"Sodium Bicarbonate Injection, USP","Hospira, Inc.",844-646-4398,Pediatric; 10 mEq/10 mL (8.4%; 1 mEq/mL); LifeShield Abboject Glass Syringe (NDC 0409-4900-34),Revised,12/20/19,Limited Supply Available. Next Delivery: December 2019; Estimated Recovery: August 2020,Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay,,Other,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1910,"Sodium Bicarbonate Injection, USP","Amphastar Pharmaceuticals, Inc./IMS",800-423-4136,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL Luer-Jet Prefilled Syringe, (NDC 0548-3352-00), (new NDC 76329-3352-1)",Reverified,12/16/19,Intermittent supply,"IMS is releasing product, but market demand continues to exceed our capacity",,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,11/16/16,
1911,"Sodium Bicarbonate Injection, USP","Athenex Pharmaceutical Division, LLC (Athenex)",855-273-0154,"Sodium Bicarbonate Injection, 8.4% (1mEq/mL), 10mL per vial, 10 vials per carton (NDC 71456-001-01)",Reverified,12/16/19,Available,"Due to the current critical shortage of Sodium Bicarbonate Injection, USP in the United States (US) market, Athenex Pharmaceutical Division, LLC (Athenex) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of Sodium Bicarbonate Injection. Athenex has initiated temporary importation of another manufacturer’s 8.4% Sodium Bicarbonate Injection (1 mEq/mL) 10 mL into the U.S. market. This product is manufactured and marketed in Australia by Phebra Pty Ltd (Phebra).",,Available,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
1912,"Sodium Bicarbonate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"4.2% Single dose vial, 2.5 mEq per 5 mL (0.5 mEq per mL) (42 mg per mL)(NDC 63323-083-05)",Revised,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
1913,"Sodium Bicarbonate Injection, USP","Fresenius Kabi USA, LLC",888-386-1300,"8.4% Single dose vial, 50 mEq per 50 mL (1 mEq per mL)  (84 mg per mL)(NDC 63323-089-50)",Revised,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
1914,"Sodium Bicarbonate Injection, USP","Exela Pharma Sciences, LLC",828-758-5474 ext. 154,"Sodium Bicarbonate Inj. USP, 8.4%, 50mL (NDC 51754-5001-1)",Revised,12/13/19,Available direct or through Premier's ProvideGx program at this time and through CIVICA Rx program in Q1 2020.,,,Demand increase for the drug,Endocrinology/Metabolism;Gastroenterology;Pediatric,Current,,
1915,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 50 mL Fleboflex Plastic Container (115 units/carton)(NDC 76297-001-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1916,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 100 mL Fleboflex Plastic Container (70 units/carton)(NDC 76297-001-21)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1917,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 250 mL Fleboflex Plastic Container (28 units/carton)(NDC 76297-001-31)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1918,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 500 mL Fleboflex Plastic Container (20 units/carton)(NDC NDC 76297-001-01)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1919,Sodium Chloride 0.9% Injection Bags,"Laboratorios Grifols, S.A.",800-848-0462,"0.9% Sodium Chloride Injection, USP 1000 mL Fleboflex Plastic Container (10 units/carton)(NDC NDC 76297-001-41)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1920,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL flexible container (Legacy Hospira NDC 0409-7984-23)
(ICU Medical NDC 0990-7984-23)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1921,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Plastic Container.  Single pack (NDC 0338-0049-48, product code 2B1307)Quad Pack (NDC 0338-0049-18, product code 2B1302) Multi Pack (NDC 0338-0049-38, product code 2B1309)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1922,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 50 mL VIAFLEX Plastic Container.  Single Pack (NDC 0338-0049-41, product code 2B1306) Quad Pack (NDC 0338-0049-11, product code 2B1301) Multi Pack (NDC 0338-0049-31, product code 2B1308)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1923,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 25 mL VIAFLEX Plastic Container Quad Pack (NDC 0338-0049-10). Product code 2B1300",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1924,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 50mL (NDC 63323-623-53)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1925,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 100mL (NDC 63323-623-61)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1926,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 250mL (NDC 63323-623-74)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1927,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 500mL (NDC 63323-623-75)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1928,Sodium Chloride 0.9% Injection Bags,"Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, 0.9%, 1000mL (NDC 63323-623-76)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1929,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 50 mL MINI-BAG Plus Container, VIAFLEX Plastic Container Product code 2B0042  (NDC 0338-0553-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1930,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG Plus Container, VIAFLEX Plastic Container Product code 2B0043 (NDC 0338-0553-18)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1931,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,0.9% Sodium Chloride Injection USP 100mL fill in 150mL PAB S8004-5264 (NDC 0264-1800-32),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1932,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,0.9% Sodium Chloride Injection USP 50mL fill in 100mL PAB S8004-5384 (NDC 0264-1800-31),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1933,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,0.9% Sodium Chloride Injection USP 25mL fill in 100mL PAB S8004-5410 (NDC 0264-1800-36),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1934,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,50 mL (5-Pack); ADD-Vantage Flexible Container (NDC 00409-7101-66),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1935,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,100 mL (5-Pack); ADD-Vantage Flexible Container (NDC 00409-7101-67),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1936,Sodium Chloride 0.9% Injection Bags,"Hospira, Inc.",844-646-4398,250 mL (Dual Pack); ADD-Vantage Flexible Container (NDC 00409-7101-02),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1937,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride in Waiter for Injection, 100 mL, in VIAFLEX Container Product code ABB1307U (NDC 0338-9525-72)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1938,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, USP, 1000 mL.  Product code JB1324 (NDC 00338-9612-12)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1939,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 250 mL, in VIAFLEX Container.   Product code FZB1322 (NDC 0338-9517-50)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1940,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 500 mL, in VIAFLEX Container.   Product code FZB1323 (NDC 0338-9517-30)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1941,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"0.9% Sodium Chloride Injection, 1,000 mL, in VIAFLEX Container.   Product code FZB1324 (NDC 0338-9517-16)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1942,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus 1,000 mL Product Code 9999-00, (NDC 0264-9999-00)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1943,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,Sodium Chloride 0.9% w/v Intravenous Infusion BP in the Ecoflac® plus container sizes: 500 mL (NDC 0264-9999-10),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1944,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL flexible container (Legacy Hospira NDC 0409-7984-13)
(ICU Medical NDC 0990-7984-13)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1945,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL flexible container-4 pack (Legacy Hospira NDC 0409-7984-37)
(ICU Medical NDC 0990-7984-37)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1946,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"0.9% NaCl 250mL bag, PVC/DEHP-free (NDC 00264-7800-20)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1947,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"0.9% NaCl 500mL bag, PVC/DEHP-free (NDC 00264-7800-10)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1948,Sodium Chloride 0.9% Injection Bags,B. Braun Medical Inc.,800-227-2862,"0.9% NaCl 1000mL bag, PVC/DEHP-free (NDC 00264-7800-00)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1949,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,150mL flexible container (NDC 0409-7983-61),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1950,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"250mL Vis-IV container, PVC/DEHP-free (NDC 0409-7983-25)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1951,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"250mL flexible container (Legacy Hospira NDC 0409-7983-02)
(ICU Medical NDC 0990-7983-02)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1952,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,250mL flexible container 2 port (NDC 0409-7983-53),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1953,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,500mL flexible container 2 port (NDC 0409-7983-55),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1954,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,500mL flexible container (NDC 0409-7983-03),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1955,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,1000mL flexible container (NDC 0409-7983-09),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1956,Sodium Chloride 0.9% Injection Bags,Fresenius Medical Care North America,800-323-5188,1000ml (NDC 49230-300-10),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1957,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"100 mL Vis-IV container, PVC/DEHP-free (NDC 0409-7984-11)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1958,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL flexible container (Legacy Hospira NDC 0409-7984-36)
(ICU Medical NDC 0990-7984-36)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1959,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,25 mL flexible container (NDC 0409-7984-20),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1960,Sodium Chloride 0.9% Injection Bags,"ICU Medical, Inc.",877-946-7747,"50 mL Vis-IV container, PVC/DEHP-free (NDC 0409-7984-06)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1961,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,250 mL Product code 2B1322Q (NDC 00338-0049-02),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1962,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,500 mL  Product code 2B1323Q (NDC 00338-0049-03),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1963,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"500 mL Non-PVC, Dripless Access Container (DAC)  VIAFLO Container  Product code UE1323D (NDC 0338-9543-04)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1964,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,1000 mL Product code 2B1324X (NDC 00338-0049-04),Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1965,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"1000 mL Non-PVC, Dripless Access Container (DAC)  VIAFLO Container  Product code UE1324D (NDC 0338-9543-06)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1966,Sodium Chloride 0.9% Injection Bags,Baxter Healthcare,888-229-0001,"250 mL, Non-PVC, Dripless Access Container (DAC) VIAFLO Container Product code UE1322D (NDC 0338-9543-02)",Revised,11/13/19,,,,,Gastroenterology;Other;Pediatric,Resolved,11/13/19,
1967,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,30 mL vials (NDC 63323-0187-30),Revised,12/20/19,Available,Check Wholesaler Inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
1968,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,100 mL vials (NDC 63323-0088-61),Revised,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
1969,Sodium Chloride 23.4% Injection,"Fresenius Kabi USA, LLC",888-386-1300,200 mL vials (NDC 63323-0088-63),Revised,12/20/19,Available,Check wholesalers for inventory,,Demand increase for the drug,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
1970,Sodium Chloride 23.4% Injection,"Hospira, Inc.",844-646-4398,400 mEq/100 mL (4 mEq/mL); Pharmacy Bulk Package Glass Fliptop Vial (NDC 00409-1141-02),Revised,12/20/19,Next Delivery and Estimated Recovery: April 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Gastroenterology;Endocrinology/Metabolism;Total Parenteral Nutrition;Pediatric,Current,,
1971,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose plastic vial, 0.9%, (18 mg per 2 mL)(9 mg per mL) (NDC 63323-186-02)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Increase in Demand,Other,Current,,
1972,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (90 mg per 10 mL)(9 mg per mL) (NDC 63323-186-10)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Manufacturing delay,Other,Current,,
1973,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP,  Single dose plastic vial, 0.9%, (180 mg per 20 mL)(9 mg per mL) (NDC 63323-186-20)",Reverified,12/20/19,Available,Check wholesalers for inventory,,Manufacturing delay,Other,Current,,
1974,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Fresenius Kabi USA, LLC",888-386-1300,"Sodium Chloride Injection USP, Single dose tear top vial, 0.9%, (900 mg per 100 mL)(9 mg per mL) (NDC 63323-186-00)",Reverified,12/20/19,Backordered.  Next release date not available at this time.,,,Increase in Demand,Other,Current,,
1975,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose Plastic Fliptop Vial (NDC 00409-4888-10),Reverified,12/20/19,Available,,,Other,Other,Current,,
1976,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,10 mL (0.9%); Single Dose LifeShield Plastic Fliptop Vial (NDC 00409-4888-12),Reverified,12/20/19,Available,,,Other,Other,Current,,
1977,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-20),Reverified,12/20/19,Available,,,Other,Other,Current,,
1978,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Single Dose Plastic Fliptop Vial (NDC 00409-4888-50),Reverified,12/20/19,Available,,,Demand increase for the drug,Other,Current,,
1979,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hikma Pharmaceuticals USA, Inc. (formerly West-Ward)",800-631-2174,"0.9%, 2 mL vial (NDC 0641-0497-25)",Reverified,12/13/19,Inventory is currently available.,Additional lots will be scheduled for manufacturing as needed.  Product will be made available as it is released.,,Demand increase for the drug,Other,Current,,
1980,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Medefil, Inc.",630-682-4600,"Sodium Chloride Injection, USP, 0.9%, in a plastic syringe (10 mL) (NDC 64253-202-30)",Reverified,12/11/19,Available,Check wholesalers for inventory,,Available,Other,Current,,
1981,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-32),Reverified,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Other,Current,,
1982,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-33),Reverified,12/20/19,Next Delivery and Estimated Recovery: August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Other,Current,,
1983,"Sodium Chloride Injection USP, 0.9% Vials and Syringes","Hospira, Inc.",844-646-4398,0.9%; Carpuject Luer Lock Glass Syringe (NDC 00409-1918-35),Reverified,12/20/19,Next Delivery and Estimated Recovery:  August 2020,Shortage per Manufacturer: Manufacturing Delay,,Other,Other,Current,,
1984,Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 15 mmol/mL, 5 mL, Sodium 20 mEq/5mL vials (NDC 63323-170-05)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,8/7/19,
1985,Sodium Phosphate Injection,"Fresenius Kabi USA, LLC",888-386-1300,"Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL (NDC 63323-170-15)",Revised,8/7/19,,,Available,,Endocrinology/Metabolism;Gastroenterology;Pediatric;Total Parenteral Nutrition,Resolved,8/7/19,
1986,Sotalol Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 100 count bottle (NDC 0378-5123-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
1987,Sotalol Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 100 count bottle (NDC 0378-5124-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
1988,Sotalol Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"160 mg, 100 count bottle (NDC 0378-5125-01)",New,5/2/19,,,,,Cardiovascular;Pediatric,To be Discontinued,5/2/19,5/2/19
1989,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 100 (NDC 0228-2803-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
1990,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"25mg tablets, bottle of 500 (NDC 0228-2803-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
1991,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 100 (NDC 0228-2672-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
1992,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"50mg tablets, bottle of 500 (NDC 0228-2672-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
1993,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 100 (NDC 0228-2673-11)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
1994,Spironolactone Tablets,Actavis Elizabeth LLC an indirect wholly owned subsidiary of Teva Pharmaceuticals USA Inc.,800-545-8800,"100mg tablets, bottle of 500 (NDC 0228-2673-50)",New,5/22/18,,"This product discontinuation is a business related decision and not related to product quality, safety or efficacy.",,,Renal,To be Discontinued,5/22/18,5/22/18
1995,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 100 (NDC 0603-5763-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
1996,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 500 (NDC 0603-5763-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
1997,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 1000 (NDC 0603-5763-32)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
1998,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"25 mg, bottle of 2500 (NDC 0603-5763-30)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
1999,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"50 mg, bottle of 100 (NDC 0603-5764-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
2000,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"50 mg, bottle of 500 (NDC 0603-5764-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
2001,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"100 mg, bottle of 100 (NDC 0603-5765-21)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
2002,"Spironolactone Tablets, USP",Par Pharmaceutical,800-828-9393,"100 mg, bottle of 500 (NDC 0603-5765-28)",New,4/19/19,,Par has made a business decision to permanently discontinue the drug product.,,,Cardiovascular,To be Discontinued,4/19/19,4/19/19
2003,Stavudine (Zerit) Powder for Oral Solution,Bristol Myers Squibb Co.,800-332-2056,1mg/mL (NDC 0003-1968-01),New,10/15/18,,,,,Antiviral,To be Discontinued,10/15/18,10/15/18
2004,Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-496-9526,20mg capsules (NDC 0378-5041-91),New,4/30/18,,,,,Antiviral,To be Discontinued,4/30/18,4/30/18
2005,Stavudine Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,40 mg  (NDC0378-5043-91),New,7/17/19,,,,,Antiviral,To be Discontinued,7/17/19,7/17/19
2006,Sterile Talc Powder,Lymol Medical Corp.,781-935-0004,Sterile Talc Powder (NDC 63256-200-05),Revised,6/12/19,,,,,Pulmonary/Allergy,Resolved,6/12/19,
2007,Sterile Talc Powder,Novatech SA,800-433-2674; email: CustomerService@bosmed.com,"STERITALC® (talc), powder, for intrapleural use 2 grams, in a 50 mL single-dose vial (NDC 62327-222-02)",Revised,6/12/19,,,,,Pulmonary/Allergy,Resolved,6/12/19,
2008,Sterile Talc Powder,Novatech SA,800-433-2674; email: CustomerService@bosmed.com,"STERITALC® (talc), powder, for intrapleural use 3 grams, in a 10 mL single-dose vial (NDC 62327-333-03)",Revised,6/12/19,,,,,Pulmonary/Allergy,Resolved,6/12/19,
2009,Sterile Talc Powder,Novatech SA,800-433-2674; email: CustomerService@bosmed.com,"STERITALC® (talc), powder, for intrapleural use 4 grams, in a 50 mL single-dose vial (NDC 62327-444-04)",Revised,6/12/19,,,,,Pulmonary/Allergy,Resolved,6/12/19,
2010,Sterile Water,"Hospira, Inc.",844-646-4398,10 mL; Single Dose Plastic Fliptop Vial (NDC 00409-4887-10),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2011,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose vial, 5 mL fill (NDC 63323-185-05)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2012,Sterile Water,B. Braun Medical Inc.,800-227-2862,Sterile Water for Injection in 250mL EXCEL container (NDC  0264-7850-20),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2013,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP (For Drug Diluent Use Only), 1000 mL VIAFLEX Plastic Container. Product code 2B0304X (NDC 0338-0013-04)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2014,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Injection 1000 mL (NDC 0409-7990-09),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2015,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, plastic vial, 10 mL fill (NDC 63323-185-10)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2016,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, plastic vial, 20 mL fill (NDC 63323-185-20)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2017,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, plastic vial, 50 mL fill (NDC 63323-185-50)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2018,Sterile Water,"Fresenius Kabi USA, LLC",888-386-1300,"Single dose, tear top vial, 100 mL (NDC 63323-185-00)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2019,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP in 2000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package.   Product code 2B0306 (NDC 0338-0013-06)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2020,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP in 3000 mL VIAFLEX Plastic Container. Pharmacy Bulk Package.  Product code 2B0307  (NDC 0338-0013-08)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2021,Sterile Water,Baxter Healthcare,888-229-0001,"Sterile Water for Injection, USP in 5000 mL VIAFLEX Plastic Container, Pharmacy Bulk Package. Product code 2B0309 (NDC 0338-0013-29)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2022,Sterile Water,B. Braun Medical Inc.,800-227-2862,Sterile Water for Injection in 500mL EXCEL container (NDC  0264-7850-10),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2023,Sterile Water,B. Braun Medical Inc.,800-227-2862,"Sterile Water for Injection in 1,000mL EXCEL container  (NDC 0264-7850-00)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2024,Sterile Water,B. Braun Medical Inc.,800-227-2862,"Sterile Water for Injection in 2,000mL Titan container (NDC  0264-7385-50)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2025,Sterile Water,B. Braun Medical Inc.,800-227-2862,"Sterile Water for Injection in 3,000mL Titan container (NDC  0264-7385-60)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2026,Sterile Water,"Hospira, Inc.",844-646-4398,20 mL; Single Dose Plastic Fliptop Vial (NDC 00409-4887-20),Revised,8/2/19,, ,,,Other,Resolved,8/2/19,
2027,Sterile Water,"Hospira, Inc.",844-646-4398,50 mL; Single Dose Plastic Fliptop Vial (NDC 00409-4887-50),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2028,Sterile Water,"Hospira, Inc.",844-646-4398,100 mL; Single Dose Glass Fliptop Vial (NDC 00409-4887-99),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2029,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Injection 2000 mL (NDC 0409-7118-07),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2030,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Irrigation 1000 mL (NDC 0409-7973-05),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2031,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Irrigation 2000 mL (NDC 0409-7973-08),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2032,Sterile Water,"ICU Medical, Inc.",877-946-7747,Sterile Water for Irrigation 2000 mL (NDC 0409-7973-07),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2033,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation USP, 1000 mL Aqualite ™ Plastic Pour Bottle (NDC 0409-7139-09)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2034,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation, USP, Aqualite 500 mL (NDC 0409-6139-03)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2035,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation, USP 1500 mL (NDC 0409-7139-36)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2036,Sterile Water,"ICU Medical, Inc.",877-946-7747,"Sterile Water for Irrigation, USP, Aqualite 250 mL (NDC 0409-6139-22)",Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2037,Sterile Water,American Regent/Luitpold,800-645-1706,5 mL vial (NDC 00517-3005-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2038,Sterile Water,American Regent/Luitpold,800-645-1706,10 mL vial (NDC 00517-3010-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2039,Sterile Water,American Regent/Luitpold,800-645-1706,20 mL vial (NDC 00517-3020-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2040,Sterile Water,West-Ward Pharmaceuticals,800-631-2174,10 mL Single Dose Vial (NDC 0641-6147-25),Revised,8/2/19,,,,,Other,Resolved,8/2/19,
2041,Sumatriptan (Sumavel DosePro) Injection,"Endo Pharmaceuticals, Inc.",800-462-3636,Sumavel DosePro (sumatriptan injection) 6mg/0.5mL (NDC 63481-367-06),New,2/27/18,,A business decision has been made to discontinue Sumavel DosePro 6 mg/0.5mL.,,,Neurology,To be Discontinued,2/27/18,2/27/18
2042,Sumatriptan Succinate Injection,Teva Pharmaceuticals,800-545-8800,6 mg/0.5 mL  (NDC 0703-7351-01),New,12/5/19,,,,,Neurology,To be Discontinued,12/5/19,12/5/19
2043,Tacrolimus Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"0.5 mg, 100s (NDC 0378-2045-01)",Revised,11/26/19,Available,,,,Transplant,Current,,
2044,Tacrolimus Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100s (NDC 0378-2046-01)",Revised,11/26/19,Unavailable. Estimated recovery: November 2019,,,,Transplant,Current,,
2045,Tacrolimus Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100s (NDC 0378-2047-01)",Revised,11/26/19,Unavailable. Estimated recovery: December 2019,,,,Transplant,Current,,
2046,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",0.5 mg 100 count (NDC 1672904101),Reverified,12/12/19,Shortage duration from July 2019 to May 2020. We would be temporarily discontinuing this product until May 2020. We will allocate any product we do have available based on API availability,,,Limited API availability,Transplant,Current,,
2047,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",1 mg 100 count (NDC 1672904201),Reverified,12/12/19,Shortage duration from July 2019 to May 2020. We would be temporarily discontinuing this product until May 2020. We will allocate any product we do have available based on API availability,,,Limited API availability,Transplant,Current,,
2048,Tacrolimus Capsules,Accord Healthcare Inc.,"866-941-7875, option 2",5 mg 100 count (NDC 1672904301),Reverified,12/12/19,Shortage duration from July 2019 to May 2020. We would be temporarily discontinuing this product until May 2020. We will allocate any product we do have available based on API availability,,,Limited API availability,Transplant,Current,,
2049,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 30 count (NDC 68992-3075-3),Revised,8/12/19,Available,,,,Transplant,Current,,
2050,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 0.75 mg Extended-Release Tablets 100 count (NDC 68992-3075-1),Revised,8/12/19,Available,,,,Transplant,Current,,
2051,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 30 count (NDC 68992-3010-3),Revised,8/12/19,Available,,,,Transplant,Current,,
2052,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 1 mg Extended-Release Tablets 100 count (NDC 68992-3010-1),Revised,8/12/19,Available,,,,Transplant,Current,,
2053,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 30 count (NDC 68992-3040-3),Revised,8/12/19,Available,,,,Transplant,Current,,
2054,Tacrolimus Capsules,"Veloxis Pharmaceuticals, Inc.",919-591-3085,Envarsus XR 4 mg Extended-Release Tablets 100 count (NDC 68992-3040-1),Revised,8/12/19,Available,,,,Transplant,Current,,
2055,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,1 mg 100 count bottles (NDC 64338-721-06),Revised,12/2/19,Available,Product available on allocation.,,Demand increase for the drug,Transplant,Current,,
2056,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,0.5 mg 100 count bottles (NDC 64380-720-06),Revised,12/2/19,"Currently, we do not distribute this product strength and NDC. We are evaluating options to potentially re-launch this product strength.",,,,Transplant,Current,,
2057,Tacrolimus Capsules,Strides Pharma Inc.,855-273-0146,5 mg 100 count bottles (NDC 64380-722-06),Revised,12/2/19,"Currently, we do not distribute this product strength and NDC. We are evaluating options to potentially re-launch this product strength.",,,,Transplant,Current,,
2058,Tacrolimus Capsules,Sandoz,800-525-8747,0.5 mg 100 count bottle (NDC 0781-2102-01),Reverified,12/18/19,Available,,,,Transplant,Current,,
2059,Tacrolimus Capsules,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-2103-04),Reverified,12/18/19,Available,,,,Transplant,Current,,
2060,Tacrolimus Capsules,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-2104-01),Reverified,12/18/19,Available,,,,Transplant,Current,,
2061,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 0.5 mg 100 count bottle (NDC 0469-0607-73),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2062,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 5 mg 100 count bottle (NDC 0469-0657-73),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2063,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® (tacrolimus) capsules 1 mg 100 count bottle (NDC 0469-0617-73),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2064,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 0.5 mg 30 count bottle (NDC 0469-0647-73),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2065,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 1 mg 30 count bottle (NDC 0469-0677-73),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2066,Tacrolimus Capsules,Astellas,800-727-7003,ASTAGRAF XL® (tacrolimus extended release capsules) 5 mg 30 count bottle (NDC 0469-0687-73),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2067,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 0.2 mg unit dose packets (NDC 0469-1230-50),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2068,Tacrolimus Capsules,Astellas,800-727-7003,PROGRAF® Granules (tacrolimus for oral suspension) 1 mg unit dose packets (NDC 0469-1330-50),Revised,6/21/19,Available; product under allocation,,,,Transplant,Current,,
2069,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-30),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2070,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-01),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2071,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg (NDC 55111-525-05),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2072,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,0.5 mg unit dose (NDC 55111-525-78),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2073,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-30),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2074,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-01),Reverified,11/7/19,Available,Releasing product as it beceomes available,,,Transplant,Current,,
2075,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg (NDC 55111-526-05),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2076,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,1 mg unit dose (NDC 55111-526-78),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2077,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-30),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2078,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-01),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2079,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg (NDC 55111-527-05),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2080,Tacrolimus Capsules,"Dr. Reddy's Laboratories, Inc.",866-733-3952,5 mg unit dose (NDC 55111-527-78),Reverified,11/7/19,Available,Releasing product as it becomes available,,,Transplant,Current,,
2081,"Talwin (Pentazocine Lactate Injection, USP, CIV)","Hospira, Inc.",844-646-4398,30 mg/mL; 1 mL glass ampul (NDC 00409-1941-01),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Analgesia/Addiction,To be Discontinued,4/16/18,4/16/18
2082,Technetium Tc99m Succimer Injection (DMSA),Theragnostics Inc.,617-286-7479,ROTOP DMSA (Kit for the Preparation of Technetium Tc99m Succimer Injection). One vial contains 1.74 mg powder with the active substance: 1.0 mg succimer.  Five vials included in a carton (NDC 71647-001-01),Reverified,12/10/19,Available,"Due to the current critical shortage of DMSA Kit for the Preparation of Technetium Tc99m Succimer, Theragnostics Inc. (Theragnostics) is coordinating with the U.S. Food and Drug Administration (FDA) to increase the availability of the drug.  Theragnostics has initiated temporary importation of DMSA Kit for the Preparation of Technetium Tc99m Succimer Injection into the U.S. market. This product is marketed in Germany and is manufactured in Dresden, Germany by ROTOP Pharmaka GmbH for Theragnostics.",,Other,Medical Imaging,Current,,
2083,Technetium Tc99m Succimer Injection (DMSA),GE Healthcare,800-292-8514,DMSA Kit for the Preparation of Technetium Tc99m Succimer Injection (NDC 17156-525-01),Revised,12/20/19,,,,,Medical Imaging,To be Discontinued,12/20/19,12/20/19
2084,Telmisartan and Amlodipine (Twynsta) Tablets,"Boehringer Ingelheim Pharmaceuticals, Inc.",203-798-4375,"Telmisartan and Amlodipine (Twynsta) tablets 80mg/10mg, 30 count blister (NDC 0597-0127-37)",New,3/6/18,,"Discontinuation is the result of a business decision made by Boehringer lngelheim Pharmaceuticals, Inc. All other strengths of Twynsta® tablets are still available.",,,Cardiovascular,To be Discontinued,3/6/18,3/6/18
2085,Testosterone Buccal System,"Endo Pharmaceuticals, Inc.",800-462-3636,"Striant® 30 mg, 6 blister cards, 60 buccal system  (NDC 52244-030-60)",New,8/21/19,,Endo has made a business decision to permanently discontinue the drug product.,,,Reproductive,To be Discontinued,8/21/19,8/21/19
2086,Testosterone Gel 1%,Par Pharmaceutical,800-828-9393,"2.5 g, 30 packets (NDC 49884-418-72)",New,4/29/19,,Par has made a business decision to discontinue the drug product.,,,Reproductive,To be Discontinued,4/29/19,4/29/19
2087,Testosterone Gel 1%,Par Pharmaceutical,800-828-9393,"5 g, 30 packets (NDC 49884-510-72)",New,4/29/19,,Par has made a business decision to discontinue the drug product.,,,Reproductive,To be Discontinued,4/29/19,4/29/19
2088,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,50 mg (NDC 0378-0616-01),Revised,11/26/19,Available,,,Other,Psychiatry,Current,,
2089,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,100 mg (NDC 0378-0618-01),Revised,11/26/19,Available,,,Other,Psychiatry,Current,,
2090,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-0612-01),Revised,11/26/19,Available,,,Other,Psychiatry,Current,,
2091,Thioridazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,25 mg (NDC 0378-0614-01),Revised,11/26/19,Available,,,Other,Psychiatry,Current,,
2092,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"1 mg, 100 count bottle (NDC 0378-1001-01)",Revised,11/26/19,Unavailable. Estimated re-supply: March 2020.,,,Other,Psychiatry,Current,,
2093,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"2 mg, 100 count bottle (NDC 0378-2002-01)",Revised,11/26/19,Unavailable. Estimated re-supply: March 2020.,,,Other,Psychiatry,Current,,
2094,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count bottle (NDC 0378-3005-01)",Revised,11/26/19,Available,,,,Psychiatry,Current,,
2095,Thiothixene Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count bottle (NDC 0378-5010-01)",Revised,11/26/19,Available,,,,Psychiatry,Current,,
2096,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"1 mg, 100 count bottle (NDC 70954-014-10)",Reverified,8/15/19,Available ; Will cater to the entire market demand,,,Other,Psychiatry,Current,,
2097,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"2 mg, 100 count bottle (NDC 70954-015-10)",Reverified,8/15/19,Available ; Will cater to the entire market demand,,,Other,Psychiatry,Current,,
2098,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"5 mg, 100 count bottle (NDC 70954-016-10)",Reverified,8/15/19,Available ; Will cater to the entire market demand,,,Other,Psychiatry,Current,,
2099,Thiothixene Capsules,Novitium Pharma LLC,845-652-0377,"10 mg, 100 count bottle (NDC 70954-017-10)",Reverified,8/15/19,Available ; Will cater to the entire market demand,,,Other,Psychiatry,Current,,
2100,Timolol Maleate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"5 mg, 100 count (NDC 0378-0055-01)",Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2101,Timolol Maleate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"10 mg, 100 count (NDC 0378-0221-01)",Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2102,Timolol Maleate Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"20 mg, 100 count (NDC 0378-0715-01)",Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2103,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,4 mg (NDC 0378-0724-19),New,11/21/19,,,,,Neurology,To be Discontinued,11/21/19,11/21/19
2104,Tizanidine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-0722-19),New,11/21/19,,,,,Neurology,To be Discontinued,11/21/19,11/21/19
2105,Tolazamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"250 mg, 100 count bottle (NDC 0378-0217-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
2106,Tolazamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100 count bottle (NDC 0378-0551-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
2107,Tolbutamide Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"500 mg, 100 count bottle (NDC 0378-0215-01)",New,5/2/19,,,,,Endocrinology/Metabolism,To be Discontinued,5/2/19,5/2/19
2108,Tolterodine Tartrate (Detrol LA) Extended Release Capsules,Pfizer Pharmaceuticals,800-533-4535,"2 mg, blisters (NDC 0009-5190-04)",New,10/1/19,,Discontinuation of the manufacture of the drug.,,,Urology,To be Discontinued,10/1/19,10/1/19
2109,Tolterodine Tartrate (Detrol LA) Extended Release Capsules,Pfizer Pharmaceuticals,800-533-4535,"4 mg, blisters (NDC 0009-5191-04)",New,10/1/19,,Discontinuation of the manufacture of the drug.,,,Urology,To be Discontinued,10/1/19,10/1/19
2110,Tositumomab and Iodine I 131 Tositumomab (Bexxar),GlaxoSmithKline,908-293-5330,N/A,Revised,2/18/14,,,"BEXXAR (Tositumomab and Iodine I 131 Tositumomab) is being discontinued.  The product discontinuation is not related to product safety or any FDA action.   BEXXAR will no longer be available effective February 20, 2014.",,Oncology,To Be Discontinued,2/18/14,2/18/14
2111,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"4 mg tablets, 100 count (NDC 16252-543-90)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
2112,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"2 mg tablets, 100 count (NDC 16252-542-90)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
2113,Trandolapril Tablets,Teva Pharmaceuticals,800-545-8800,"1 mg tablets, 100 count (NDC 16252-541-30)",New,4/18/18,,This discontinuation is due to a business decision.,,,Cardiovascular,To be Discontinued,4/18/18,4/18/18
2114,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 30 Tablets per Bottle,  (NDC 60505-3638-3)",New,12/4/19,,Apotex has decided to Discontinue the manufacture of the drug,,,Hematology,To be Discontinued,12/4/19,12/4/19
2115,Tranexamic Acid Tablets,Apotex Corp.,800-706-5575,"Tranexamic Acid 650 mg per Tablet, 100 Tablets per Bottle,  (NDC 60505-3638-1)",New,12/4/19,,Apotex has decided to Discontinue the manufacture of the drug,,,Hematology,To be Discontinued,12/4/19,12/4/19
2116,"Triamcinolone Acetonide (Triesence) Injection, Suspension",Novartis,888-669-6682,Triesence (Triamcinolone acetonide injectable suspension) Vial 40mg/mL 1mL in 1 vial (NDC 0065-0534-01),Revised,12/11/19,Unavailable. Estimated Shortage Duration: December 2019,,,Requirements related to complying with good manufacturing practices,Ophthalmology,Current,,
2117,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg/1g (NDC 40085-029-80),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
2118,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,1mg/1g (NDC 40085-029-16),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
2119,Triamcinolone Acetonide Cream,Mylan Pharmaceuticals Inc.,800-796-9526,0.25mg/1g (NDC 40085-028-80),New,3/20/18,,"The discontinuation of this product is a business decision and not related to product quality, safety or efficacy",,,Dermatology,To be Discontinued,3/20/18,3/20/18
2120,Triamterene and Hydrochlorothiazide (Dyazide) Capsules,GlaxoSmithKline,888-825-5249,25 mg; 37.5 mg (NDC 0007-3650-30),New,6/28/19,,This product discontinuation is a business related decision.  The anticipated date that GSK will cease distribution of the product is approximately October 2019.,,,Cardiovascular,To be Discontinued,6/28/19,6/28/19
2121,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 0781-5068-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2122,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 0781-5068-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2123,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 0781-5067-01)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2124,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 0781-5067-05)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2125,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 100 count bottle (NDC 68001-0216-00)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2126,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 37.5 mg/25 mg, 500 count bottle (NDC 68001-0216-03)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2127,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 100 count bottle (NDC 68001-0215-00)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2128,Triamterene and Hydrochlorothiazide Tablets,Sandoz,800-525-8747,"Triamterene and Hydrochlorothiazide tablets, 75 mg/50 mg, 500 count bottle (NDC 68001-0215-03)",New,2/23/18,,Sandoz Inc. has made a business decision to permanently discontinue Triamterene and Hydrochlorothiazide tablets.,,,Cardiovascular,To be Discontinued,2/23/18,2/23/18
2129,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,1 mg (NDC 0378-2401-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2130,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,2 mg (NDC 0378-2402-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2131,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,5 mg (NDC 0378-2405-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2132,Trifluoperazine Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0378-2410-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2133,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0781-8028-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2134,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,1 mg 100 count bottle (NDC 0832-0494-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2135,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0781-8032-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2136,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,2 mg 100 count bottle (NDC 0832-0495-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2137,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0781-8034-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2138,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,5 mg 100 count bottle (NDC 0832-0496-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2139,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0781-8036-01),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2140,Trifluoperazine Hydrochloride Tablets,Sandoz,800-525-8747,10 mg 100 count bottle (NDC 0832-0497-11),Revised,12/10/19,,,,,Psychiatry,Resolved,12/10/19,
2141,Trifluridine Ophthalmic Solution,Sandoz,800-525-8747,Trifluridine 1% 7.5 mL (NDC 61314-044-75),Revised,12/18/19,"Limited supply available, on allocation, release of recently received stock expected end-4Q2019.",,,Shortage of an active ingredient,Ophthalmology,Current,,
2142,Valacyclovir Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1 gram  (NDCs 0093-7259-98 and 0093-7259-56),New,11/15/19,,This product is being discontinued due to a business decision.,,,Antiviral,To be Discontinued,11/15/19,11/15/19
2143,Valacyclovir Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,500 mg tablets (NDCs 45963-558-30 and 45963-558-08),New,2/21/19,,,,,Antiviral,To be Discontinued,2/21/19,2/21/19
2144,Valacyclovir Hydrochloride Tablets,Teva Pharmaceuticals,800-545-8800,1 G tablets (NDCs 45963-559-30 and 45963-559-08),New,2/21/19,,,,,Antiviral,To be Discontinued,2/21/19,2/21/19
2145,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"40 mg, 30 ct bottle (NDC 65162-837-03); 60 ct bottle (NDC 65162-837-06); 500 ct bottle (NDC 65162-837-50)",New,8/16/18,"Estimated release September 7, 2018",,,Other,Cardiovascular,Current,,
2146,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"80 mg, 90 ct bottle (NDC 65162-838-09); 500 ct bottle (NDC 65162-838-50); 1000 ct bottle (NDC 65162-838-11)",New,8/16/18,"Estimated release September 7, 2018",,,Other,Cardiovascular,Current,,
2147,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"160 mg, 90 ct bottle (NDC 65162-839-09); 500 ct bottle (NDC 65162-839-50); 1000 ct bottle (NDC 65162-839-11)",New,8/16/18,"Estimated release September 7, 2018",,,Other,Cardiovascular,Current,,
2148,Valsartan Tablets,Amneal Pharmaceutical,866-525-7270,"320 mg, 90 ct bottle (NDC 65162-840-09); 500 ct bottle (NDC 65162-840-50); 1000 ct bottle (NDC 65162-840-11)",New,8/16/18,"Estimated release September 7, 2018",,,Other,Cardiovascular,Current,,
2149,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,40 mg (NDC 31722-745-30),Reverified,12/17/19,Currently not marketing this product,Subject to nationwide voluntary recall,,Shortage of an active ingredient,Cardiovascular,Current,,
2150,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,80 mg (NDC 31722-746-90),Reverified,12/17/19,Currently not marketing this product,Subject to nationwide voluntary recall,,Shortage of an active ingredient,Cardiovascular,Current,,
2151,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,160 mg (NDC 31722-746-90),Reverified,12/17/19,Currently not marketing this product,Subject to nationwide voluntary recall,,Shortage of an active ingredient,Cardiovascular,Current,,
2152,Valsartan Tablets,Camber Pharmaceuticals Inc.,866-827-3647,320 mg (NDC 31722-748-90),Reverified,12/17/19,Currently not marketing this product,Subject to nationwide voluntary recall,,Shortage of an active ingredient,Cardiovascular,Current,,
2153,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,40 mg (NDC 51660-140-30),New,8/3/18,Manufacturing resumes from September  2018 dependent on API supplies.,Manufacturing stopped temporarily and currently not supplying.,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2154,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,80 mg (NDC 51660-141-90),New,8/3/18,Manufacturing resumes from September  2018 dependent on API supplies.,Manufacturing stopped temporarily and currently not supplying.,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2155,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,160 mg (NDC 51660-142-90),New,8/3/18,Manufacturing resumes from September  2018 dependent on API supplies.,Manufacturing stopped temporarily and currently not supplying.,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2156,Valsartan Tablets,Ohm Laboratories Inc.,800-818-4555,320 mg (NDC 51660-143-90),New,8/3/18,Manufacturing resumes from September  2018 dependent on API supplies.,Manufacturing stopped temporarily and currently not supplying.,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2157,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 40mg x 30's Bottle Pack (NDC 33342006207),Reverified,6/11/19,Available,,,Available,Cardiovascular,Current,,
2158,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 80mg x 90's Bottle Pack (NDC 33342006310),Reverified,6/11/19,Available,,,Available,Cardiovascular,Current,,
2159,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 160mg x 30's Bottle Pack (NDC 33342006410),Reverified,6/11/19,Available,,,Available,Cardiovascular,Current,,
2160,Valsartan Tablets,Macleods Pharmaceuticals Limited,888-677-0778,Valsartan Tablets 320mg x 30's Bottle Pack (NDC 33342006510),Reverified,6/11/19,Available,,,Available,Cardiovascular,Current,,
2161,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,40mg 30’s (NDC 43547-0367-03),Revised,12/13/19,Currently not marketing this product,,,Other,Cardiovascular,Current,,
2162,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,160mg 90’s (NDC 43547-0369-09),Revised,12/13/19,Currently not marketing this product,"Valsartan tablets are the subject of a nationwide voluntary recall for all lots, which was announced on July 13, 2018.",,Other,Cardiovascular,Current,,
2163,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,80mg 90’s (NDC 43547-0368-09),Revised,12/13/19,Currently not marketing this product,"Valsartan tablets are the subject of a nationwide voluntary recall for all lots, which was announced on July 13, 2018.",,Other,Cardiovascular,Current,,
2164,Valsartan Tablets,"Solco Healthcare US, LLC",866-931-9829,320mg 90’s (NDC 43547-0370-09),Revised,12/13/19,Currently not marketing this product,"Valsartan tablets are the subject of a nationwide voluntary recall for all lots, which was announced on July 13, 2018.",,Other,Cardiovascular,Current,,
2165,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 40 mg. - 30/Bottle (NDC 65862-0570-30),Revised,12/13/19,Temporarily discontinued,,,Demand increase for the drug,Cardiovascular,Current,,
2166,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 80 mg. - 90/Bottle (NDC 65862-0571-90),Revised,12/13/19,Temporarily discontinued,,,Demand increase for the drug,Cardiovascular,Current,,
2167,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 160 mg. - 90/Bottle (NDC 65862-0572-90),Revised,12/13/19,Temporarily discontinued,,,Demand increase for the drug,Cardiovascular,Current,,
2168,Valsartan Tablets,Aurobindo Pharma,732-839-9400,Valsartan Tablets USP 320 mg. - 90/Bottle (NDC 65862-0573-90 ),Revised,12/13/19,Temporarily discontinued,,,Demand increase for the drug,Cardiovascular,Current,,
2169,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,40 mg (30’s) (NDC 0378-5807-93),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2170,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,160 mg (90’s) (NDC 0378-5814-77),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2171,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,80 mg (90’s) (NDC 0378-5813-77),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2172,Valsartan Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,320 mg (90’s) (NDC 0378-5815-77),Reverified,11/26/19,Available,,,Other,Cardiovascular,Current,,
2173,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,40 mg (30's) (NDC 59746-0360-30),Revised,6/17/19,Available,,,Other,Cardiovascular,Current,,
2174,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,80 mg (90's) (NDC 59746-0361-90),Revised,6/17/19,Available,,,Other,Cardiovascular,Current,,
2175,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,160 mg (90's) (NDC 59746-0362-90),Revised,6/17/19,Available,,,Other,Cardiovascular,Current,,
2176,Valsartan Tablets,"Jubilant Cadista Pharmaceuticals, Inc.",800-313-4623,320 mg (90's) (NDC 59746-0363-90),Revised,6/17/19,Available,,,Other,Cardiovascular,Current,,
2177,Valsartan Tablets,Teva Pharmaceuticals,800-545-8800,"Valsartan Tablets, USP 40mg, 90 count, (NDC 0591-2167-19)",New,8/3/18,,This was a business-related decision to discontinue manufacturing these products.,,,Cardiovascular,To be Discontinued,8/3/18,8/3/18
2178,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,40 mg (NDC 13668-067-30),Reverified,12/13/19,Unavailable,Subject to nationwide voluntary recall,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2179,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,80 mg (NDC 13668-068-90),Reverified,12/13/19,Unavailable,Subject to nationwide voluntary recall,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2180,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,160 mg (NDC 13668-069-90),Reverified,12/13/19,Unavailable,Subject to nationwide voluntary recall,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2181,Valsartan Tablets,Torrent Pharma Inc.,908-280-3333,320 mg (NDC 13668-070-90),Reverified,12/13/19,Unavailable,Subject to nationwide voluntary recall,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2182,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® scored tablets 40mg 30s 1 bottle of 30 tablets (NDC 0078-0423-15),Reverified,12/11/19,Available,Novartis’ Diovan Tablets are readily available and currently not in shortage,,Demand increase for the drug,Cardiovascular,Current,,
2183,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® tablets 80mg 1 bottle of 90 tablets (NDC 0078-0358-34),Reverified,12/11/19,Available,Novartis’ Diovan Tablets are readily available and currently not in shortage,,Demand increase for the drug,Cardiovascular,Current,,
2184,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® tablets 160mg 1 bottle of 90 tablets (NDC 0078-0359-34),Reverified,12/11/19,Available,Novartis’ Diovan Tablets are readily available and currently not in shortage,,Demand increase for the drug,Cardiovascular,Current,,
2185,Valsartan Tablets,Novartis,888-669-6682,DIOVAN® tablets 320mg 1 bottle of 90 count (NDC 0078-0360-34),Reverified,12/11/19,Available,Novartis’ Diovan Tablets are readily available and currently not in shortage,,Demand increase for the drug,Cardiovascular,Current,,
2186,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 40 mg 1 bottle of 90 tablets (NDC 0781-5607-31),Reverified,12/11/19,Manufacture of the drug  has been discontinued,Discontinuation of the manufacture of the drug,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2187,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 80 mg 1 bottle of 90 tablets (NDC 0781-5608-92),Reverified,12/11/19,Manufacture of the drug  has been discontinued,Discontinuation of the manufacture of the drug,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2188,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 160 mg 1 bottle of 90 tablets (NDC 0781-5618-92),Reverified,12/11/19,Manufacture of the drug  has been discontinued,Discontinuation of the manufacture of the drug,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2189,Valsartan Tablets,Novartis,888-669-6682,Valsartan Tablets 320 mg 1 bottle of 90 tablets (NDC 0781-5619-92),Reverified,12/11/19,Manufacture of the drug  has been discontinued,Discontinuation of the manufacture of the drug,,Discontinuation of the manufacture of the drug,Cardiovascular,Current,,
2190,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,40 mg bottle of 30 counts (NDC 62332-044-30),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2191,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,40 mg bottle of 90 counts (NDC 62332-044-90),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2192,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,40 mg bottle of 500 counts (NDC 62332-044-71),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2193,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,80 mg bottle of 30 counts (NDC 62332-045-30),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2194,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,80 mg bottle of 90 counts (NDC 62332-045-90),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2195,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,80 mg bottle of 500 counts (NDC 62332-045-71),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2196,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,160 mg bottle of 30 counts (NDC 62332-046-30),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2197,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,160 mg bottle of 90 counts (NDC 62332-046-90),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2198,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,160 mg bottle of 500 counts (NDC 62332-046-71),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2199,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,320 mg bottle of 30 count (NDC 62332-047-30),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2200,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,320 mg bottle of 90 count (NDC 62332-047-90),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2201,Valsartan Tablets,Alembic Pharmaceuticals,908-393-9604,320 mg bottle of 500 counts (NDC 62332-047-71),Revised,12/18/19,Product available to existing customers.,,,Other,Cardiovascular,Current,,
2202,Vardenafil Hydrochloride (Levitra) Tablets,Bayer,888-842-2937,Levitra® (vardenafil HCL) tablets 2.5 mg tablet strength (NDC 0173-0828-13),New,5/15/18,,"Bayer will continue to market the 5 mg, 10 mg and 20 mg tablet strengths.",,,Other;Reproductive,To be Discontinued,5/15/18,5/15/18
2203,Vardenafil Hydrochloride (Levitra) Tablets,Bayer,800-245-1040,"5mg, 30 count (NDC 0173-0829-13)",New,7/25/19,,Bayer will continue to market the 10 mg and 20 mg tablet strengths.,,,Reproductive,To be Discontinued,7/25/19,7/25/19
2204,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"120mg, 100 count, (NDC 0093-3043-01)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
2205,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"180mg, 500 count, (NDC 0093-3044-05)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
2206,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"180mg, 100 count, (NDC 0093-3044-01)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
2207,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"240mg, 100 count, (NDC 0093-3045-01)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
2208,Verapamil HCl Extended-Release Tablets,Teva Pharmaceuticals,800-545-8800,"240mg, 500 count, (NDC 0093-3045-05)",New,2/22/19,,This was a business-related decision to discontinue manufacturing these products,,,Cardiovascular,To be Discontinued,2/22/19,2/22/19
2209,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"100 mg capsule, 100 count bottle (NDC 0378-6201-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2210,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg capsule, 100 count bottle (NDC 0378-6202-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2211,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"200 mg capsule, 500 count bottle (NDC 0378-6202-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2212,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg capsule, 100 count bottle (NDC 0378-6203-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2213,Verapamil Hydrochloride Extended-Release Tablets and Capsules,Mylan Pharmaceuticals Inc.,800-796-9526,"300 mg capsule, 500 count bottle (NDC 0378-6203-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2214,Verapamil Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"80 mg, 100 count bottle (NDC 0378-0512-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2215,Verapamil Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 100 count bottle (NDC 0378-0772-01)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2216,Verapamil Hydrochloride Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,"120 mg, 500 count bottle (NDC 0378-0772-05)",New,5/2/19,,,,,Cardiovascular,To be Discontinued,5/2/19,5/2/19
2217,Vinblastine Sulfate Injection,"Fresenius Kabi USA, LLC",888-386-1300,10 mg per 10 mL (1 mg per mL); MDV (NDC 63323-0278-10),Revised,12/20/19,Available on allocation for direct and drop ship orders.  Please contact customer service (888)-386-1300.  Next release January 2020.,Check wholesalers for inventory,,Manufacturing delays,Oncology,Current,,
2218,"Vincristine Sulfate (VINCASAR PFS) Injection, USP",Teva Pharmaceuticals,800-545-8800,"Vincasar PFS -- vincristine sulfate injection, solution, 1 MG/ 1 ML (NDC 0703-4402-11)",New,7/5/19,,Teva made a business decion to discontinue the product.,,,Oncology,To be Discontinued,7/5/19,7/5/19
2219,"Vincristine Sulfate (VINCASAR PFS) Injection, USP",Teva Pharmaceuticals,800-545-8800,VINCASAR PFS (vincristine sulfate injection USP) 2 mg/2 mL Vial (1 mg/mL) (NDC 0703-4412-11),New,3/20/19,,Teva made a business decision to discontinue this product size (2mL).,,,Oncology,To be Discontinued,3/20/19,
2220,"Vincristine Sulfate Injection, USP (Preservative-Free)","Hospira, Inc.",844-646-4398,1 mg/mL Single Dose Glass Fliptop Vial (NDC 61703-0309-06),Reverified,12/20/19,Next Delivery: December 2019; Estimated Recovery: January 2020,"Shortage per manufacturer: Manufacturing delay. Product available to order and being released for direct shipment to health care providers to meet patient needs. Please contact Pfizer Supply Continuity Team between 7:00am – 6:00pm CT at 1-844-646-4398 (select option 1 [Customer], then option 3 [Supply Continuity Team]), for additional support.",,Other,Oncology,Current,,
2221,"Vincristine Sulfate Injection, USP (Preservative-Free)","Hospira, Inc.",844-646-4398,2 mg/2 mL (1 mg/mL) Single Dose Glass Fliptop Vial (NDC 61703-0309-16),Reverified,12/20/19,Next Delivery and Estimated Recovery: December 2019,"Shortage per manufacturer: Manufacturing delay. November deliveries received. Please check with wholesaler for available inventory. Product available to order for direct shipment to health care providers to meet patient needs. Please contact Pfizer Supply Continuity Team between 7:00am – 6:00pm CT at 1-844-646-4398 (select option 1 [Customer], then option 3 [Supply Continuity Team]), for additional support.",,Other,Oncology,Current,,
2222,Vinorelbine Tartrate Injection,"Pierre Fabre Pharmaceuticals, Inc.",855-737-4276,"10 mg/mL Single Dose Glass, Vial (NDC 64370-532-01)",New,11/8/19,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,11/8/19,11/8/19
2223,Vinorelbine Tartrate Injection,"Pierre Fabre Pharmaceuticals, Inc.",855-737-4276,"50 mg/5mL Single Dose Glass, Vial (NDC 64370-532-02)",New,11/8/19,,"Limited availability; distribution to end December 31, 2019. Discontinuation of the manufacture of the drug.",,,Oncology,To be Discontinued,11/8/19,11/8/19
2224,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-06),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Oncology,To be Discontinued,4/16/18,4/16/18
2225,Vinorelbine Tartrate Injection,"Hospira, Inc.",844-646-4398,10 mg/mL; 50 mg/5mL Single Dose Onco-Tain Glass Fliptop Vial (NDC 61703-0341-09),New,4/16/18,,Discontinuation of the manufacture of the drug.,,,Oncology,To Be Discontinued,4/16/18,4/16/18
2226,Zoledronic Acid (Zometa) Injection,Novartis,888-669-6682,Zometa (zoledronic acid) VIAL 4mg/5mL 5mL in 1 Vial (NDC 0078-0387-25),New,10/29/18,,"Novartis Pharmaceuticals has made a business decision to permanently discontinue commercial sale of the product Zometa Vial 4mg/5mL. Discontinuation of the product is not due to manufacturing, product quality, safety, or efficacy concerns. There are therapeutic equivalents available.",,,Oncology,To be Discontinued,10/29/18,10/29/18
2227,Zoledronic Acid (Zometa) Injection,Novartis,888-669-6682,Zometa (zoledronic acid) VIAL 4mg/100mL 100mL in 1 Vial (NDC 0078-0590-61),New,10/29/18,,"Novartis Pharmaceuticals has made a business decision to permanently discontinue commercial sale of the product Zometa Vial 4mg/100mL. Discontinuation of the product is not due to manufacturing, product quality, safety, or efficacy concerns.There are therapeutic equivalents available.",,,Oncology,To be Discontinued,10/29/18,10/29/18
2228,Zoledronic Acid Injection,Teva Pharmaceuticals,800-545-8800,"0.8 mg/mL, 4 mg 5 mL/Vial (NDC 45963-440-55)",New,5/1/19,,Discontinuation of the manufacture of the drug.,,,Musculoskeletal;Oncology,To be Discontinued,5/1/19,5/1/19
2229,Zolpidem Tartrate (Edluar) Sublingual Tablets,Mylan Pharmaceuticals Inc.,800-796-9526,10 mg (NDC 0037-6010-30),Revised,11/21/18,,,Available,,Psychiatry,Resolved,11/21/18,
2230,Zolpidem Tartrate Extended Release Tablets,Teva Pharmaceuticals,800-545-8800,6.25 mg tablets (NDC 0228-3481-11),New,2/22/19,,,,,Psychiatry,To be Discontinued,2/22/19,2/22/19
2231,Zolpidem Tartrate Tablets,Wockhardt,800-346-6854,5 mg  (NDCs 64679-0714-01 and 64679-0714-04),New,7/18/19,,,,,Psychiatry,To be Discontinued,7/18/19,7/18/19
2232,Zolpidem Tartrate Tablets,Wockhardt,800-346-6854,10 mg  (NDCs 64679-0715-01 and 64679-0715-04),New,7/18/19,,,,,Psychiatry,To be Discontinued,7/18/19,7/18/19